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ABSTRACT OF THE DISSERTATION 
 
The Psycho-Economic Model of Ecstasy Consumption and related Consequences:  
A Multi-Site Study with Community Samples 
by 
Arbi Ben Abdallah 
Doctor of Philosophy in Economics 
Washington University in St. Louis, 2011 
Professor Robert P. Parks, Chairperson 
 
The consumption of mind-altering drugs is well recognized as a complex 
behavior entailing many different etiological precursors. To understand its 
complexity, drug use has to be considered from multiple perspectives. Over time, 
numerous theories have been advanced to explain drug use, the pattern of its use, and 
its related consequences. Because they approach such a behavior from slightly 
different vantage points, these theories offer unique explanations with different take 
on its genetic, physiological, psychological, and environment risk factors. A 
substantial body of research suggests that there exist multiple perspectives on 
psychological precursors to drug abuse; however, the same literature also implicates 
economic measures that can explain drug etiology. Economic models of consumption 
suggest that "market forces" adequately explain the use of drugs. Market forces alone 
are however necessary but not sufficient to account for drug consumption. Other 
  iii
factors that appear involved include psychological motivation and other intra-
individual characteristics (i.e., depression and risk-taking) that also explain use and 
problems arising from drug use. Until now, the confluence of both economic and 
psychological theories has not been tested empirically. The present study used latent-
variable Structural equation modeling to examine the influence of both economic 
(social anomie, monetary price, opportunity cost) and psychological risk factors 
(motivation, depression, and risk-taking) on self-reported Ecstasy use and its related 
consequences, referred to as dependence. Data used in this research were obtained 
from 640 recreational Ecstasy users between 2002 and 2005 in three sites in the 
United States and Australia participating in a NIDA-funded nosological study 
examining trends in club drug use. The sample was mainly Caucasian (62%), male 
(58%), and young [mean age =23years (SD=5.01)]. All the hypothesized latent 
constructs were statistically reliable and correlated in the expected direction. A Full 
“saturated” model indicated that, among the three key economic measures, monetary 
and opportunity cost, but not income, significantly predicted Ecstasy consumption. 
On the other hand, among the psychological measures, motivational cues were the 
strongest predictors of both consumption and dependence. Dependence was also 
impacted by depression and sex-risk. Inclusion of demographic measures (gender, 
age, race, and education) and site location did not appreciably alter the final model 
parameters. Findings are discussed with regard to incorporating the role of economic 
and psychological factors in shaping a more refined understanding of Ecstasy 
consumption and its consequences.   
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CHAPTER I:  INTRODUCTION 
 
Throughout history, mankind has sought ways to alter its consciousness with 
the use of natural herbal products and derivatives of native plants. The most common 
parts of plants used to create medicinal potions and concoctions have been leaves, 
roots, and seeds. Even without knowing their medicinal properties or their 
pharmacological action, many ancient societies used a variety of plants for their 
soothing effects, inducing relaxation, and even their psychotropic effects. Some of the 
more popular forms of native plants that possess mind-altering properties include 
cannabis, coca, datura, ergot, khat, mescal, opium, and peyote.  
With time, and advances made primarily through pharmacology, chemists 
were able to figure out the structural properties corresponding to the “active 
ingredients” of native plants that cause altered states of consciousness. Within a short 
period of time, laboratory advances provided a means to synthesize the active 
ingredients that conveyed psychoactive properties from plant derivatives. Common 
examples encountered in the literature include the coca leaf, which can be ground into 
a milky white paste or refined into a more pure form of powdered cocaine. Likewise, 
scoring the opium poppy produces the discharge of a thick viscous, pasty, tar-like 
resin that can eventually be processed as street grade heroin. In 1804 the opiate 
analgesic morphine was first of several plant alkaloids extracted from the opium 
plant; it was eventually marketed by the pharmaceutical company Merck (1827) as a 
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major pain reliever. As scientists have become more familiar with the behavioral and 
psychological effects of numerous plant alkaloids, and particularly their narcotic and 
analgesic effects, emphasis has been placed on delineating whether they cause 
addiction. 
One of the first steps in the process of understanding the psychoactive 
properties for all mind altering substances (i.e., all kind of drugs, including native 
plants, known to alter mood, perception, and behavior) was to classify them 
according to their addictive potential. In 1970, the United States (U.S.) Congress 
enacted the Controlled Substance Act, part of the “Comprehensive Drug Abuse 
Prevention and Control Act of 1970,” to provide the Drug Enforcement 
Administration (DEA) a mechanism to classify all chemical substances into 
categories, also known as drug schedules or classes.1 Today, the scheduling (or 
classification) of drugs encompasses a wide range of illicit drugs including marijuana, 
cocaine (both powder and crack that can be manufactured in crystalline form), 
opioids (morphine, heroin, and any derivatives of plant alkaloids in chemical form 
such as Hydrocodone, Oxycontin, or codeine), and methamphetamines. The 
classification system has also been extended to include legal substances, such as 
 
1For more details on this law and a complete description of these drug schedules, visit 
U.S. DEA website: http://www.usdoj.gov/dea/index.htm, last retrieved on December 
12, 2010. 
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nicotine, alcohol, and prescription medications.2 When consumed for recreational 
purposes to achieve a certain altered state of consciousness [e.g., to promote instant 
rush (euphoria), induce hallucinations, or to get “high”], these psychoactive drugs 
have a great potential for abuse and can lead to addiction and are responsible for 
causing a wide range of adverse medical (physical and/or mental health) and other 
consequences (Chen & Lin, 2009; Rehm et al., 2006). 
The consumption of mind-altering substances by individuals of all socio-
economic strata and age groups, including adolescents and young adults, continues to 
be a matter of public health concern and represents a tremendous social problem. This 
is because continued use of these drugs can lead to serious physical as well as mental 
health problems, including death by overdose (CDC, 2010). The costs (monetary and 
otherwise) of drug use and addiction are enormous to society, including financial 
outlays for treatment, loss of economic productivity, disruption to the family, and 
legal incarceration for manufacturing, distribution, possession, and/or consumption. 
Importantly, increasing rates of individuals seeking treatment for drug addiction 
[Based on data from the Substance Abuse and Mental Health Services Administration 
(SAMHSA) National Survey on Drug Use & Health (NSDUH) 2010 and Treatment 
Episode Data set (TEDS) 2009] coupled with a relatively high rate of illicit drug use 
 
2There is yet an ongoing debate as to whether other legal natural-substances, such as 
sugar, coffee, and chocolate; as well as activities, such as binge eating, gambling, TV 
viewing, internet surfing, playing video games and even having sex, can be addictive. 
For additional discussion on this continuing debate, see for example, Black (1996), 
Brown (1993), Clark (2006), Harpaz & Snir (2003), Mule (1981), and Song, Larose, 
Eastin & Lin (2004). 
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among some segments of our nation’s secondary school students (Johnston et al., 
2010a & 2010b) underscore an urgent need for improving efforts at prevention and 
treatment. Developing effective programs for both drug prevention and drug 
treatment requires, however, a deeper understanding of the various developmental 
risk processes underlying drug etiology and likewise involves obtaining a more 
refined understanding of individual differences in susceptibility to drug use and the 
processes leading to addiction.  
Clinical and epidemiological research on the causes of drug use and abuse 
have helped scientists gain a better understanding of the genetic, physiological, 
psychosocial, and environmental dimensions of both the beginning stages of drug use 
and the more protracted abuse, and even addiction. Lately, economic theories of 
rational choice and consumer behavior have also been used to account for drug 
etiology and the various pathways to addiction (Chaloupka & Grossman, 1996; 
Godfrey & Maynard, 1989; Marvel & Hartmann, 1986; Stigler & Becker, 1977). 
Economic theories, however, have not been considered mainstream with regard to the 
dominant psychological explanations of drug use and thus are less widely accepted 
(Bridges, 1999; Rachlin, 2003). Nonetheless, the economic explanation of behavior 
has become markedly more prominent, especially as consumerism in the U.S. and 
abroad has risen and more companies compete worldwide for scarce resources and 
market share. Understanding the decision-making rationale that leads to product 
selection has received increasing interest not only for its commercial implications but 
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also for its application in other fields such as drug use and addiction. In the case of 
drug abuse, consumer behavior emphasizes the acquisition and consumption of 
psychoactive products, which are associated with an array of medical, psychological, 
and social problems. 
1. Statement of the Problem 
The concept of addiction is difficult to pin down. There is also some 
theoretical confusion when discussing "addiction" because of its diverse etiology, 
multiple outcomes, and numerous ways to discuss the activity that underlies drug 
taking and drug seeking behaviors. Even the process of becoming addicted is 
complex with many pathways and courses. Individual addicts each have their own 
story, painting a detailed picture describing the myriad of ways their life became 
entangled with an overwhelming sense of urgency, craving, and desire for drug 
consumption. Added to this, there are developmental considerations that come into 
play. It is unquestionable that individuals do not become addicted overnight but that 
addiction results from a prolonged involvement with a drug, and even this basic 
understanding must consider a wide range of environmental, social, physical, and 
economic cues that stimulate drug taking. At its earliest stages, addiction begins with 
experimental or recreational drug use, where an individual smokes a joint, sips a 
drink of alcohol, takes a pill, or ingests some plant derivative (psilocybin or 
mescaline) for the first time. Most cigarette smokers state their first cigarette made 
them cough, and they felt nauseous and sickly. Many say cocaine makes them feel 
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“racy” and their heart beat uncontrollably. Others smoke marijuana and feel their 
head “buzz” and they quickly crave food. However, within a short period of time, 
drug users wish to relive the euphoric “high” they experienced, seeking to consume 
more of the drug in question, in larger quantities and more frequently, inevitably 
leading to abuse or addiction. 
During the past few decades, a large number of competing theories have been 
advanced to explain drug-taking as well as individual susceptibility to addiction. 
Focusing on somewhat different aspects of the problem, these various psychological, 
sociological, economic, and more recently neurological theories offer unique 
explanations of the drug addiction process. Because they approach drug consumption 
and addiction from slightly different vantage points, these theories suggest different 
social policies and interventions. While each theoretical approach provides some 
empirical support attesting to its validity, the different explanatory models proposed 
also possess certain limitations in their ability to account for the diverse facets of use, 
abuse, and addictive behavior. 
One limitation, in particular, has been the failure to integrate across diverse 
theoretical views producing a “myopic” focus within each theory; each one struggling 
to develop a satisfactory explanatory model of drug consumption. This has created 
diffuse and often contradictory explanations of drug use and abuse. Psychological 
theories of addiction, for instance, because of their emphasis on individual 
differences, fail to integrate larger macro or structural forces, including the role of 
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environmental and community influences. Sociological explanations, on the other 
hand, attend to the dynamics of larger institutions including the family, but fail to 
include micro-forces that may involve genetic explanations. To explain drug use and 
the addiction process, economists focus on familiar economic factors, assuming that 
psychological and sociological factors can be held “constant.” This narrowness in 
perspective is particularly startling given that most current models of drug use and 
addiction agree that the use, misuse, and addiction to drugs is the result of a complex 
interaction of many contributing factors at multiple levels of influence. Recognizing 
that drug addiction is etiologically complex and multi-faceted is generally regarded as 
a more realistic view of the behavior. Support for a multi-factorial approach comes 
also from the observation that no single theory can sufficiently account for the full 
spectrum of drug addiction and even more so from the fact that no intervention 
program based on a single theoretical model has ever been shown to be consistently 
effective, especially in the long run (Burke, 2002; West & O’Neal., 2004). The 
complexity of human behavior, in general, and addiction, more specifically, requires 
a more encompassing and theoretically rich model that incorporates a multi-
disciplinary and more “ecologically” sound approach (Brewer, 2000; Scheier et al., 
2010).  
In recent years, two models of drug use and addiction, one derived from 
psychology and the other from economics, have generated considerable debate and 
empirical research. Although models based on economic theory have focused 
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attention on external or market-based factors, such as income, market prices, and 
opportunity costs; psychological models of human behavior have emphasized internal 
cues, such as emotional self-regulation, cognitive functioning, and motivation, all of 
which regulate an individual’s intention to consume psychoactive drugs. Each theory 
offers important insights into the complexity of drug use and addiction. However, 
very few empirical studies have fully integrated these competing explanations.3 The 
integration of economic and psychological factors into a comprehensive model of 
addiction is not only essential for a better understanding of addictive behavior, but 
also represents an important step towards developing scientifically rational and more 
effective prevention efforts and treatment strategies (Montoya et al., 2000). 
2. Purpose of the Study 
The purpose of this dissertation is to develop, for the first time, a “hybrid” 
model that effectively combines select components of both economic and 
psychological theories to predict drug consumption and its related consequences. The 
model is not designed to test the utility of these theoretical frameworks; rather, it 
aims essentially to: (1) assess the theoretical importance of combining economic 
 
3An earlier example of such confluence between economic theory and psychology 
can be found in Edwards’ (1954), who provides a scholarly dissection of the 
particular components of individual decision-making that overlaps quite nicely with 
some of the main tenets of economic rationality [see also, Camerer (1995), for a 
excellent discussion of decision making from an economic perspective]. Also, Rabin 
(2002) presents an excellent discourse on the potential cross-fertilization (i.e., a 
merger) between psychology and economics, which he terms “behavioral 
economics.” A good deal of Rabin’s writing highlights the need for psychological 
realism in economic theory, lest we forget that people do not always act “sanely,” i.e., 
rationally. 
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models of consumption with existing psychosocial theories of addiction; and (2) 
estimate the unique influence of economic factors on drug consumption in the 
presence of psychological constructs. The methodology used also advances previous 
attempts in this direction by using latent-variable Structural Equation Modeling 
(SEM), a multivariate statistical technique appropriate for theory testing (Bentler, 
1978; Nachtigall et al., 2003). 
More specifically, this dissertation proposes a novel “psycho-economic” 
model of addiction, simultaneously combining and testing the unique influence of key 
economic indicators along with psychosocial risk factors on a specific type of 
substance that has become popular among youth and young adults.4 The proposed 
model represents an outgrowth and further refinement of an earlier, preliminary study 
published in Substance Use & Misuse (Ben Abdallah et al., 2007). In the current 
dissertation study, the main research questions address: 1) whether specific economic 
indicators remain statistically and significantly associated with substance use 
behaviors in the presence of psychosocial influences and more importantly 2) 
whether a combined “psycho-economic” model is “ecologically” valid. The question 
of ecological validity has been neglected in the literature despite its inherent 
 
4Actually, Cameron’s (2000) “psycho-economic” model of cigarette consumption 
was first to suggest the confluence of psychological and economic factors to account 
for drug behaviors. However, while the author did not completely dismiss the role of 
economic factors, such as drug prices and income, his work emphasized how “the 
psychopharmacological addictive properties of cigarette smoking influences demand” 
(p. 212). 
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relevance to the design, implementation, and evaluation of drug prevention and 
treatment programs (Brewer, 2000).  
3. Significance of the Study  
There are several other unique features worth noting to the present study. 
First, the study weaves together competing behavioral science disciplines to explain 
human behavior. Additionally, the study offers a number of significant contributions 
to the field of behavioral economics in general and drug abuse in particular, 
emphasizing several theoretical and methodological concerns that have yet to be 
addressed in the literature. One of the more striking concerns is that prior empirical 
studies have focused on at most one or two domains of influence as putative risk 
factors for drug use and abuse. The exclusion of important domains of influence that 
could explain drug use and even the more harmful course of addiction is likely to 
increase the risk of spuriousness and foster erroneous inferences. To address this 
concern, the present study models a wider array of economic indicators, including 
measures of income, opportunity and monetary cost along with measures of 
psychological functioning, health risks, and behaviors related to drug abuse. Inclusion 
of these diverse sets of economic and psychosocial influences in a single 
comprehensive model should help advance the field of behavioral economics, in 
particular, toward constructing an ecologically sound and valid model of drug use.  
Second, numerous studies of drug use are characterized by the absence of 
reliable measures assessing different putative domains of risk. The use of at most one 
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or two items to characterize a broad range of inter- or intra-personal functioning runs 
the risk of model misspecification and introduces some degree of unreliability into 
the model. To address this concern, the present study relies on a state-of-the-art 
diagnostic and risk factor assessment, including measures with excellent 
psychometric properties; measures that were designed and repeatedly tested in 
diverse settings by investigators at Washington University with a world-wide 
reputation for developing diagnostic assessments with clinical and research 
significance (Cottler et al., 2010).  
Related to this point, the analyses used in this study incorporate latent-
variable Confirmatory Factor Analysis (CFA) to adjust for unreliability in the 
putative risk factors. This approach is ideal for assessments that contain multiple 
indicators of an underlying behavior or risk factor (Bollen, 2002). Briefly, with a 
CFA or measurement model, the moderate association among several observed 
manifest indicators is hypothesized to be statistically caused by some underlying 
latent or unobserved “factor.” This is a common approach used when modeling 
psychological processes, many of which are latent or unobserved behavioral 
tendencies. Estimation of latent-variable constructs is based on classic psychometric 
theory, which disaggregates error variance from the true variance component of an 
observed measure. The more reliable, common or shared variation between multiple 
measures tapping a single construct is then modeled to reflect predictive variance in 
the model or as an endogenous factor influenced by other model terms. With the CFA 
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model in hand, a second step in the theory development involves testing predictive or 
structural relations among hypothesized constructs and other exogenous covariates. 
This multivariate approach, known as structural equation modeling (SEM), provides a 
more rigorous and parsimonious analytic framework to address simultaneous 
influences within a single specified model (Nachtigall et al., 2003). 
A third concern rests with the homogeneous nature of data collection used in 
past studies. Sampling drug users from at most one or two geographic locales runs the 
risk of creating a limited view of drug use cultures or drug markets specific to a 
region or country of interest. In the present study, drug users were recruited 
simultaneously from three racially and culturally heterogeneous sites located in St. 
Louis, Missouri; Miami, Florida; and Sydney, Australia. Significant cultural and 
geographic variation should help furnish new information on patterns and trends in 
drug use as well as open doors to testing differences in economic factors as they may 
vary across sites and therefore have different influences on drug user’s behavior.  
The large cross-site community samples also provided a unique chance to 
examine patterns of consumption among Ecstasy users and investigate a drug surging 
in popularity among various age groups particularly during the time of the present 
study was conducted.  
A fourth concern is that the economic model, which has been advanced in the 
literature, has primarily been tested with licit drugs. Thus, relatively little is known 
whether a model accentuating market factors can account for illicit drug 
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consumption. To address these and related concerns, the present study uses 
“nosological”5 data obtained from the “Tri-City Study of Club Drug Use, Abuse and 
Dependence” [a National Institute on Drug Abuse (NIDA) funded study (DA14854-
01, PI: Dr. Linda B. Cottler), referred to as CDSLAM]. Access to the CDSLAM tri-
city sample provided a rare opportunity to test a psycho-economic model of drug use 
with the largest to date out-of-treatment sample of Ecstasy users.  
Ecstasy/MDMA and its effects --- Ecstasy,6 otherwise identified by its 
pharmacological name as 3,4 methylenedioxymethamphetamine (or MDMA for 
short), is a Schedule I drug (i.e., an illegal, controlled substance, in the same drug 
category that includes heroin, cocaine, and LSD), with no substantiated therapeutic 
value, and extreme potential for abuse. It is one of several drugs belonging to a group 
called “club drugs.”7 Although the emergence of MDMA was first reported in the 
U.S. in the late 1980’s by NIDA’s Community Epidemiology Work Group (CEWG), 
information on its consumption and its effects (both short-term side effects and the 
                                                 
5Nosology refers generally to the classification of diseases. A “nosological” study in 
drug addiction deals with the classification of psychoactive substances based on their 
pharmacological, behavioral, affective, and cognitive properties. 
 
6Other street names for Ecstasy are Adam, E, eve, decadence, M&M, X, and XTC. 
 
7Club drugs are also referred to as “party drugs” or “Recreational drugs” because, 
when first popularized, they were commonly used for “recreation” at dance parties or 
clubs. MDMA (or Ecstasy) is probably the most common of all the recreational drugs 
used at those parties. Other club drugs also used at dance or “rave” parties include 
Rohypnol (also called Roophies, Roche, Forget-me Pill), GHB [γ-hydroxybutyrate] 
(liquid Ecstasy, Georgia Home Boy), and Ketamine (special K, Cat Valiums) (Cohen, 
1998). 
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possible long-term consequences) are still quite limited (NIDA, 2006b).8 In fact, 
“each of these [club] drugs has very different pharmacological, psychological, and 
physiological properties” and the literature documents profound differences in the 
patterns of use, risk profiles and characteristics of users (Maxwell, 2004, p. 1). 
MDMA is a synthetic hallucinogenic, psychoactive stimulant, which is 
usually consumed in a pill (tablet or capsule) form (NIDA, 2006a). During the time 
period (2002-2005) coinciding with the parent study (CDSLAM), street buy-back and 
ethnographic information yielded estimates of a market prices ranging from $20 to 
$40 per tablet.9 Early studies of club drug users also created the impression that this 
“designer drug”, MDMA (again, commonly known on the street as Ecstasy), was a 
“safe drug” with few and minor negative health effects (Beck & Rosenbaum, 1994; 
Moore, 1993; Peroutka et al., 1988; Solowij et al. 1992). Additionally, sporadic 
reports and clinical vignettes confirm that psychotherapists in the U.S. have used 
Ecstasy to facilitate psychotherapy sessions with patients suffering from psychiatric 
disorders, including post-traumatic stress disorder (PTSD) (Greer & Tolbert, 1998; 
 
8MDMA was first synthesized and patented as “diet aid” in 1914 by a German 
pharmaceutical company that eventually became Merck & Co. (see Grinspoon & 
Bakalar, 1986, for details on the history of MDMA before its criminalization in the 
U.S.). MDMA was not, however, marketed at that time nor utilized for any purpose 
till the 1950’s when it was used in animal studies supported by the U.S. Army to 
investigate new approaches to “brainwashing, espionage and mind-control”  in the 
1950s during the Cold War (for more details on these studies, see Hardman et al., 
1973). In the early 1980’s, MDMA began to be used for non-medical purpose (as a 
recreational drug) in the U.S. under its street name Ecstasy (Rosenbaum, 2002). 
 
9The price per Ecstasy pill has gone down since then and became relatively cheaper 
due to its abundance through black market channels and illicit drug manufactures. 
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Ruse et al., 2010). However, the criminalization of MDMA use in 1985 eliminated 
physicians’ ability to prescribe or even use it for any medical purpose.10 
Nevertheless, users describe Ecstasy as being a popular recreational drug used in 
nightclubs or all-night dance parties, called also “raves” or “trance events,”11 
especially for its ability to produce the “feelings of increasing energy” and to promote 
“euphoric sensations of well-being,” “heightened sensory awareness”, and 
“interpersonal feeling of closeness” to others (Baylen & Rosen
As clinical data became available from controlled laboratory trials and 
epidemiological information was obtained from survey research, it has become clear 
that Ecstasy consumption induces both stimulant and hallucinogen-like effects with 
deleterious consequences.12 Several reports have described numerous medical 
complications and fatalities associated with Ecstasy use (Henry et al., 1992; Lee, 
 
10Recently, however, the U.S. Food and Drug Administration (FDA), with approval 
from the Drug Enforcement Administration (DEA), has given permission to a limited 
number of investigators from medical institutions (the University of South Carolina 
in Charleston, Harvard, and the University of San Francisco medical schools), to 
conduct clinical trials with Ecstasy. These studies involve the use of MDMA-assisted 
psychotherapy for subjects with treatment-resistant PTSD, for anxiety and depression 
in advanced-stage cancer patients (Doblin, 2002; Sessa & Nutt, 2007). 
 
11While under its influence, Ecstasy users report feelings of happiness, energy, and 
greater acceptance of others. This allows them to party and dance for an extended 
period of time, hence the name party- or club-drug (Davison & Parrott, 1997). 
 
12Stimulant-like effects include increases in energy, euphoria, and cognitive 
improvement, and hallucinogen-like effects include changes in perception, some 
dysphoria, changes in thought process, and reduced concentration (Harris et al. 2002; 
Hernandez-Lopez et al. 2002; Tancer & Johanson, 2001). 
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MDMA
1994; Maxwell et al., 1993; CDC, 2010), owing perhaps to extreme hyperthermia, 
dehydration, high blood pressure, cardiac and even renal failure (Mathias, 1999). 
Frequent use can also cause long-lasting damage to areas of the brain underlying 
memory (Casco et al., 2005; Ricaurte et al., 2002). After the reported “high” 
subsides, Ecstasy users often feel depressed, irritable, and experience drug craving, 
leading them to take more drugs to extend the high and/or offset withdrawal (Baggott 
et al., 2001; Jerome 2005; Parrott, 2007; Scholey et al., 2004). Ecstasy users also 
report using, at the same time, other substances such as alcohol, marijuana, cocaine 
and opiates to relieve the post-stimulant effects, which may even put them at a higher 
risk for adverse health issues (Cottler et al., 2001, 2009; Degen
& Cottler, 2008; Parrott & Lasky, 1998; Topp et al., 1999). 
Recent studies suggest that Ecstasy use is no longer limited to “party goers” 
characterized as young adults between the ages of 18 and 25. National prevalence 
data gathered from representative samples of secondary school students (i.e., 
Monitoring the Future (MTF): Johnston et al., 2010b), households (i.e., National 
Survey on Drug Use and Health (NUSDUH): SAMHSA, 2010b), and medical 
information based on drug-related emergency department visits [i.e., Drug Abuse 
Warning Network (DAWN): SAMHSA, 2009 & 2010a], all indicate that
 is spreading to the rest of the population, including adolescents.   
In particular, drug surveillance surveys show estimates of past year initiates of 
Ecstasy use among Americans aged 12 or older peaking between 2001-2002 
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his drug (Cottler et al., 2001; Degenhardt et al., 2009, 
2010; Leung & Cottler, 2008). 
(reaching 1.2 million in 2002), followed by a three-year period of decline, which was 
then followed by a period of significant increase from 2006 onwards (reaching 1.1 
million in 2009; SAMHSA, 2010b). At the same time, between 2005 and 2009, past-
year use of Ecstasy increased among 12th-graders from 3.0% to 4.3%; and among 
10th-graders from 2.6% to 3.7%; while past-year use among 8th-graders showed a 
modest decline from 1.7% to 1.3% (Johnston et al., 2010b).  Despite these differences 
in rates, the prevalence of self-reported Ecstasy use among 8th, 10th, and 12th graders 
surveyed in schools across America is determined to be comparatively higher than 
that for cocaine, heroin, and LSD; almost making it seem as if Ecstasy has repl
older” illicit drugs as the drug of popular choice (Johnston et al., 2010a).  
Adding to these compelling statistics, emergency department (ED) statistics 
show that Ecstasy mentions for critical and/or traumatic care have steadily increased 
since 1994 (from 253 to 5,542 in 2001), only slightly decreasing in 2002 (4,026, a 
non-significant change), then rising significantly every year to reach 17,865 in 2008 
(DAWN: SAMHSA, 2009). Further, since 2004, there has been a continuous drop in 
perceived risk of harm associated with Ecstasy use among adolescents, suggesting 
few barriers to their future use (DAWN: SAMHSA, 2009). The high prevalence of 
Ecstasy use among secondary school students, coupled with the medical and 
psychological problems reported after both recreational and prolonged use, argue for 
increased research attention to t
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More importantly, rising prevalence rates and knowledge of existing cost 
structures suggest that regular Ecstasy users may not be sensitive to economic factors. 
Shedding light on this important research question, in itself, makes the contribution of 
the psycho-economic model even more compelling for empirical study. 
4. Organization of the Study 
This dissertation is structured as follows: Chapter II provides a brief 
theoretical background of drug use and abuse with further discussion of addiction as 
it relates to the current research. This material is not meant to represent an exhaustive 
review of all existing addiction theories per se, but rather a fairly comprehensive 
overview of the major models of substance use and addiction, including the key 
economic and psychological models, and an evaluative review of the factors 
highlighted in the recent literature that are pertinent to the argument being made in 
this thesis. The conceptual model and hypotheses of this dissertation are elaborated 
and also presented in Chapter II. Next, Chapter III describes in detail the study data 
and methods, including the derivation and construction of measures used in the 
psycho-economic model as well as the statistical modeling procedures utilized to test 
the specific research hypotheses. Chapter IV presents the study results based on a 
series of latent-variable structural equation models, testing the unique and combined 
influence of economic and psychosocial measures of influence on Ecstasy 
consumption and related consequences. Finally, Chapter V discusses the study 
findings in detail, including their relevance to previous work, with specific attention 
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paid to the implications of joining theoretical models and the limitations of the study. 
This last chapter also elaborates the application of the findings for drug prevention as 
well as treatment, and provides directions for future research.   
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CHAPTER II:  BACKGROUND 
 
1. Introduction 
Over four decades of concentrated studies indicate that there are multiple 
pathways to substance use and misuse. These pathways involve a host of risk factors, 
mechanisms, and contexts that foster the early stages of drug consumption. Many of 
the same risk factors, mechanisms, and contexts are also implicated in the processes 
leading to addiction. The same research literature shows that no one particular 
etiological factor provides the best explanatory mechanism overall to account for 
behavior. There is historical context for the varied arguments why people take drugs 
with family, cultural, and environmental factors that seem to contribute to the use and 
abuse of drugs. 
At different times in history the reasons for drug use have included the 
“devil,” a “rotten society,” and even “dormant intra-psychic conflict” (Johnson, 
1999). Although a significant focus of empirical research has emphasized the 
“causes” of drug use, studies of the consequences of drug use and abuse have been 
just as varied with numerous outcomes used to justify policy initiatives to deter use. 
For instance, public concern with drug use has emphasized cognitive and physical 
impairment, loss of productivity in the workforce, and negative social consequences 
stemming from continued use of drugs (NIDA, 2007). Overall, the effects of drug use 
can have ruinous effects on the family, community and even society as a whole. 
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Despite continued use during adolescence and sometimes even continuing 
into young adulthood, most people eventually “mature out” and relinquish their drug-
using behaviors (Jochman & Fromme, 2009; Robins et al., 1974; Robins, 1980, 
1993). However, for some individuals continued drug use eventually propels them 
into a downward spiral of addiction. Clinical case studies indicate that for every 
person who becomes addicted there is a unique story that captures the slow drift into 
his/her compulsive drug-taking. As a result, there has been a proliferation of theories 
to account not only for early and more problematic drug use but also for addiction, 
linking different stages of etiology, maintenance, and even relapse.13  
This chapter provides a brief overview of the literature examining drug use 
and abuse in order to provide a more complete picture of the different prevailing 
etiological theories. Etiology concerns root causes and in this respect details the 
myriad of reasons why people engage in drug use, the processes resulting in abuse, 
and the manifest ways this can lead to addiction (Scheier et al., 2010). The overview 
presented here provides a theoretical backdrop for the psycho-economic model 
proposed in this study. The chapter begins with a brief historical perspective of what 
are generally considered to be relevant models of addiction.14 The materials 
 
13For a review of the most relevant drug addiction theories, see Addiction, 
Supplement-2, 2000; Addiction, Supplement-1, 2001; and Addiction, no. 4, 2002. 
 
14Although a model can present a more detailed description or explanation of why 
and how something happens, it is usually based on a theory with specified axioms, 
postulates and syntax. Absent specific details, both a model and theory can be framed 
as means to account for reality. For the present purpose, both theory and model will 
be used interchangeably throughout this chapter. 
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presented clarify how the addiction field has changed conceptually over time, 
marking the transition from the “moral” view to the traditional medical model, and 
more recently introducing the biopsychosocial and behavioral-disorder perspective.  
Following this brief introduction the chapter introduces the two theoretical 
models currently used in the field to account for drug addiction: one clarifying the 
role of psychological factors and the other highlighting economic measures that 
presage consumption. A substantial body of research suggests that there exist 
multiple perspectives on psychological precursors to drug abuse; however, the same 
rich literature also implicates economic measures that can explain drug etiology. This 
review is by no means exhaustive, but rather meant to evaluate the strengths of each 
perspective and provide a means to acquire a more refined picture regarding the 
unique contributions that each theory provides regarding the processes leading to 
drug use, abuse, and even addiction. In this respect, this review focuses on causal 
factors in each theory that are thought to play a role in shaping a person’s decisions to 
use drugs and their eventual course to addiction. Next, the psycho-economic model is 
discussed in terms of other pertinent literature reviews. Finally, a conceptual model 
and the hypotheses of this research study are outlined as a prelude to the empirical 
models that are presented in the subsequent chapter. 
2. A Historical Perspective of Addiction Theories 
From the earliest recorded history of antiquity and even stretching into the 
early 20th century, drunkenness and intoxication from alcoholic beverages and 
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“getting high” on drugs was regarded as largely a voluntary behavior and therefore 
the result of personal misconducts, bad and even “sinful decisions” (Keller, 1972). 
Society regarded the inability to control one’s temptations as a character flaw 
providing a basis for the “moral” view of addiction. Adherents of this position relied 
on the philosophical position of “free will,” postulating that people are in control of 
their own actions and thus free to behave in any way they choose. Accordingly, 
consumption of addictive substances results from choosing a shameful lifestyle for 
which those consumed by addiction are to blame because it is a matter of choice; they 
control their own destiny and are in charge of their own actions. Only people with 
“poor moral standards” and “low willpower” or “self-control” would therefore choose 
to indulge in “demon’s behaviors” (Bobgan & Bobgan, 1990; Levine, 1978; Room, 
1983). As a consequence, addiction was depicted as “punishment for sinful habits” 
that can only be overcome through complete abstinence. The process of ridding 
oneself of the demons of alcohol requires a “spiritual awakening” and a devout 
“commitment to religious beliefs.” Despite the popularity of this view and its 
foothold in the treatment community during the 18th and 19th centuries, the “moral” or 
“puritanical” view of drug use and addiction contributed very little to our 
understanding of why people initiate and continue to use psychoactive substances. 
Within a short period of time, scholars and influential public leaders realized 
that the moral view offered no credible scientific evidence that could help fuel the 
development of effective prevention strategies or contribute to viable treatment 
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options. Although this position was plagued by limited utility, adoption of the moral 
view was responsible for many of the anti-drug legislative activities that took place in 
the early 20th century. For instance, pointing the finger at a moral deficiency in the 
addict’s personality or a character flaw renders the use of addictive substances strictly 
a sin and/or led to legislation criminalizing drug consumption. This view eventually 
acted as stimulus for the prohibition policy era in the U.S. (1920-1933), a 
constitutional “faux pas” that inevitably increased alcohol consumption, stimulated 
corruption, and increased crime (Health, Education & Welfare, 1968). Although 
certain aspects reminiscent of the moral approach continue to be invoked,15 scientific 
research has long challenged this philosophical position by showing that addiction is 
not the result of a character defect or a moral weakness. 
Introduction of the Disease Model --- Shortly after the repeal of Prohibition, a 
new approach to drug addiction became popular and grew rapidly, based on advances 
that took place in medicine and a growing body of scientific knowledge (McMurran, 
1994). According to this perspective, alcoholism and addiction, in general, are 
defined as “chronic and progressive conditions” or “diseases” (like other medical 
conditions including, for example, asthma, hypertension or diabetes) caused by the 
prolonged effects of the substance used. Moreover, other factors, some often ascribed 
                                                 
15The influence of this view can still be found, though to a lesser degree, in the 12-
step program of the Narcotics Anonymous (NA). The NA requires each member “to 
confess” out loud during group meetings their addiction and that they lost control 
over their drug use. Also, the ‘war on drugs' policy of the 1980’s represented an anti-
drug policy to some degree based on shame, guilt, and personal character weakness. 
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as common sense, helped derail the moral view. For instance, although many people 
use alcohol and/or drugs, not all individuals lose control over their use. Furthermore, 
the moral view was not encompassing and its adherents regarded as myopic and 
somewhat reluctant to consider alternative views to account for addiction. Within the 
new approach, however, drug addiction became rooted in a medical condition like 
any other common physical malady or disease. Many in the scientific community also 
argued that the undesirable behaviors associated with addiction are only the 
symptoms of the substance user’s ailment. The user shows progressive worsening in 
terms of loss of control over the drug taken, as his/her body physiologically adapts to 
the presence or absence of the drug of choice (Leshner, 1997). 
The addiction disease-theory as it became known was introduced formally in 
the late 1940’s and early 1950’s by E. M. Jellinek (1946, 1952). His view entailed  
essentially five considerations: (1) addiction reflects an illness and should not be 
characterized as “the demon’s act,” (2) denial is usually a common feature of this 
disease, (3) addiction is a progressive, irreversible condition characterized mostly by 
the “loss of control” or compulsion over the intake of a substance, (4) addiction 
cannot be cured, but can be controlled through abstinence and some form of medical 
intervention or treatment that extends over the rest of the drug user’s lifetime, and (5) 
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addiction to alcohol and other drugs can lead to other problems in the user’s life such 
as health problems, mental illnesses, and relationship problems.16 
The “conventional” disease concept of addiction was quickly embraced for 
both its personal as well as social utility. Many viewed it as a superior approach to 
the moral model because it removed blame and stigma from the addicts and offered 
them new hope (White, 2001a; 2001b). Wrapped up inside this hope is the possibility 
for treatment instead of punishment (Spicer, 1993). The disease concept also 
provided “an organizing construct, which makes it easier for society as a whole to 
understand, accept and deal with” (White, 2001a, p. 43). 
Over the years, numerous social sciences and medical studies provided 
credible support for the addiction disease concept. Perhaps some of the strongest 
evidence for the disease model thus far has come from the biological studies of gene-
environment (GE) interactions. According to the biological view, addiction is caused 
by physical characteristics that can lead certain individuals to abuse drugs to the point 
that they lose control. In fact, there is now convincing evidence that factors related to 
genetic, prenatal and early childhood experiences predispose individuals to develop 
alcohol and/or drug addiction. Numerous proband and twin studies drawing from the 
strengths of biologically related individuals have investigated the full extent of 
genetic influences. The biological closeness between twins raised separately or 
 
16A detailed discussion of these assumptions can be found in White, Kurtz & Aker as 
part of a literature review available on the web at:  
http://www.bhrm.org/papers/addpapers.htm, last accessed February 15, 2011. 
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together as well as parent-offspring combinations enables researchers to provide 
estimates of the relative contributions of genes and environmental influences to 
alcoholism and drug addiction (Cloninger et al., 1981; Cloninger, 1987; Heath, 1989). 
In particular, behavioral transmission studies have shown an increased propensity 
among children of addicted parents to become addicted themselves. These family 
history studies have confirmed that to some degree “addiction runs in families” and 
have been able to identify familial components associated with addiction.17  
Additionally, genetic heritability studies using twins and adopted children 
have also confirmed that the risk for addiction is greater for twins with addicted than 
with non-addicted biological parents even when the twins have been separated at 
birth or adopted and were unaware of their natural parent's condition (Cadoret et al., 
1995; Goodwin et al., 1977; Heath et al., 1998; Kendler et al., 2000; Tsuang et al., 
2001). Estimates from these studies suggest that the genetic makeup explains about 
40% to 60% of people’s overall vulnerability to alcoholism and, to a lesser extent, 
 
17Several genes have, in fact, been identified as causing or at least linked to 
alcoholism and drug addiction. In particular, the D2 dopamine receptor A1 gene, for 
example, has been found to be more common in alcoholics and cocaine addicts 
(Comings et al. 1994). Researchers believe that as many as seven out of ten 
alcoholics carry this so-called “alcoholism gene,” compared to only one in five (or 
two out of ten) in the general population (Hyman, 2001; Pandey, 2004; Uhl, 1999 & 
2004; Uhl & Grow, 2004; Wang  et al., 2004).  
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drug addiction (Kendler et al., 2000; Prescott & Kendler, 1999; Tsuang et al., 
2001).18 
Scientists engaged in research on biological marker have argued that genetic 
and bio-physiological factors play an essential role in drug abuse. Most experts in the 
field initially believed that reward or pleasure centers of the brain [part of the central 
nervous system (CNS)] may be genetically predisposed, in certain individuals, to be 
especially sensitive to alcohol and other psychoactive drugs, making substance use 
particularly pleasant and more rewarding. In contrast, for others lacking a genetic 
vulnerability, the effects of drugs might not be as pleasant; such individuals are not 
likely to become addicted to or even seek drugs. In other words, biologists have 
emphasized that CNS sensitivity at a cellular or molecular level determines the 
brain’s sensitivity to psychoactive substances and this “susceptibility” has been 
offered as the reason why some people are particularly prone to addiction more than 
others (Mathias, 1995).  
The strength of genetic arguments is highlighted by the tremendous emphasis 
in the scientific community to identify gene “markers.” With all of the supporting 
genetic and neurobiological evidence, the “brain disease” approach to substance use 
and addiction (also referred to as the “biological,” “medical” or simply “biomedical” 
 
18Some still argue however, that, although genetic predisposition or biological 
markers are associated with alcoholism and drug addiction, current research has not 
been yet helpful in discovering direct gene effects, i.e., people’s inheritance 
vulnerability to addictive substances (Reich et al., 1998). In other words, researchers 
have yet to explain how genetic factors inevitably cause drinking or lead to the 
consumption of drugs (Uhl & Grow, 2004). 
  29
model” (Gordis, 2001; White, 2002) has increasingly gained professional as well as 
public acceptance and support over time in the U.S. as well as by the larger 
international drug abuse scientific community. The 1990s was, in fact, proclaimed as 
the “Brain Decade,” a period highly regarded for its numerous advances in brain-
imaging technologies. Three advances in particular that have had an indelible impact 
on the field include the discovery of Positron Emission Tomography (PET), Magnetic 
Resonance Imaging (MRI), and then later on Functional Magnetic Resonance 
Imaging (fMRI) techniques. Since the inception of these neuro-imaging techniques, 
researchers and clinicians have been able to gain a more acute picture of the brain 
activity as it parallels the actual physical craving and consumption of psychoactive 
substances. The visual interface and close analysis of the underlying anatomical 
structure of the brain helped provide a more accurate picture supporting biological 
theories of drug addiction (Goldstein & Volkow, 2002). 
In particular, neuroimaging studies of the “brain on drugs” have demonstrated 
that psychoactive substances have, without doubt, physiological effects on the brain 
“reward circuits,” a mechanism through which “electrical impulses” (i.e., signals in 
the form of action potentials) are transported from one area of the brain to another. 
These signals are the basis for information flow in the brain and connected to the 
underlying capacity for thought, memory, perception and sensation. Specifically, 
brain imaging studies suggest that psychoactive drugs enhance the pleasure centers of 
the brain by causing a massive and rapid release of the neurotransmitter, dopamine 
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(DA).19,20 The pleasurable feelings created, referred to as rewards, have been 
construed as “positive-reinforcers” that induce the individual to continue using the 
drugs responsible for initiating the central DA release (Robinson & Berridge, 1993). 
Another advanced reason for the self-motivation view of drug use was that the 
brain cells become sensitized to the presence of neurotransmitters such as DA and 
this may be responsible for the underlying “craving” when brain levels return to their 
normal state and are no longer elevated (Robinson & Berridge, 1993). This “negative-
reinforcer” role has been implicated as important in maintaining drug use and the 
development of addiction. As a result, positive (achieving a “pleasurable high” or 
euphoric state) as well as negative (avoiding the unpleasant feelings of withdrawal 
and craving) reinforcement contingencies have been suggested as the main reason for 
continued and even compulsive use of psychoactive substances.21 This explanation 
 
19The brain reward circuits, known anatomically as the “mesolimbic dopamine 
system” (MDS), involve important parts of the midbrain regions, primarily the 
“ventral tegmental area” (VTA) and the “nucleus accumbens” (NAc) among other 
forebrain areas (such as amygdala and hippocampus). These two central 
neuroanatomical regions are heavily implicated in the reward process: The VTA 
responds to the presence of drugs by releasing DA into the NAc, inducing a 
pleasurable experience (Bespalov et al. 1999).  
 
20Although there are many neurotransmitters involved in the brain reward circuits, 
such as opioid peptides (endorphins), glutamate, serotonin, and gamma-aminobutyric 
acid (GABA), dopamine is the neurochemical transmitter most directly implicated in 
the reinforcement effects of all addictive substances (Tomkins & Sellers, 2001).  
 
21It has also been suggested that this same brain DA system is also involved in 
mediating reward behavior and motivational aspects of “natural” activities such as 
feeding and sexual interaction, among others (Berridge & Robinson, 1998).  
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(referred to as the “dopamine-reward hypothesis”) led to the development of a 
number of “reinforcement models” of drug use and addiction (Wise, 1996, 2002). 
Starting in the early 1950s, several organizations, including the World Health 
Organization (WHO) and the American Psychiatric Association (APA), began to 
formally acknowledge that addiction is a disease of the brain and these influential 
scientific bodies endorsed the medical model of addiction (Room, 1983). Both of 
these highly respected professional organizations have also made important 
contributions to the disease model by (1) providing operational definitions and 
therefore “modernizing” the addiction disease concept and (2) providing standardized 
diagnostic criteria (a “nomenclature”) for the different disorders that result from the 
use and misuse of drugs.  
The APA, in particular, started this process by establishing a workgroup, 
referred to as the “Work Force on Nomenclature and Statistics,” to analyze and 
synthesize major addiction research findings. Since 1980, the APA Work Force has 
also developed and continued to revise and publish a manual called “Diagnostic and 
Statistical Manual of Mental Disorders” (DSM) that is widely used as a guide by 
clinicians and researchers for the diagnosis of various forms of addiction and other 
mental health disorders (APA, 1994).22 The APA began formulating the criteria with 
 
22A similar diagnostic classification system has also been established by the World 
Health Organization (WHO) in 1951, which led to the publication of similar clinical 
manual referred to as the International Classification of Diseases, or ICD for short.  
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the DSM-I and II early on; although those initial compendia were works in progress 
and not considered complete. The DSM- III became widely used in 1980; it was later 
revised in 1987 with the DSM-III-R criteria, and again in 1994, with DSM-IV.  
The current DSM-IV defines addiction as a “maladaptive pattern of substance 
use” (APA, 1994, p. 181) that can best be conceptualized as existing on a “behavioral 
continuum” ranging from “normal to pathological.” When diagnosed clinically, any 
alcohol or drug user may fall anywhere along this continuum of severity. The generic 
DSM diagnosis of “substance-use related disorders” was however categorized into no 
diagnosis (negative), abuse, and dependence, based on a specific set of criteria23 
(each criterion defined by a specific aggregation or cluster of symptoms).  
In this “hierarchical diagnostic classification scheme,” drug dependence, a 
term often used interchangeably with the term addiction, indicates an advanced stage 
of drug-consumption; characterized mainly by “impaired control” over the 
consumption of a “drug-of-choice,” craving, increased tolerance and/or withdrawal, 
 
The WHO ICD is currently in its 10th version (WHO, 2004), while the Current DSM 
manual is in its fourth edition (referred to as DSM-IV), published in 1994. There is 
also a recent text-revised version of the DSM (DSM-IV-TR), published in 2000. 
Both the WHO and APA are currently in the process of developing newer revised and 
updated versions of their respective manuals. More likely, these manuals will be 
referred to as ICD-11 and DSM-V, respectively (Saunders & Cottler, 2007). 
 
23The two categories of abuse and dependence are defined as independent substance 
use states, but the former can only be diagnosed if the threshold criterion for the latter 
state is not met. In other words, this “condition” has been made into a “conventional 
rule” stated commonly as “dependence takes precedence over abuse.” This implies 
that dependence can be present with or without abuse (APA, 1994). 
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and continued use despite the physical, emotional and social consequences.24 When 
conceived of in this manner and as a “disorder syndrome,” this problematic state of 
drug use (defined as drug dependence or addiction) is usually specified as being with 
or without specific psychological and/or physiological aspects of dependence, the 
latter evidenced by the presence or absence of tolerance and/or withdrawal symptoms 
(APA, 1994). Drug dependence can therefore manifest itself with features of either 
psychological and/or physical symptoms or neither (Edwards & Gross, 1976).  
Drug abuse, on the other hand, is essentially regarded as a level of drug use 
causing persistent or recurrent personal problems, such as role impairment or multiple 
legal problems.25 Overall, the detailed classification of abuse and dependence 
provided by the DSM nomenclature added great value to the field of addiction 
research and gave researchers as well as clinicians useful and practical information in 
their attempt to understand and treat alcoholism and drug addiction. The diagnostic or 
nosological view is referred to as the “Symptomatic Theory of Addiction” 
(Lindstrom, 1992). 
 
24The DSM-IV defines seven possible criteria for the diagnosis of drug dependence 
(APA, 1994, pp. 176-181). The threshold to make a positive drug dependence 
diagnosis requires that three or more dependence criteria must be endorsed and that 
those criteria must occur within the same 12-months period. 
 
25There are four possible DSM-IV criteria for the diagnosis of drug abuse (APA, 
1994, pp. 176-181). Abuse has a simple threshold: At least one of the four criteria 
must be endorsed in order to make a positive diagnosis. A drug abusing person may 
report, however, all four criteria. 
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In spite of its benefits and widespread acceptance, the brain disease (or 
biological) model of addiction has experienced numerous challenges over the years 
(White, 2001a; 2001b). One challenge in particular tests that the disease model 
created more of the same problems it allegedly tried to resolve (Peele, 2003; Schaler, 
2002). The “no-fault disease” approach, while stripping addicts from any personal 
responsibility, discourages them from seeking help. Furthermore, the disease model 
does not in fact provide an adequate framework for prevention (Peele, 1990). 
Addiction, according to this view, is primarily a “voluntary choice” or specifically a 
behavioral problem that is influenced in part by the user’s biological constitution. As 
such, opponents of the medical model argue that addictive behavior can best be 
justified by the psychological, social, situational or environmental factors 
contributing to the drug addicted person’s decision to use drugs (Schaler, 2002; 
Vuchinich & Heather, 2003). 
Other opponents to the unavoidable disease concept debate whether the 
medical model is able to adequately account for the full spectrum of behaviors that 
are symptomatic of drug abuse and even addiction (Milkman & Shaffer, 1985).  
Epidemiological data lends some support for this view, suggesting, for instance, that 
not everyone who is a long-term “chipper,” “weekend” or recreational drinker and/or 
drug user (also referred to as a “weekender”) becomes necessarily addicted [Satel and 
colleagues  (1998, 2001), citing national prevalence rates from the Epidemiologic 
Catchment Area study]. Chippers, in fact, stymie many drug abuse researchers 
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because they are chronic in their consumption patterns, but still able to function at 
high levels in society, in essence, staving off many of the negative problems that are 
frequently hallmark characteristics of addiction. Others cite cases of “natural 
recovery” from drug addiction or “maturing out” without treatment [Fingarette 
(1989), citing the study findings from Schuckit (1984) and Fillmore (1988); and 
Heyman (1996), citing Robins et al. (1974 & 1980) well-known seminal findings 
regarding Vietnam veterans returning stateside and naturally relinquishing their 
addiction to heroin]. The disease model, despite all these challenges, continues to be 
regarded as the “conventional wisdom” in most present day addiction treatment 
programs (White, 2002). 
3. Contemporary Addiction Theories 
While the brain disease model gained a significant foothold in the academic 
community, there has been a substantial amount of research to refine this position and 
provide a more detailed causal explanation of addiction in terms of brain 
mechanisms. This effort has managed to shift the focus away from the conventional 
“biological disease” (or purely medical) explanation, towards a more elaborate view 
of addiction, depicting it as a complex “neuro-behavioral” disorder. In these terms, 
addiction is not just a chronic medical disease but more importantly a neurological 
disorder that involves higher brain functions; including “cognitive processes,” such as 
attention and memory as well as deficits in learning and motivation; which are 
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essential to the addictive decision-making processes (Mauron, 2003; Nestler & 
Malenka, 2004). 
Proponents of this view cast some doubt on dopamine’s (DA) causal role in 
reward mechanisms.26 As stated earlier, the projection of dopaminergic neurons in the 
nucleus accumbens (NAc) has been thought for many years to be implicated in the 
hedonic (feeling of pleasure) and motivational (rewarding) characteristic of drugs 
(Wise, 1996). Again, the “hedonia hypothesis” was originally presented as strong 
evidence that addiction is a “reward-motivated” disorder characterized by numerous 
symptoms including the compulsive urge or need (craving) to consume the drug. In 
other words, the “liking” of a drug, caused by mimicking the brain’s “natural reward 
system,” was thought to promote the motivation (intrinsic reasons) for its use, which, 
in turn, was thought to promote addiction with its concomitant harmful consequences. 
Thus, the DA reward mechanism was thought to encourage the addict’s vigorous 
drug-seeking and drug-taking behaviors. Support for this “pleasure” theory of 
addiction has been challenged within the past 10 to 15 years based on evidence from 
sophisticated “in vivo” laboratory animal studies (Shippenberg & Koob, 2002). 
Although this challenge does not discount the hedonic effects of drugs, the findings 
of several studies have been used as evidence that the brain DA activity is not 
necessarily sufficient, as a reward motivation per se, to account for the persistent and 
 
26For a thorough review of the recent debate over the role of the dopaminergic 
neurons process in the brain reward system, see Salamone et al., 1975; Berridge, 
2007, and Di Chiara & Bassareo, 2007.  
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compulsive pattern in the drug addict’s behavior (Garris et al, 1999). This point of 
departure opens the door to consider alternative hypotheses explaining the DA 
functional role in the drug addiction process. Among these at least three competing 
theories have evolved. 
One such theory holds that addiction is a “dopamine-dependent associative 
learning disorder” (Di Chiara, 1999). According to this theory, psychoactive drugs 
activate the brain motivational systems by continually “tricking” it into responding as 
if the drugs are biologically needed. In addition to their reinforcing or rewarding 
properties, addictive drugs alter the brain learning and memory processes by forming 
an association between the drug-rewards value (“the high”) and the drug-related 
environmental cues [environment where drugs were taken previously, places and 
people associated with drugs, and sight of objects such as drug paraphernalia (e.g. 
syringes or smoking devices)]. This is caused by the sustained increase of DA 
induced by drugs and the brain’s lack of “habituation” to external stimuli (Di Chiara, 
2002; Wise 2002). Through this reward “associative conditioning” process, the 
motivation for drugs is strengthened with each repeated exposure; causing the 
overwhelming desire or craving that can evolve into compulsive patterns of drug 
acquisition and consumption habits. In light of these neural and behavioral 
mechanisms, addiction is hypothesized as a “disease of learning and memory” 
(Hyman, 2005), resulting from the impact on the addict’s behavior by the midbrain 
DA “stimulant role” acquired by the “conditioned stimuli” or reinforcing properties. 
  38
                                                
Schultz and colleagues (Schultz et al., 1997; Schultz, 1998) advanced another 
theory for the DA neuron function, conceptualizing addiction as the outcome of a 
compulsive “trial and error” process to obtain the best future reward.27  In this 
“reward-dependent” learning theory, the drug-induced midbrain-DA activity is 
hypothesized to reflect the anticipation (“prediction error”) of drug rewards and not 
its actual “euphorogenic” or hedonic effects (experience of pleasure). According to 
this “reward-prediction-error” hypothesis, the computational role of DA firing is 
driven by the unpredictability of the drug reward value (i.e. “high”): The burst of 
neurons signals a surprising reward (positive prediction error), while the pause 
signals an expected reward (no difference between received and anticipated rewards). 
Consequently, these phasic bursts and pauses of electrical activity, which are 
naturally used to maximize future rewards, play a motivational role in the 
pathological reward-seeking behaviors typical of long-term drug users’ behavior 
(Berke & Hyman, 2000; Di Chiara & Bassareo, 2007; Schultz, 2002). 
Finally, an alternative theory of the dopaminergic function proposes that the 
primary role of the DA released into the mesocorticolimbic dopamine system 
(MCDS) is to mediate the “incentive salience” (or “noticeableness”) of rewards, that 
reflects different motivational value for drugs than the traditional hedonic “liking” 
(Robinson & Berridge, 1993, 2000, 2003). Incentive salience is a characteristic of a 
 
27 This “trial and error” concept is taken from computational theory of “reinforcement 
learning”, originally developed by Andrew Barto. For more details, see Sutton & 
Barto, 1990. 
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stimulus that makes the drug rewards associated with it more noticeable or important 
(i.e., attention grabbing), and, therefore, desirable (Berridge, 2003, 2006). This 
hypothesis emphasizes that extended or excessive use of psychoactive drugs can act 
directly as well as indirectly on the DA receptors, which may have long-lasting (and 
possibly permanent) effects on the brain’s anatomical substrate and cellular molecular 
biology responsible for attributing significance to environmental stimuli (i.e., 
memory).  
Specifically, the neurological actions of drugs on the brain’s biochemistry and 
neuronal activity have been shown to deplete the DA from the reward pathways (the 
NAc, in particular), which may cause “natural rewards” (like food and water) to lose 
their motivational importance (referred to as motivational toxicity). At the same time, 
the chronic exposure to drugs is hypothesized to “sensitize” the MCDS to 
environmental cues or stimuli, so that the incentive salience of the perceived drug-
rewards becomes pathologically exaggerated, causing the external stimulus to trigger 
a strong psychological motivational state of “wanting” for the drug rewards and thus 
the typical addict’s compulsive habits (Robinson & Berridge, 2003; Ranaldi & Wise, 
2002). In other words, the “incentive-sensitization” theory posits that the midbrain 
DA activity interferes with the “normal” decision making process by falsely 
enhancing the incentive-motivational properties of the drug rewards and therefore 
influencing the drug-user’ behavior. This view suggests that the DA may be involved 
in the “wanting” (desire) rather than in the “liking” (pleasure) of drugs. The 
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psychological distinction between the concept of “wanting” and “liking” was 
advanced as a better explanation of why addicts continue to seek and consume drugs 
aggressively despite the continued threat of enormous adverse consequences (Hobbs 
et al., 2004). 
Although the debate continues over the precise causal contribution made by 
the midbrain DA activity to the addiction process (Berridge, 2007), two common 
themes have already emerged from the three advanced “neurochemical” models or 
theories of addiction. First, the experimental evidence behind these theories has 
strengthened the view that the neurotransmitter DA is more involved in the 
behavioral motivation and decision of procuring and consuming drugs than just 
mediating their euphoric feelings. While its specific involvement is much less clear; 
DA activity has been found to play a key role in explaining drug addiction from the 
initiation of use to the end-stage of addiction, including craving and relapse even after 
a long period of abstinence (WHO, 2004). It is therefore quite possible that all the 
above theories about the role of DA are correct, they may however explain different 
stages in the addiction process (Volkow et al., 2003). 
The second common theme to surface across the three theories of DA neuron 
function is their shared conceptual view of addiction. For all three theories, drug 
addiction is not just a “disease,” but rather a complex neuro-behavioral disorder that 
occurs in some individuals from their chronic use of psychoactive substances. These 
addictive drugs have been shown to affect, one way or the other, the “normal” brain 
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functions, including emotions and motivations, which directly influence thought and 
behavior. According to this perspective, drug addiction is viewed as “an extension of 
normal behavioral processes” that results from the ability of psychoactive substances 
to influence the brain mechanism involved in decision making and behavior. 
Addiction manifests itself as an excessive pattern of “reward-seeking” that continues 
over time at the expense of most other functional activities. In other words, all three 
DA theories agree that addiction can best be viewed as an extreme case of drug-use 
habits with a behavioral control problem caused by a neurobiological alteration of the 
brain motivational systems.  
Based on these new complex brain-behavioral models of addiction, diverse 
risk factors have been advanced to account for the causes of drug addiction and their 
variation among users. Clearly, the reinforcement properties of the psychoactive drug 
involved, together with the user’s own genetic predispositions and other biological 
factors play some role in this process. There is, however, consensus that neither the 
drug itself nor the genes alone can generally initiate the cycle of addiction. Addicts 
have to decide voluntarily to initiate taking drugs and continue acquiring them. 
Moreover, most addiction theories agree that the desire to use psychoactive drugs and 
the process of addiction depend a great deal on the individual’s emotional make-up as 
well as other contextual or environmental factors, such as the availability of the drug 
and its cost. These arguments come from addiction models based on two dominant 
social science theories: psychology and economics. Thus, in the next section, these 
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two approaches are presented and discussion ensues as to how each perspective 
informs the other. 
Economic Models --- Economists have always considered behavior to be the 
result of an individual-based, cognitive, decision process based on an informed 
choice between options that are subject to specific budget constraints (or limitations). 
Within this framework, rationality is defined as the pursuit of happiness. Any 
individual “economic actor” is assumed, therefore, to behave rationally if he/she does 
things expecting maximum personal benefits (or utility, i.e., satisfaction derived) and 
he/she is aware and willing to accept any adverse consequences of such a behavior. 
In the past, economists generally downplayed the study of drug use and 
addiction or treated it specifically as an impulsive and irrational behavior, therefore 
not suitable for conventional economic analysis (Schelling, 1984). Over time, 
however, several economic models have been proposed that offer a unique view 
depicting drug users as “rational,” guided by his/her own self-interest. Chaloupka, 
Tauras, and Grossman (2000) identified three types of economic models that define 
addiction as myopic, imperfectly rational, or a fully rational process.28 Within the 
group of rational choice models (Vuchinich & Heather, 2003), Becker’s Rational 
Addiction Model (RAM) is often regarded as the gold standard with respect to 
                                                 
28All three models owe their foundation to the original behavioral theory of choice, 
the matching law (Herrnstein, 1970), which postulates that the value of drug use is a 
function of the relative cost/benefit ratio of its consumption. The three models differ 
however in their assumptions about the extent of rationality among substance users.  
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microeconomic theories.29  It is frequently used to explain addictive behavior as an 
“intertemporal, rational process” compelling the pursuit of the best self-interest or 
happiness (Becker, 1962, 1993; Becker & Murphy, 1988; Stigler & Becker, 1977).30  
Based on Rational Choice Theory (RCT), the RAM asserts that drug use, like 
other rational choices, is part of a solution to the consumer’s expected lifetime 
“utility” (satisfaction) maximization. Accordingly, drug users are motivated, like all 
consumers who purchase a wide variety of goods, by the satisfaction or long-term 
happiness caused by the induced pleasure from drug consumption. In this respect, 
“satisfaction” (i.e., utility) is controlled or dependent on market-based economic 
criteria. To date, successful applications of the RAM have largely included prediction 
of cigarette smoking (Becker, Grossman, & Murphy, 1991, 1994; Cameron, 2000; 
Chaloupka, 1991; Suranovic, Goldfarb, & Leonard, 1999) and consumption of 
alcoholic beverages (Grossman et al., 1995; Waters & Sloan, 1995). Further 
extensions have included models to account for drug initiation (e.g., Saffer & 
Chaloupka, 1999) and for patterns as well as levels of consumption of marijuana, 
 
29Becker and Murphy (1988) actually claim that the RAM has important antecedents 
in the literature, including the work by Ryder and Heal (1973), Boyer (1978, 1983) 
and Iannaccone (1986).  
 
30In the RAM, addiction is not limited to drug consumption. The model can be 
applied to a wide range of addictive products and behaviors, such as coffee drinking 
(Olekalns & Bardsley, 1996), gambling, and watching TV/movies (Cameron, 1999).  
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cocaine, and/or heroin (e.g., Bretteville-Jensen & Biørn, 2003; Grossman & 
Chaloupka, 1998; Jofre-Bonet & Petry 2004; Pacula, et al., 2000).31 
The RAM is clearly distinguished from other economic models because it 
regards addictive behavior as forward-looking32 and consistent over time. What this 
means is that the rational component of Becker’s model derives from consumer 
awareness of future implications of continued product selection and the weight of this 
awareness on current consumption decisions (i.e., rational behavior conveys forward 
thinking and is based on salient market information). As informed decision-makers, 
drug users are assumed to recognize that their addictive behavior has negative long-
term consequences; however, weighing both the present and future into their 
consumption decision, they judge that the benefits outweigh the costs. According to 
Becker’s model, drug users who think only in terms of present consumption (i.e., 
current satisfaction) are ‘myopic’ (or impulsive) because they do not consider the 
future or reflect on the potential adverse consequences of their current behavior. 
Discounting future implications of current consumption also underscores the fact that 
drug users are risk-takers, as they are willing to consume psychoactive drugs in spite 
 
31Despite using different economic measures, relying on diverse samples, and 
applying different methodologies, these studies have provided empirical support for 
the RAM. In all of the examples provided, estimated models showed significant 
effects for price as well as past and future consumption, highlighting the basic notion 
that economic principles guide drug user’s thoughts and actions (Caulkins & Nicosia, 
2010). 
 
32This feature of Becker’s RAM represents a distinct departure from previous 
economic models; especially those based on a myopic view of addiction, where the 
user does not fully consider the future consequences of his/her present use of drugs. 
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of the detrimental consequences, and they do so because they expect the “highs” 
(satisfaction) to outweigh the “lows” (harm). Elaborating further on the rational 
process of addiction in Becker’s model, Orphanides and Zervos (1995) argued that 
drug users do not wish to become addicts; that would in fact be entirely irrational. 
Drug users might not even recognize their implicit susceptibility to addiction or they 
simply choose to ignore it. In either case, addicts are regarded as consumers who lost 
a “rational gamble.” 
Another important feature of the economic approach to drug addiction 
concerns the core idea supporting the mainstream economic concept of a “rational 
economic man.” In economic RCT, everyone is assumed to have a given set of 
personal tastes and preferences, referred to as a utility function (a measure of 
satisfaction derived from the consumption of commodities and based on the 
individual tastes and preferences). The model also assumes that everyone’s choices 
are limited by the level of income or wealth accumulated, referred to as budget 
constraints (a measure of purchasing power). To act rationally, the “economic man” 
has to choose a course of action that maximizes his/her own utility function subject to 
whatever monetary constraints he/she faces; i.e., the “economic man” makes the best 
of his/her situation. Becker’s RAM postulates that drug users are also rational (or 
competitive) as they are forward-looking people who constantly maximize their 
satisfaction within the limitations of their personal preferences, given their lifetime 
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budget, and being fully aware of the future implications of their decision (Becker & 
Murphy, 1988).  
Yet another essential feature of the rational economic-approach to drug 
addiction involves the formulation of certain constructs, such as the concept of “stock 
of addictive capital.” In the RAM, Becker assumed that, in order to become addicted, 
a drug user must have consumed the drug and thus reached a certain “critical level” 
of past drug habits or “stock of consumption capital” (i.e., addictive level based on 
past drug use). This concept of addictive stock is introduced in the RAM in terms of 
an investment function form. As a “human capital,” this construct of stock of past 
drug use plays a critical role in the drug user’s rational decision-making process. 
Indeed, addiction is assumed in this model to involve reinforcement and tolerance, 
which are mediated via the stock effect of past consumption. An increase in past 
addiction stock fuels the craving for present consumption because of the adjacent 
complementarily nature of psychoactive drugs [i.e., the marginal utility of drug use 
increases with experience due to its reinforcing effects (Becker & Murphy, 1988, p. 
677)]. At the same time, the satisfaction from present consumption is lower when 
past consumption is greater due to the harmful addictive effects of drugs [i.e., 
negative marginal utility (Becker & Murphy, 1988, p. 682)]. Under the RAM 
assumptions, drug users seek to maximize their own satisfaction and, therefore, 
constantly compare the negative (future harm) with the positive (current satisfaction) 
effects of an increase in their addictive stock due to an increase in current use. The 
  47
rational decision to consume drugs requires that the marginal increase in pleasure 
from an increase in current consumption exceeds future harmful effects from a higher 
stock. In other words, the reinforcement effect must outweigh the tolerance effect 
(Becker, Grossman, & Murphy, 1991).  
Another key concept built into Becker’s model of rational behavior is the 
discounting of the monetary utility of drug consumption based on the idea of stable or 
consistent rational preferences. The RAM parameterization is based on the 
assumptions of perfect information regarding the potential dangerous effects of drugs 
and time consistency in the drug user’s preferences. Taken together, these two 
assumptions lead to the formulation of an additive discounted value (utility) function 
over the lifetime stream of drug consumption with a higher weight on immediate use 
of drugs and a lower weight on future consumption. The assumptions behind the 
formulation of this exponential discount function in the RAM have recently been 
called into question [West, 2006 (Chapter 7)]. The end result is an alternative option 
to improve the model allowing for flexible preferences (e.g., Winston, 1980), 
hyperbolic discounting (Skog, 1999), and imperfect information to take into account 
the possible future regret and learning from past choices (e.g., Orphanides & Zervos, 
1995). Although the more recent refinements have provided useful insights into 
explaining some aspects of addictive behavior, they ultimately represent “simple” 
modifications and/or extensions of Becker’s original model (i.e., the RAM). As such 
these refinements maintain the assumption that drug users are forward-looking 
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consumers who make rational choices based on the constrained maximization of their 
utility function. 
Through this constrained maximization, economic theory suggests that drug 
users pay attention to the price of drugs (as a cost measure) and that income (a 
measure of “purchasing power” introduced via the “budget constraints”) weighs 
heavily in their individual decision to acquire and to use drugs. Depending on the 
magnitude of reinforcement and the strength of a drug’s addictive properties, the 
actual market fluctuations in costs determine consumption patterns as a downward-
sloping demand schedule (Becker, Grossman, & Murphy, 1991; Chaloupka, Emery, 
& Liang, 2003). This framework suggests that if the price of a drug increases, while 
holding income constant, demand for the drug will fall. Economists call the 
relationship between market fluctuations in unit price and consumption patterns 
‘price elasticity’ (a measure of responsiveness of consumption to changes in price). In 
their empirical studies of smoking initiation and cessation, Chaloupka and colleagues 
showed that young smoking initiates, for example, attend to current market 
fluctuations in price (i.e., they are price sensitive), whereas older smokers decide to 
quit based on future cigarette prices (Chaloupka & Grossman, 1996; Chaloupka & 
Wechsler, 1997). Overall, economists suggest that young people and individuals with 
less income pay less attention to the future and heavily discount or ignore future 
events (including health). As a result, their economic reality is heavily based on 
current price (Becker, 1990). Price sensitivity among young people may be tied to 
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their lack of disposable income. On the other hand, older adults, especially those 
contemplating (or attempting) to quit smoking, may find resolve and support for 
quitting based on future pricing for cigarettes (i.e., they justify quitting based on the 
share of their income allotted to cigarette purchases). 
Economists use a broad definition of price that covers not only monetary 
value of a product (or market unit price), but also the value of time and other costs 
associated with acquiring and consuming a product. Rich or poor, people must spend 
time to procure a product and consume it. Such time is therefore considered as an 
investment in ‘human capital.’ Given this broad definition of price, neo-classical 
economists suggest that ‘opportunity cost,’ as measured by the amount of time spent 
searching for goods or services and their consumption, is a reflection of market 
transactions related to price. In the case of drugs, time spent searching and consuming 
them must therefore be considered as part of the total cost of substance use given that 
it takes time away from other activities including work, family, or other leisure 
activities. It is also easy to see how ‘rationality’ requires a measure of opportunity 
cost to be incorporated into the economic explanation of drug use, even when drugs 
are easily accessible.  
This complex economic model of addiction, involving opportunity cost and its 
manifest influence on behavior, can easily be illustrated. Consider that it is lunchtime 
on a Friday and an individual decides to purchase a drug to “enhance” their weekend 
activities (i.e., getting high). Also consider that the dealer is located far from the 
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buyer’s place of employment. The buyer, needing the drug for the weekend, has to 
make a decision whether or not it is worth traveling across town and perhaps running 
the risk of returning late to work. The individual becomes torn, so to speak, by the 
choice of being late to work and getting chastised by their boss as opposed to 
procuring the drug so they can get high and party with friends over the weekend. 
Rationality, in this case, captures the intricate decision tree used to evaluate the 
various ‘costs’ associated with drug use and juxtaposes these anticipated costs against 
the perceived benefits (i.e., the high) from acquiring and consuming the drug. 
In sum, the RAM is the “gold standard” of behavioral-economic model of 
addiction, treating drug consumption as a perfectly rational behavior, positing that 
drug users are assumed to be fully aware of their options and make their decision 
based uniquely on the maximization of their personal utility function that discounts 
their future pay-offs and consequences from their current drug consumption. As a 
result, economists believe that drug addiction responds to economic factors (e.g., 
monetary price, opportunity cost, and income) like any other commercial product. 
While many regard the RAM as a mathematically elegant economic explanation of 
human behavior, it has been criticized by social scientists because it fails to consider 
other important factors that affect drug users’ decision-making processes and the 
context in which they make their decisions (e.g., Archer & Tritter, 2000; Elster, 1993; 
Rogeberg, 2003). A number of economists also argue that a rational choice does not 
necessarily have to be economically rational (Zafirovski, 2003). To these economists, 
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rational choice theory does not explain adequately how drug users actually behave in 
the real world or how they justify their actions (Legrenzi, Girotto, & Johnson-Laird, 
1993, p. 38). In fact, an individual’s decision-making process is often influenced by a 
range of factors that are not “utility driven” (Rachlin, 2007). Psychologists, in 
particular, believe that people maintain inner motivations (other than maximizing 
welfare) like attitudes and beliefs that influence behavior. Proponents of this view 
argue that motives are usually needed as incentives or reasons to carry out a desired 
course of action or behavior, including drug use (Miller & Rollnick, 1991).  
Psychological Models --- Psychologists have had a profound influence on 
addiction research and treatment. Their influence began to take shape in the early 
1950s around the time the American Psychological Association endorsed the disease 
concept of addiction (Room, 1983). Historically, numerous schools of thought in 
psychology proposed different theories to account for substance use problems, 
focusing mainly on the individual mental process that leads to behavior. Prevalent 
themes emphasized: (1) Personality processes, involving certain individual pre-drug 
use traits or characteristics such as novelty seeking, harm avoidance, and reward 
dependence (Conway et al., 2003); (2) Associative-learning theories, focusing on the 
idea that all behaviors are acquired mainly through operant conditioning (Schwartz & 
Lacy, 1982); and (3) Intrinsic-motivation theories, taking into account the internal 
states (or cognitive aspects) of the drug user such as feelings, emotions, motivations 
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and their influence on the decision-making process to explain behavior (Arnkoff & 
Glass, 1992).  
Most of the psychological theories assumed people are goal-oriented and their 
individual behavior is seen as the pursuit and enjoyment of their goals (Klinger & 
Cox, 2004). Based on this common assumption, psychologists offered numerous 
models to address the wide range of attentional, emotional, expectance and other 
cognitive processes involved in choosing and pursuing personal goals. 
In the case of drug addiction, it is conceivable that economists and 
psychologists examine the same behavior merely from different viewpoints. For 
instance, marginal utility, satisfaction, discounting, stock of addictive capital are all 
economic terms used to characterize the many factors used by an individual as they 
weigh or evaluate whether they will consume a product (behavioral motivation). 
Likewise, psychological theories use value expectancy models in which the 
individual weighs or evaluates the pros and cons of whether to engage in behavior. 
The Theory of Reasoned Action (TRA) suggests that the determining factor in 
behavioral choice and action is intention (Ajzen & Fishbein, 1980). Intention is 
assumed to be based on the combined effects of personal attitudes (subjective 
evaluations of importance and pleasantness), beliefs (or behavioral expectations) an 
individual holds about the consequences of the behavior as well as the perception of 
its social acceptance (i.e., normative climate). According to the TRA, the intention to 
act is formed when a person weighs the pros and cons (values) about the outcome 
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(expectancy) associated with the behavior. The attitude toward a behavior is deter-
mined by the overall expectancy-value of the behavior (Fishbein & Ajzen, 1974).  
Furthermore, psychologists argue that although behavior can reliably be 
predicted by intention, it may not be performed unless the person is motivated to act 
(Coon, 2006). Motivation influences and directs behavior toward achieving the 
intended goal. According to Miller and Rollnick (1991), “motivation is not [however] 
a stable trait that exists within the person.”  For drug users, motivation can take two 
forms: a personal enjoyment or an escape from negative feelings (e.g., self-
medication hypothesis (Cohen & Baum, 1995; Khantzian, 1985). Either way, the 
nature of drug users’ motivation makes their preferences endogenous to their internal 
states (Bickel & Marsch, 2001). Thus, although psychologists and economists agree 
that drug use is a personal “choice” based on “self-interest,” they approach crafting 
the factors that influence the drug user’s choice quite differently (Vuchinich & 
Heather, 2003). While economists posit that drug consumption is a rational choice 
based on external factors such as prices and income, psychologists put forth the 
notion that such a choice is based on internal motivations and could be irrational or at 
least not completely under individual rational control [West, 2006 (Chapter 7)]. 
Rather than price, utility, and other market factors, psychologists propose that 
individuals make decisions whether to engage in behavior based on perceived 
behavioral sanctions from “referent others” (norms regarding what other important 
people regard as acceptable) and “behavioral expectancies” (perceived benefits of 
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behavior). In this respect, addictive behavior needs to be understood in terms of the 
constraints and limitations of the drug user’s cognitions. According to psychologists, 
only those “inner limitations” can explain why drug addicts frequently behave in 
certain ways that might not be rational (Baron, 2000).  
Bandura’s Social Learning Theory (Bandura, 1977; 1997; 1999) goes one step 
further and offers a more complete social-cognitive framework describing human 
behavior. According to Bandura, intention or behavioral belief is not enough to 
explain behavior; in fact, intention alone cannot differentiate performance. Rather, an 
individual’s decision to engage in a behavior, his/her relative level of persistence, and 
energy expend on that behavior are based on a self-efficacy formulation. 
Fundamentally, self-efficacy represents a cognitive schema or “impetus” that captures 
whether an individual perceives that he/she has the skills to cope with the situation 
and to engage in the behavior in question. Self-efficacy comes from past performance 
linked with response contingencies and is motivational because individual engages a 
task after evaluating their efficacy. 
These and other dominant psychological theories argue that cognitive 
representations inside a person’s head that take shape as “motivations” are 
responsible for an individual’s behavioral activity and choice. In the psychological 
literature, the construct “motivation” has received a good deal of attention with 
respect to drug use (e.g., Cox & Klinger, 1988; Mook, 1996), primarily highlighting 
the role of affect regulation (e.g., Cooper et al., 1995), psycho-biological factors (e.g., 
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Baker, Morse, & Sherman, 1987), and expectancy models (e.g., Mann, Chassin, & 
Sher, 1987; Smith, 1994; Stacy, Widaman, & Marlatt, 1990). According to 
expectancy theory, people drink alcoholic beverages, for example, because they 
believe the effects of drinking alcohol will be positive both now and in the future.  
As we can see, the construct ‘motivation’ takes on a slightly different 
meaning for psychologists and economists. Economists believe that lack of income 
combined with drug price and opportunity cost might encourage users to network 
with other users in order to reduce or minimize cost and time spent procuring drugs in 
order to maximize happiness. Economists also believe that frequenting places where 
drugs are readily available results in reduced economic costs associated with a drug-
abusing lifestyle (i.e., attending rave parties where there is an abundance of Ecstasy). 
Bars and restaurants, for instance, that make alcohol readily available during “happy 
hour,” essentially offer a product at reduced monetary as well as opportunity costs. 
Despite the relative strength of these economic and psychological arguments 
in studies of alcohol use, applications of these concepts together to study drug use 
have rarely been attempted. This suggests a tremendous need to combine these 
theoretical models and examine the relative influence of economic as well as 
psychological motivational factors in the prediction of drug user’s behavior. 
4. Conceptualizing a Psycho-Economic Model of Ecstasy Use 
As mentioned in Chapter I, Ecstasy is one of several “club drugs” that has 
recently witnessed increased use by adolescents and young adults. The drug itself is 
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avior in particular.  
                                                
known to be both a stimulant and a hallucinogen, and its effects are potentially life-
threatening. However, users claim that Ecstasy produces an altered state of 
consciousness with sensual euphoria and heightened feelings of self-awareness. It has 
also been associated with sexual activity and other drug use.33 In particular, 
numerous studies have documented close associations between high-risk sexual 
activity (e.g., lack of protection, multiple partners, sexual activity while under the 
influence) and Ecstasy use, pointing toward evidence of causality or shared common 
factors, such as risk-taking, compulsivity and/or vulnerability (Cooper, Peirce, & 
Huselid, 1994; Justin, Finn, & Steinmetz, 2000; MacDonald, Zanna, & Fong, 1998; 
Schafer, Blanchard, & Fals-Stewart, 1994; Tapert et al., 2001). Increasingly, these 
relations are more commonly observed among adolescents (e.g., Graves, 1995; 
Lowry, Holtzman, Truman et al., 1994; Mezzich, Tarter, Giancola et al., 1997; 
Strunin & Hingson, 1992) and young adult populations (e.g., Castillo, Barrio, Belza, 
& De la Fuente, 1999). As with many drugs, the attractiveness of immediate gain and 
feelings of euphoria overshadows potential negative consequences that may be 
experienced down the road. This view has often had an effect on drug users’ 
decisions in general and their addictive beh
Sexual risk-taking and drug use are associated, due to intoxication leading to 
“disinhibition” or “impairment in judgment” that prompts increased sexual risk-
 
33More details on the subject can be found in Nicholas Saunders book “E for Ecstasy” 
published in 1993 and made available on the web at: 
http://www.ecstasy.org/books/e4x/e4x.ch.04.html, last accessed February 16, 2011. 
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taking (Murphy, Monahan, & Miller, 1998). Economic views suggest that lack of 
buying power and the absence of wealth may prompt drug users to trade sex acts for 
drugs (or for money to buy drugs of their choice), thus increasing the likelihood users 
can acquire drugs at minimal cost to maximize their benefit or “high.”  
One other area of concern revolves around linkages between psychiatric 
disorders and substance use. Psychoactive drugs may also be consumed to escape 
negative physical and/or psychological feelings. A great deal has been written about 
substance use as a means of regulating affective distress, its role as a palliative coping 
mechanism, or form of self-medication for physical and mental health issues. In 
particular, drugs such as cocaine and marijuana, among other substances, have been 
associated with depression (e.g., Johnson & Kaplan, 1990; Swaim, Oetting, Edwards, 
& Beauvais, 1989). In many respects, the euphoric qualities associated with Ecstasy 
may help mask affective disturbance or ameliorate disturbing self-referent thoughts. 
The possibility of third-variable alternatives including depression and/or sexual risk 
as valid explanations of Ecstasy use and dependence makes it essential to control for 
these and other motivational measures.  
To summarize, the present study weaves together hallmark components 
representing both economic and psychological theories of addiction to account for 
Ecstasy use. Using external market-based factors including price and income departs 
significantly from the more traditional psychological views of addiction that 
showcase the strengths of internal characteristics and motivation (e.g., control, self-
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efficacy, and reasoned action to name a few) to account for addictive processes. The 
common or shared conceptual underpinnings hold that individuals make choices 
regarding consumption based on self-interest. In psychology, the Theory of Reasoned 
Action, and likewise in economics, Rational Choice Theory, identify reinforcement 
as critical in understanding drug use and abuse (in addition both disciplines regard 
tolerance as important components necessary to understand addiction). 
Reinforcement, in economic terms, expresses the link between past and current drug 
use in terms of perceived utility. Increases in the addiction stock lead to increases in 
the utility (i.e., satisfaction) of current consumption and consequently tolerance. 
Because of diminishing return (due in part to tolerance to the drug), current 
consumption fuels future consumption. The nature of reinforcement in this decision 
tree (and the suggested learning mechanism that is not too distant from what 
psychologists’ term reinforcement) considers the weight given to current 
consumption, future costs, and the discounting process. In psychology, reinforcement 
plays a prominent role in linking external activity with internal cognitive processes 
and ultimately expression of behavior (e.g., Bolles, 1972). Where these two 
approaches depart is that psychologists herald the importance of internal 
(unobservable) processes as a fundamental part of the decision tree, whereas 
economists place greater emphasis on external (observable) market indicators beyond 
the immediate control of the individual as influential in consumption decisions (e.g., 
Montoya, Atkinson, & Trevino, 2000). It goes without saying that, for a 
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comprehensive and adequate understanding of such a complex behavior, the 
confluence of both economic and psychological theories is necessary. The 
combination of both theoretical views might shed additional light on our 
understanding of drug addictive behavior bringing into scrutiny at the same time both 
external and internal factors.  This was the objective of the psycho-economic model. 
5. The Proposed Psycho-Economic Model and Research Hypotheses  
Based on the above review of the most dominant theories of drug addiction, a 
structural equation model of Ecstasy use and its consequences was developed and 
tested. Figure 1 graphically depicts the conceptual framework underlying the 
proposed psycho-economic model. As depicted, the two major domains of influence 
included psychological (defined mainly by motivation to use drugs) and economic 
measures (income and monetary as well as opportunity costs), which are 
hypothesized to influence the designated outcomes of Ecstasy use (or Consumption) 
and Dependence (included in oval frames).34 A third domain of influence, referred to 
as “Other Risk Factors,” entailed personality characteristics (Risk Taking) and 
 
34There is no precise definition of addiction, per se, albeit many consider “compulsive 
use” as a singular defining feature. There are other ways to conceptualize addiction 
including based on problems from continued use, which by necessity occur from 
consumption. “Problems from drug use” were categorized by the American 
Psychiatric Association “Diagnostic and Statistical Manual” (DSM) into “Abuse” and 
“Dependence,” representing two different facets of addiction. The latter measure was 
chosen for two reasons, (1) dependence captures more serious consumption level, and 
(2) dependence problems are directly associated with the motivational strength (due 
to the craving and/or tolerance) that characterizes drug users compulsive behavior to 
procure and consume a drug. Dependence provides a viable behavioral analog to 
consumption by measuring the severity of the individual’s drug use practices. 
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psychological status (Depression). Additionally, other individual characteristics (i.e., 
demographics) were included in a separate domain to assess the broader implications 
of whether immutable factors such as gender, race, age, and education would enhance 
the explanatory power of the model. Because variables forming each domain might 
measure common constructs, latent-variable methods were used in the actual model. 
Specifically, the psycho-economic model was hypothesized to include four latent 
constructs (Ecstasy Use, Dependence, Motivation, and Depression), several observed 
measures (income, price, opportunity cost, and risk-taking), and demographics.  
In Figure 1, a straight line with a single-headed arrow indicates a causal 
process where one variable or construct directly influences another. A curved line 
with a double-headed arrow indicates a correlation, or statistical association. Thus, 
the relationship between Dependence and Consumption is posited as a covariance 
(correlation) because causal relations between these two measures are at best 
complex. It is common to think of using more drugs as causing more problems, or 
that consumption will "drive" the dependence on the drug. It is also possible that by 
becoming dependent, which includes physiological indicators of tolerance and 
withdrawal, the individual increases his/her consumption to diminish or forestall 
these effects, i.e., Dependence fuels Consumption. Another criterion for Dependence 
is continued use despite psychological problems, leading to the same interpretation. A 
person’s continued drug use increases their dependence but also increases their 
psychological problems.  
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Based on this theory-driven conceptual model, the following hypotheses were 
tested: Hypothesis 1. Economic factors such as price and income will directly 
influence Ecstasy consumption, controlling for psychosocial factors and other control 
measures. 
Hypothesis 2. The psychological measures (e.g., motivation) and other intra-
individual characteristics (i.e., depression and risk-taking) will influence both Ecstasy 
Consumption and Dependence, controlling for economic factors and other control 
measures. 
Hypothesis 3. The combination of adding psychological and economic 
measures into a model of drug consumption will increase significantly the overall 
proportion of variance accounted for by the full set of measures. 
 
 
 
Figure 2.1. A Conceptual Psycho-Economic Model of Ecstasy Use and Dependence
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CHAPTER III:  RESEARCH METHODOLOGY 
 
This chapter outlines the study design and methodology used to test the 
specific research hypotheses addressing the proposed psycho-economic model for 
Ecstasy consumption and dependence. It describes the data collection procedures, 
assessment strategy and interview methods, sample characteristics, and measures 
utilized as well as their psychometric properties. The chapter then provides a brief 
overview of the specific parameter estimation and statistical modeling procedures 
used to test the study formulated hypotheses.  
Like most secondary data analyses, where data has been already collected to 
address specific research questions, the present study faced certain challenges. Hence, 
the chapter begins with a discussion of several pressing methodological concerns, 
outlining the strategies used to address them. This is followed by a detailed 
description of the secondary data sources utilized, the measures available to define 
the economic and psychological concepts included in the model. The chapter 
concludes with a brief introduction to the latent-variable Structural Equation 
Modeling (SEM) procedure employed to estimate the model parameters. This last 
section also includes a discussion of the statistical indices used to gauge model fit as 
well as the strengths and weaknesses of SEM for theory testing. 
  63
1. Overview: Study implementation challenges and their resolution 
A central challenge in testing the proposed psycho-economic model was to 
locate an appropriate data source that provided suitable information on drug users’ 
consumption patterns, economic measures, and the necessary psychological measures 
linked etiologically with drug use behavior. Underscoring the difficulties inherent in 
studying drug use, Harrison (1997, p. 17) noted, “Drug use is an illegal activity and 
illicit drugs are illegal commodities; therefore, {drug} use cannot be measured by 
normal marketing procedures.” 
As a consequence of the potential legal consequences if caught, illicit drug 
users are generally inaccessible for direct inquiry regarding their drug involvement. 
Information regarding the use of controlled substances and related activities therefore 
must be obtained from alternative sources including archival records. Examples of 
useful official record sources include information culled from police reports about 
drug arrests and narcotic seizures, drug-use treatment admissions, and drug-related 
medical emergencies. 
Information abstracted from official records offers several advantages, 
including immediate accessibility to the data, the potential quality of information that 
could be available, the unobtrusive nature of the data collection (extraction) method, 
and its relative cost-effectiveness. However, there are a number of limitations with 
this type of data source that can restrict its utility for research. In particular, 
information from official records may not always be entirely satisfactory and/or error 
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free. The accuracy of such information depends mainly on the consistency of record 
keeping, which may be questionable (van Kerckvoorde, 1995).  
In addition to their potential deficiencies, official records on drug arrests are 
susceptible to administrative and policy changes. McAuliffe et al. (1999 & 2002), 
among others (e.g., DeFleur, 1975; MacDonald, 2002; Schmidt & Weisner, 2000), 
suggested that “public pressures,” the “quality of leads” from “cooperating arrestees" 
and other “drug-trade informants,” as well as “changes in funding” may exert a huge 
influence on drug enforcement arrests. The operation of these external forces may 
bias drug use data, limiting what we truly know about the actual patterns of drug 
market activities (McAuliffe et al., 2002). Seconding this concern, DeFleur pointed 
out that “these biases distorted the validity of drug arrest rates as measures of drug 
use to unknown degrees” (1975, p. 102).  
The biggest problem with official records is that they reflect merely the “tip of 
the iceberg” thus providing only a snapshot of what may really be going on.  In other 
words, official records document occurrences of individuals who came in contact 
with the criminal justice system or sought treatment. For example, given the fact that 
the prevalence of treatment is notoriously low among drug users, there is a large and 
inherent bias resulting from the fact that treatment records reflect only a subset of the 
large population of drug users.  
These concerns suggest that measures of illicit drug use collected from 
official sources should not be used for research purposes, particularly in etiological 
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studies of drug use and abuse. In fact, today, more than ever, most drug addiction 
researchers bypass official agencies and access directly the relevant drug-using 
population, applying standard self-report and semi-structured interview survey 
methods to gather information from the drug users themselves.   
Survey methods have been used routinely in social and behavioral sciences to 
gather information about personal, sensitive, and delicate matters, including opinions, 
attitudes, perceptions, and even behaviors or experiences known only to the 
respondent. It is obvious, for instance, that questions addressing motivations to use 
illicit drugs can only be obtained from the drug user. Also, given the clandestine 
nature of illicit drugs, survey questionnaires provide ideal tools for accessing and 
engaging out-of-treatment drug users who are usually difficult to reach (Cottler et al., 
1996). It is therefore not surprising that self-report surveys are the most widely used 
means of data collection for exploring drug-users’ behavior. 
The basic approach to survey methods requires asking questions and 
recording the respondents’ answers. Such a “direct method” of data collection can 
provide a wealth of information, including patterns of use, risk and protective factors, 
and consequences of use. Over time, the survey methods have become sophisticated, 
incorporating various improvements particularly in question design and techniques of 
administration, expanding its applicability to various sensitive areas such as sexual 
practices, victimization, and even crime (Hagan, 1993; Thornberry & Krohn, 2000). 
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Despite the enormous advances made in these techniques and their wide 
applicability, survey methods have continued to face great skepticism concerning the 
reliability (consistency of the collected information over time) and validity (accuracy 
of the data) of information obtained using this approach (Hagan, 1993). In particular, 
there has always been doubt about whether respondents would voluntarily disclose 
accurate information about their own drug consumption and reflect accurately on 
their habits and motivations for drug use. Whether caused by intentional distortion 
(due to “social desirability” or “fear of repercussions”) or simply inaccurate recall 
(poor introspection), “response biases” associated with survey data can systematically 
distort and even bias the hypothesized relations between a self-reported measure and 
other variables of substantive interest. Despite these concerns, careful research has 
shown that “self-reports of drug users are sufficiently reliable and valid to provide 
accurate descriptions of drug use, drug-related problems and the natural history of 
drug use” (Drake, 1998, p. 253).  
Beyond the credibility of respondents, there has also been a concern about 
other sources of measurement error, which may occur at any stage in a survey-based 
research. These concerns include but are not limited to problems of sample selection, 
poor questionnaire design, and inadequate survey administration (Pepper, 2001). 
Methodological or measurement issues can contaminate the data, which can, 
in turn, reduce the precision of the models being tested and affect the power of the 
study. The potential effect of “measurement error” can however be avoided, if not 
  67
reduced to a negligible level, by 1) conducting a validation sub-study prior to the 
actual data collection, using focus groups and pilot studies to help formulate better 
questions that can improve the precision of responses, 2) selecting an adequate study 
sample size in order to have sufficient statistical power to address the research 
questions, 3) implementing stringent study protocols and appropriate data quality 
control procedures to manage the conditions of the survey administration and 
eliminate any possibility of interviewer-induced systematic errors in the data, 4) 
carefully choosing and appropriately training interviewers to improve data quality 
and minimize the risk to study participants (Ellsberg et al., 2001), 5) replicating the 
findings with different samples under the same conditions, and 6) accounting for 
possible residual measurement error by choosing appropriate statistical techniques for 
data analysis.  
The concern over having error-free survey data particularly when dealing with 
illicit-drug users transcends finding “relevant” information to answer the research 
questions. It requires a thorough knowledge and solid understanding of the data 
collection procedures and study protocols used to assemble such information as well 
as implementation of appropriate statistical data analysis procedures.  
Another concern stemming from reliance on secondary data analysis is the 
challenges of locating an appropriate and comprehensive source of data that 
incorporate all of the relevant information needed. Toward this end the present 
dissertation study was facilitated by the oversight provided by Dr. Linda B. Cottler, 
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Principal Investigator (PI) of the “Tri-City Study of Club Drug use, Abuse and 
Dependence” (CDSLAM). This federally funded study was conducted by research 
staff working at the Epidemiology and Prevention Research Group (EPRG), affiliated 
with the Department of Psychiatry at Washington University, School of Medicine. 
Several factors suggest this study provides a unique opportunity for secondary 
data analysis: The CDSLAM is a multi-site study establishing the reliability and 
validity of diagnostic criteria for substance use disorders. Furthermore, the study 
involved specifically examining the suitability of the DSM-IV (APA, 1994) 
classification of “club drugs,” including Ecstasy, which has yet to be classified as a 
separate drug category in the DSM (Cottler et al., 2001, 2009). The CDSLAM 
(hereinafter referred to as the “parent study”) also included the largest known sample 
of out-of-treatment Ecstasy users, amassed comprehensive and detailed self-report 
data, covering most aspects of substance (alcohol and drugs, including Ecstasy) use 
and related consequences that are central to DSM-IV abuse and dependence criteria. 
Moreover, self-report data from this study was found to be highly reliable and valid 
(Cottler et al., 2009; Shacham & Cottler, 2009). 
One other concern underscores perhaps the most significant challenge faced in 
this investigation. Even though the parent study provides a rich resource for 
developing and testing the model under consideration and answering related research 
questions, its data were not specifically collected for the purpose of the present 
investigation. In other words, the CDSLAM measures were not originally designed 
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with the aim of testing a psycho-economic model of Ecstasy use. For instance, in 
some cases, the variables of interest for testing a psycho-economic model may have 
been coded or treated differently than expected. To exemplify this concern, the 
survey questions pertaining to respondents’ income were coded as categorical rather 
than as continuous measures. Although the categorical levels of an income measure 
should indeed underlie its continuous dimension, the latter type of measurement is 
generally more precise and therefore more informative than the former. This does not 
however invalidate the data in any way, but highlights the problems that may arise 
from obtaining data through secondary data analyses. 
There are other measurement considerations that reinforce similar concerns. 
Economists have long debated whether current income or earnings provide an 
“absolute” indicator of the consumer’s “purchasing power.” Some suggest that other 
measures of economic status such as “permanent (also known as lifetime) income” or 
wealth should be given a more prominent role in empirical analyses of the pattern of 
consumption behavior (Friedman, 1956; Modigliani & Brumbergh, 1955). For drug 
users, in particular, this matter is even more complicated, as some users may turn to 
illegal and criminal activities to pay for their drug habits. There is considerable 
debate whether “financial reward” obtained thorough criminal activities should be 
considered as part of income. It is common practice, in this situation, to create a 
composite variable (or multi-item scale) consisting of all available information 
(encompassing a broad spectrum of survey items) related to potential sources of 
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income, and using this proxy measure to indicate purchasing power. Such an 
aggregate measure may require additional data transformation (dichotomizing some 
variables and/or re-categorizing others) and decisions regarding proper weighting 
schemes to enhance the formulation of a composite score (Markus, 2008). In certain 
instances, these same concerns were addressed in the present study through data 
manipulations to create unit-weighted composite scores that provide the type of 
information needed (Bentler, 2004; Mentzer & Flint, 1997). 
Modern innovations in statistical modeling also influence the way we can test 
various hypotheses. For example, individuals providing information in this study 
responded to multiple questions about specific behaviors. As is common when more 
than one question is used to query a particular behavior, there was some conceptual 
and empirical overlap between these items, reinforcing shared variance. The 
moderate associations between multiple items or indicators (scales) are hypothesized 
to be “statistically caused” by an unobserved latent factor (also called a latent 
“construct’). This type of latent variable approach is common in psychological 
research, where researchers often infer a “hypothetical” construct based on the shared 
association among multiple items or indicators. Depression is one good example and 
problems from consumption or “dependence” provide another. In the case of 
depression, a person will report that they are slow to get out of bed; they experience 
mood swings or sad affect, and also note somatic experiences (i.e., loss of appetite). 
These items often appear related statistically and they are common features of 
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“depression.” The point is that by itself, depression is not observable but rather 
inferred from the collection of symptoms reported. In other words, one does not “see” 
depression, rather one infers that a person is depressed based on a collage of 
symptoms or behaviors reported by the individual. 
The same conceptualization of latent variable methods holds for problems that 
arise from chronic drug use, which is termed in the extreme form “dependence.” Here 
a drug user taking a survey might report they cannot control their urges, cravings, or 
desires to use drugs and even indicate that during the day they constantly think about 
using drugs. The same person might also answer affirmatively that they continue to 
use drugs even though they experience side effects that impair their normal day-to-
day functioning. In this brief example, the “inference” about a drug user’s 
consumption is they may be addicted or dependent again based on the collage of 
symptoms reported and the strength of empirical association between these items. 
As these two examples show, there is a conceptual argument that supports 
hypothesizing a latent construct, given that symptoms of sad affect, feeling blue, 
behavioral and somatic complaints, are all signs or markers of depression. There is 
also an “empirical” side to consider given that inspection of a correlation matrix 
containing these items would reveal modest overlap or shared variance between these 
items. Using covariance structure analysis a researcher hypothesizes a latent construct 
that statistically “causes” the association among the symptoms. In other words, the 
variation underlying the latent construct is attributed to the close correspondence 
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between the multiple measures. In the case of depression, the symptoms are observed 
responses on a survey but the latent construct is inferred based on the statistical 
association between the symptoms. 
Self-report information is not always one hundred percent accurate, suffering 
from reliability concerns as with any measure. The problem of accuracy in recall or 
measurement error is just one of the many factors that can influence self-report or 
interview data at any moment in time. The lack of total reliability introduces 
measurement error into the model that can be accounted for statistically. The standard 
approach to deal with these measurement problems is to a) use an appropriate 
statistical technique that combines information from multiple indicators, b) 
disaggregate the measurement error using techniques from classic psychometric 
theory; and c) create hypothesized latent constructs to account for the moderate 
association among the multiple indicators. Latent-variable Structural Equation 
Modeling (SEM) is one of several covariance structure techniques that can handle 
these measurement issues in a unified statistical framework. 
As detailed below, the SEM combines the strengths of confirmatory factor 
analysis (CFA) with multivariate structural regression. The confirmatory factor 
analysis represents relations between latent constructs and measured or observed 
indicators in a single measurement model. This portion of the model addresses how 
well we have conceptualized the latent factors based on the hypothesized model.  The 
CFA provides “error-free” estimates of factor loadings indicating the magnitude of 
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relations between an observed (manifest) indicator and a hypothesized latent 
construct. The model is specified in such a way that the factor loading represents true 
or shared variance (representing the overlap between several items) and a separate 
variance term indicates the error component. Following estimation of the 
measurement model, the structural equation portion of the model then provides 
estimates of the relations between latent constructs and also between measured 
variables and latent constructs in a single multivariate model.  
The structural component is unique in that it can estimate several multiple 
regressions simultaneously posting both independent predictors and dependent 
outcome measures (both latent and observed). Combining the measurement and 
structural portions of the model into a single overarching framework increases the 
reliability of the model, provides a more parsimonious way to represent the multiple 
relations, and increases power. For these reasons a latent-variable SEM procedure 
was used to test a psycho-economic model of drug use and abuse in this study. 
Having discussed the conceptual and methodological challenges faced by the 
current investigation and the appropriate resolutions, the next sections in this chapter 
present the research data used and the method of statistical analysis used to test a 
latent-variable psycho-economic model of Ecstasy consumption and addiction. 
2. Data Source and Concepts Measurement 
This section begins with a description of the parent study, the “Tri-City Study 
of Club Drug use, Abuse and Dependence” (CDSLAM). It includes formal discussion 
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of the study design focusing on participants’ eligibility and recruitment, survey 
instruments, research protocols, and data collection procedures. The section ends with 
a presentation of the measures used to test the psycho-economic model. 
The CDSLAM Study: An Overview 
The CDSLAM is a multi-site study funded in 2001 by the National Institute 
on Drug Abuse [NIDA, (R01 DA14584)],35 Generally speaking, the CDSLAM was 
designed to examine whether club drugs (i.e., Ecstasy, Ketamine, GHB, and 
Rohypnol) form a separate class of psychoactive drugs, requiring their own set of 
DSM diagnostic criteria. The DSM or “Diagnostic and Statistical Manual of Mental 
Disorders” currently in its fourth edition (DSM-IV), contains the official diagnostic 
nomenclature of the American Psychiatric Association (APA, 1994). Specifically, the 
CDSLAM was designed to 1) ascertain the utility of using the DSM-IV diagnostic 
criteria for each specific club drug, including tolerance, withdrawal, loss of control 
and other social and personal consequences; and 2) assess the reliability and validity 
of club-drug users’ self-reported drug use practices and habits and any associated 
problems and consequences that stem from continued drug use. 
The CDSLAM study recruited out-of-treatment, club-drug users starting in 
November, 2002 to January, 2005. Participants were drawn from geographical areas 
indicated by NIDA’s International Epidemiology Work Group (IEWG) surveillance 
network as “emerging or current high-risk areas” for club drugs (IEWG on Drug 
                                                 
35NIDA is one of many centers and institutes forming the National Institutes of 
Health (NIH). 
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Abuse, 1999). Three sites were selected: St. Louis [Missouri, US; PI: Dr. Linda B. 
Cottler, Ph.D. - Washington University (data collection lasted between 2002 and 
2004)], Miami [Florida, US; Co-Investigator (Co-I): Dr. Jim A. Inciardi, Ph.D. - 
University of Delaware (2002-2004)], and Sydney [New South Wales, Australia; Co-
I: Dr. Jan Copeland, Ph.D. - University of New South Wales (2003-2005)].  
Trained interviewers located at all three sites received the same instructional 
procedure and followed the same research design and study protocol, including 
identical subject recruitment procedures and applying the same assessment strategy. 
Potential study participants were presented with detailed information at each site 
outlining the purpose of the study and their rights as research subjects. Participants 
were also told that their information was completely confidential; written consent was 
obtained from each participant prior to the start of the interview. All human subject 
and study protocol procedures for data collection received approval from the three 
respective institutional review boards. 
Research Design -- The CDSLAM project employed a mixed-design 
approach (Green et al., 1989), combining elements of both quantitative and 
qualitative research methods (Creswell & Plano, 2007). Specifically, the study was 
carried out in two phases. The first phase involved focus group discussions 
(unstructured “group” interviews) that were used to engage club drug users in 
discussion about their consumption preferences. Focus groups are part of an 
exploratory qualitative (ethnographic) phase that provides in-depth information 
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confirming special idiomatic expressions used to describe drug-related experiences 
and how individuals “think” about socially or culturally taboo subjects.36 This 
ethnographic component of the study was done to acquire a better understanding of 
the subculture and the contextual factors that promote club drug use. The groups were 
audio taped and then transcribed, coded, and analyzed to develop an understanding of 
the thoughts, feelings, and behaviors described by the respondents (Reich et al., 
2006). The findings from the focus groups were then later used to guide the 
development and/or refinement of the survey questionnaires used in the quantitative 
portion of the study. 
The second (or quantitative) phase of the CDSLAM project involved 
psychometric evaluation, including establishing the reliability and validity of self-
reported data pertaining to the potential abuse and dependence liability of each club 
drug. This phase also involved establishing the psychometric properties of various 
risk factors that have been suggested in the literature as putative causes of drug use 
and drug consequences. This phase began with a pilot study conducted in each site to 
determine the applicability, acceptability, and practicality of the questionnaires that 
have been developed and further revised based on the focus groups information.  
The pilot study focused first on comprehension issues (e.g., clarifying 
terminology, and gaining insight whether respondents had difficulty answering and/or 
 
36Focus groups are a common practice in behavioral science and entail group 
discussion involving anywhere from 8 to 12 individuals who informally “chat” about 
some topic of interest. The topics are presented in order by a moderator or trained 
facilitator and the group discusses the topic from several different angles.  
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interpreting questions) and the flow of the questions asked (e.g., problems with 
interview skip patterns). Members of the evaluating team [including the study PI, Co-
PIs, Project Director (or Coordinator), and interviewers (or raters) hired in St. Louis] 
took turns experimenting with the assessments by interviewing each other. Findings 
from this intense pilot test were subsequently used to revise and improve the 
computerized interviews. 
The computerized version of each assessment was carefully tested locally for 
contents (e.g., no spelling errors or missing survey items) and programming errors. 
Next, all the assessments were tested by conducting interviews with a small (5 to 10) 
number of drug users in each of the three sites for final pilot validation. The 
information gathered from this step was also used to correct or refine the final version 
of the computerized instruments. The revised questionnaires were finally 
implemented first at the home-study site, St. Louis, and then distributed to the other 
sites for their own data collections. 
The instruments for the CDSLAM project were administered to the same 
individual at two separate (about one week apart) occasions (referred to as “Time-1 & 
Time-2” interviews or “test-retest”). A different lay interviewer was used at each time 
to provide estimates of inter-rater reliability (i.e., assessing the concordance of the 
interview process). A diagnostic validation component included a semi-structured 
interview that was later administered (Time-3) by a certified clinician. Additionally, 
the test-retest component included a short debriefing and a Discrepancy Interview 
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Protocol (DIP) to identify the reasons for inconsistencies between the respondent’s 
answers at Time-1 and Time-2 interviews. Tests of research hypotheses for the 
psycho-economic model rely on Time-1 interviews only. 
Subject Recruitment -- The CDSLAM study recruited out-of-treatment, 
community club-drug users in order to ensure a broad cross-sectional representation 
of the research sample. Given the difficulty in randomly (probability) sampling such 
a hard-to-reach, illicit-drug-using population, the CDSLAM sampling plan used a 
modified “non-probability” approach, combining “targeted” sampling (Carlson et al., 
1994; Watters & Biernecki, 1989) with a “chain-referral network” or “respondent-
driven” sampling technique that draws on the drug users’ social networking 
familiarity (Heckathorn, 1997).  
Both sampling methods have been widely applied to reach hidden or “hard-to-
reach” populations including drug users (Heckathorn et al., 1999, 2002; Semaan et 
al., 1998; Peterson et al., 2008). Also, since the parent study emphasized establishing 
the psychometric properties of DSM-IV adopted criteria for club drugs use, it did not 
require validating prevalence information, making the applied sampling techniques 
appropriate. More importantly, the combined sampling procedures minimize as much 
as possible their respective sources of biases37 and create statistically representative 
                                                 
37This concern refers to the potential biases associated with a) the volunteerism in 
target sampling (participation from interested subject only) and b) the selection of 
initial respondent in chain referral sampling (i.e., referring subjects that are 
behaviorally similar through peer or friendship “selection” mechanisms: Salganik & 
Heckathorn, 2004). 
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samples of hard-to-reach subjects (Heckathorn, 2002; Magnani et al., 2005; Robinson 
et al. 2006; Salganik & Heckathorn, 2004). 
Based on the combination of these two sampling methods, a number of 
distinct subject recruitment techniques were implemented to ensure diversity in the 
final sample. Recruitment efforts included posting and/or distributed flyers in public 
areas and locations frequented by young adults, including dance clubs and bars; 
running advertisements in local newspapers; postings in high-school and college 
newspapers; internet postings on bulletin board systems, blogs and social network 
sites (such as “FaceBook” and MySpace); and referrals from the community. 
Additionally, the study also used respondent-driven recruitment techniques 
(Watters & Biernacki, 1989). Once the Time-2 interview was completed, recruited 
participants were asked to refer acquaintances and friends from their social networks. 
An incentive of $5 was offered for each recruited referral. 
Potential participants approached directly on the streets or referred to the 
study were briefly informed about the study aims and given a flyer providing them 
information on the CDSLAM project. The flyer included the local study-site phone 
number that participants were asked to call to find out more about the study and/or to 
confirm their willingness and eligibility to participate. During the call, a trained 
Research Assistant (RA) verified the caller’s eligibility and addressed relevant 
questions about the study. 
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To be eligible for enrollment in the quantitative study phase, participants in all 
three sites were required to be between 15 and 45 years old, and to have used at least 
one club drug (i.e., Ecstasy, Ketamine, GHB, and Rohypnol) more than five times 
lifetime, with the most recent use occurring within the last 12 months. 
In addition to these study eligibility criteria, potential participants were also 
required to a) provide a signed parental permission for legal minors, younger than 18 
years; b) have not participated in the study’s prior focus group phase; c) be willing to 
take part in potentially three interview sessions within a 10 days period; and d) speak 
and understand English, as all interviews were conducted in English. Once eligibility 
of the prospective calling-participant was determined, a verbal consent was sought 
while on the phone and Time-1 & 2 interviews were scheduled. 
Study Protocol and Procedures -- Figure 3.1 below outlines the CDSLAM 
study protocol and “timeline” (i.e., flow chart) for the procedures and measurements 
used. The three study sites followed this same protocol for data collection with two 
non- essential exceptions to the current investigation. Specifically, St. Louis, the 
home-study site, had an additional ethnographic sub-study aimed to provide an in-
depth understanding of Ecstasy withdrawal and tolerance. In addition, Sydney 
participants were not tested for “Human Immunodeficiency Virus” (HIV) nor were 
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they tested for other sexual transmitted diseases (STDs), such as Chlamydia, 
Gonorrhea, hepatitis B and C, Herpes and Syphilis.38 
Figure 3.1. CDSLAM Study Flowchart for the Psychometric Testing Phase 
Flyer posting & distribution, Advertisements 
in local papers, Internet posting & respondent-driven 
recruitment efforts
Eligibility I: Aged 15 to 45, used Ecstasy 5+ times lifetime & 
 1+ time past 12 months
Eligibility II: Subjects screened, informed about study 
confidentiality & asked to sign IRB approved consent
Time I: Subjects administered
 
 
38STDs and HIV testing was required by NIDA for all studies among drug users 
conducted in the US. More details on this requirement can be found on the following 
NIH web site: http://grants1.nih.gov/grants/guide/notice-files/NOT-DA-07-013.html, 
last accessed February 17, 2011. 
SAM, RBA & CES-D Test
Recruitment:
Facesheet & Contacts,
STDs & HIV testing
Time II: Subjects administered Re - TestDIPSAM RBA &,
Randomly 50% 50%
assigned
Clinical Interview : Ethnographic Sub-Study: (St. Louis)
Subjects administered the WHO SCAN ‘Adopted’ DSM--IV Withdrawal criterion
[Random (1:3) selection in 2 groups] 
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As Figure 2 shows, the qualitative phase included three interviews: the two 
test-retest (reliability) interviews and an in-depth clinical (validity) or ethnographic 
interview.39 For the reliability arm of the study, all confirmed eligible subjects were 
required to participate in at least two interview (Time-1 & 2) sessions. After the 
second interview (Time-2), respondents were randomized to have either a clinical or 
an ethnographic interview.40 At all three sites all of the interviews were conducted by 
independent interviewers.  
Prior to initiating Time-1 interview, each participant was provided important 
details about the study, consented in writing, and informed that all information 
gathered are protected (using a NIDA Certificate of Confidentiality) and treated as 
confidential.41 At that point, all participants were reminded that one of the aims of the 
CDSLAM study was to examine item-specific reliability of DSM-IV criteria as 
adopted for club drugs, based on their Time-1 & 2 interviews. They were also told 
that the same questions are asked at both interviews and that the same answers could 
be given each time. Additionally, study participants were advised that they could 
 
39Reliability refers to the extent to which, if repeated, the same questionnaire leads 
consistently to the same answer. Validity, on the other hand, refers to the extent to 
which the questionnaire measures what it is supposed to measure (Joppe, 2000).    
 
40Randomization to the ethnographic interview applied to St. Louis participants only. 
Participants in Miami and Sydney where only randomized to have the clinician 
interview. 
 
41Several steps were taken to assure the confidentiality of data, including de-
identifying each individual record and storing the final data on a secure and privately 
managed server. Only research staff with the highest investigator clearance could 
access personal records (FaceSheet & Contact data). All data were only accessible 
through password protected files and secure servers. 
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withdraw from the study at any time and that there would be no penalty or loss of 
compensation. Following a discussion of these study and other ethical issues, detailed 
locating information on each participant was solicited to facilitate mailing study 
reminders and/or tracking each one for follow-up (Time-2) interviews.  
After gathering the locating information, urine and hair samples were 
collected from each participant in all three sites and analyzed for marijuana, cocaine, 
heroin, PCP, and methamphetamine. The urine samples from St. Louis and Miami 
participants were also tested for the presence of STDs. Additionally, oral fluid 
collection device, “OraSure®,” was used to test participants in St. Louis and Miami 
for HIV/AIDS and other STDs. All HIV tested participants received counseling 
regarding HIV infection and were given up to one hour of individualized pre- and 
post-test counseling, as required by the funding institute (NIDA). Following the 
collection of biological specimens, the Time-1 interview proceeded. A week later, 
each participant was invited back for Time-2 interview.   
Once Time-2 interview was completed, all participants were interviewed with 
the Discrepancy Interview Protocol (DIP) to determine the reasons for any 
differences in their answers at both times (Cottler et al., 1994). Immediately after 
completing the DIP interview, each participant was handed a sealed envelop 
concealing their random assignment to the validity portion of the study, including the 
clinical interview (referred to as Time-3 interview). In each site, only half of the 
participants were randomly selected and scheduled for a clinical appraisal. The other 
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half were either told that the study was completed or invited to participate in a one-
on-one ethnographic interview to discuss their experience with tolerance and 
withdrawal from club drugs.42 The clinician (or Time-3) interview was conducted 
using a revised substance use section of the World Health Organization (WHO) 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Either (the clinical or 
ethnographic) interview was conducted within the next four days following Time-2. 
The clinician as well as the ethnographic interview took less than one hour each.  
Interviews Setting and Quality Control -- All interviews were conducted face-
to-face by trained interviewers and a certified clinician in private settings (study-site 
office building, mostly) and behind closed doors to assure privacy. In each site, 
recruited interviewers underwent a week-long formal training on the protocol and the 
study assessment tools. The training was conducted by a St. Louis team, including the 
Principal Investigator (PI) and the Project Director, in all three sites. After the group 
training, interviewers were required to pass a final quality control check (a “mock 
interview”) prior to interviewing in the field.  
Throughout the project, interviews were audio-recorded and their electronic 
medium was mailed to the St. Louis site for quality and accuracy evaluation. At the 
start of the data collection, all audiotapes of each interviewer were reviewed in their 
                                                 
42Only St. Louis participants had these options. Miami and Sydney participants, who 
were not selected for clinical interview, were basically told that the study required no 
further participation after the Time-2 interview. The selection for the ethnographic 
interview was not randomized. Instead, it was based on whether the participant has 
endorsed tolerance and/or withdrawal symptoms, and was not eligible for the clinical 
(Time 3) interview.  
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entirety by an experienced Quality Control supervisor. Later on during the study, a 
random sample of 20% and then 10% of each interviewer’s tapes were reviewed to 
ensure quality of the data. Feedback on each reviewed tape was immediately sent to 
their appropriate site for the local Project Coordinator to discuss with the 
interviewers. In addition, teleconference meetings involving all three sites were held 
on a regular basis during which the Project Director, and Coordinators discussed the 
project progress and site specific issues. Participants were remunerated up to $70 as a 
compensation for their time and inconvenience completing up to three (Time-1, 
Time-2, and clinical or ethnographic) interviews. 
Study Instruments -- The purpose of the CDSLAM quantitative phase was to 
collect information about various aspects of club drugs consumption and related 
consequences. Five standard research questionnaires were selected to fit the study 
areas of interest, revised to focus mainly on club drugs, and evaluated in terms of 
their content, depth, sensitivity, and responsiveness as described earlier. The 
originally selected survey questionnaires were: The Substance Abuse Module (SAM), 
The Risk Behavior Assessment (RBA), The Center for Epidemiological Studies 
Depression Scale (CES-D), The Discrepancy Interview Protocol (DIP), and The 
WHO Schedules for Clinical Assessment in Neuropsychiatry (SCAN). 
After revisions, the selected assessments were computerized for ease of use 
and to minimize interviewers’ mistakes. The first four (SAM, RBA, CES-D, and DIP) 
instruments were used for the test-retest interviews [or reliability (Time-1 & 2)] while 
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the fifth (SCAN) instrument was used by the study clinician during the validity 
interview session (Time-3). Data gathered for the current investigation were derived 
directly from Time-1 interview, using the SAM, RBA, and CES-D instruments only.  
The remainder of this section provides a brief history and a description of each 
instrument. 
Substance Abuse Module for Club Drugs (SAM-CD) – The SAM-CD was a 
revised version of a preexisting instrument known as the Substance Abuse Module 
(SAM: Cottler et al, 2001). The original SAM (CIDI-SAM: Cottler, 1990) was an 
expansion of the substance use disorders (SUD) sections of the Composite 
International Diagnostic Interview (CIDI Version 1.0, WHO 1987; Robins et al, 
1988; Robins, Cottler & Babor, 1990), which itself was an amalgamation of two 
preexisting instruments at the time: The Diagnostic Interview Schedule (DIS) 
developed at Washington University (Robins et al., 1981) and the Present State 
Examination developed at the Institute of Psychiatry, London (Wing et al., 1974).43  
The CIDI was initially the product of a collaborative effort led by the World 
Health Organization (WHO) and the former Alcohol, Drug Abuse and Mental Health 
Administration (ADAMHA) [parent agency of the three current NIH institutes, 
including: National Institute of Mental Health (NIMH), National Institutes of 
Alcoholism and Alcohol Abuse (NIAAA), and National Institute on Drug Abuse 
                                                 
43The CIDI-SAM represents the third-generation of diagnostic schedules for 
psychiatric disorders. See Robins (2004) for a detailed account of the historical 
evolution of the current psychiatric instruments.  
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(NIDA)] to facilitate collaborative psychiatric epidemiologic research throughout the 
world. Robins and colleagues from Washington University led the Psychiatric 
Assessment Task Force effort in the development of the original CIDI (Robins et al., 
1988). 
The WHO-CIDI (CIDI-Core) is a fully-structured diagnostic interview 
designed for use by well-trained lay interviewers, who are not necessarily clinicians, 
to assess lifetime as well as current mental disorders according to the definitions and 
criteria established by the two most widely endorsed diagnostic systems: the WHO 
International Classification of Diseases (ICD) and the APA Diagnostic and Statistical 
Manual (DSM) for mental and behavioral disorders (WHO CIDI, 1990). The CIDI-
Core questionnaire was intended to “serve cross-cultural epidemiologic and 
comparative studies of psychopathology” (Robins et al., 1988, p. 1069). In field trail 
testing across 18 sites in major geographic regions of the world during 1988, the 
CIDI-Core was reported to be generally reliable and valid (Wittchen et al., 1991). 
However, certain symptom questions and diagnoses for substance use disorders 
(SUD) were reported difficult to understand, had less then ideal reliability, and 
therefore required further revisions for a better acceptability and consistency across 
cultures (Cottler et al., 1991). 
The CIDI-SAM, which started as a revised version of the SUD sections of the 
WHO-CIDI (Cottler et al., 1989; Cottler, 1990; Cottler & Compton, 1993), was soon 
expended to thoroughly assess psychoactive substance use, abuse, and dependence 
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based on criteria for DSM-III, DSM-IIIR and ICD-10 diagnostic systems.  Over time, 
the CIDI-SAM has undergone further refinement and expansion and started being 
referred to as the SAM (Version 4.1). In 1992, the SAM was updated to include 
DSM-IV SUD taxonomy; was subsequently computerized in 1998  (C-SAM); and 
field tested for validity in 2000 by its developer Dr. Cottler and her Washington 
University team with support from NIDA (DA05585) (Cottler et al., 2000). The C-
SAM has also been used in numerous “nosological” (i.e., classification of SUD) 
studies in the U.S. as well as abroad and was deemed to be acceptable with good to 
excellent psychometric (reliability and validity) properties (see, for example, 
Compton et al., 1996; Cottler et al., 1993, 1995, 1997, 2001, 2009; Horton et al., 
2000; Howard et al., 2001).  
Consistent with its parent interview format (the CIDI), the SAM is a highly 
structured instrument with closed-ended questions; each question included specific 
instructions for the interviewers. The SAM instrument contains five sections: Section 
A covers socio-demographic questions, Section B is reserved for questions relating to 
tobacco, Section C contains alcohol questions, Section D asks about drug use, and 
Section E deals with caffeine. 
More specifically, Section D assesses lifetime as well as current (in the past 
12 months) abuse and dependence on substances and categories of substances used 
more than five times lifetime such as those defined by the DSM and ICD taxonomies. 
These substances include: cannabinoids (marijuana and hashish), cocaine and crack, 
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hallucinogens (DMT, LSD, acid, mescaline, mushrooms, peyote and psilocybin), 
inhalants (glue, toluene, gasoline, paint and paint thinner), opiates [opioids (codeine, 
Darvon, Demerol, Dilaudid, methadone, morphine, Percodan, and Talwin), opium, 
T's & blues and heroin], PCP, stimulants (amphetamines, diet pills, Ritalin, or any 
other stimulant), sedatives (barbiturates, Librium, Seconal, sleeping pills, 
tranquilizers, Valium, Xanax, or any other sedative), and other miscellaneous 
substances (amyl nitrite, poppers, anabolic steroids, and nitrous oxide).   
The SAM for Club Drugs (SAM-CD) included additionally a specific 
category for club drugs with individual questions for Ecstasy (or MDMA), GHB, 
Ketamine, and Rohypnol. The SAM and its predecessors contain numerous questions 
about symptoms from the use of each specific drug. The nosological classification of 
DSM divides these symptoms into those operationalizing abuse and dependence. An 
example of an abuse symptom includes “getting into physical fights” whereas a 
dependence symptom includes “continued use despite physical health problems.” To 
gain clarity on these conceptual distinctions consider that abuse (either symptoms or 
criterion) refer to functional impairment in day-to-day functioning with regard to role 
responsibilities (obligations of work or social functioning), legal problems, or 
disruption to home life. 
Dependence symptoms, on the other hand, are those reflecting physiological 
manifestations (withdrawal and tolerance) and continued use despite warning signs of 
psychological or physical health problems (this is only meant to exemplify the bi-
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axial formulation). According to the DSM classification rules, the individual 
symptoms are then bundled into aggregate clusters or “criterion,” which is then used 
to make clinical diagnoses of abuse or dependence, the latter two categories used to 
define substance use disorders as a basis for understanding addiction.  
A distinguishing feature of the SAM is its ability to provide information 
regarding age of onset and most recent occurrence of each of the bundled criterion, as 
well as the individual withdrawal symptoms, and specific physical, social, and 
psychological consequences of each substance. This information is then used to 
estimate duration and course of the individual symptoms as well as to formulate the 
criterion. Coupled with this information, additional data on the quantity and 
frequency of use are then used to judge the severity and course of each disorder. The 
SAM also provides an evaluation of each respondent’s substance use impairment and 
treatment history.  
Risk Behavior Assessment for Club Drugs (RBA-CD) – The RBA-CD was 
adopted from the Risk Behavior Assessment (RBA) questionnaire, which was 
originally developed by the National Institute on Drug Abuse (NIDA) in the early-
1990s as a standard method for collecting HIV risk-taking data related to drug abuse 
and sexual behaviors at the community level (NIDA, 1991). The original RBA was 
first used in a NIDA-funded, multi-site study conducted during the 1990s entitled 
“Cooperative Agreement on AIDS Community-Based Outreach/Intervention 
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Program” (CA). The study targeted out-of-treatment crack-cocaine and injection drug 
users and included 38 cities throughout the U.S.44  
The RBA was designed to identify risk factors for HIV acquisition and 
transmission. It was specifically used to collect self-reported data on socio-
demographic characteristics (e.g., gender, age, race, education level attained, past 12 
month employment and income, as well as general health status), recent drug use 
behaviors [including drug use patterns, injection drug use (IDU) habits, and drug use 
treatment history], and sex practices (e.g., type and number of sex activities, number 
of male and female sex partners, condom use patterns, sex trading behaviors, and 
perceptions of risk as well as belief in risk reduction behaviors). All questions 
pertaining to drug use practices and sexual behaviors refer to past 30-days period 
from the interview date to reduce “response biases” that could be attributed to 
inaccurate recall. The drug section covers also last 48 hours drug usage, 
corresponding to the approximate maximum time period during which urinalysis is 
sensitive for drug detection. The reliability and validity of the original RBA 
questionnaire has been thoroughly tested with favorable results. In particular, the 
drug-use questions have been found to have excellent test-retest reliability and good 
 
44Dr. Cottler and the EPRG team were one of several NIDA grantees on the CA study 
tasked with conducting a randomized intervention study (referred to as “Each One 
Teach One [EOTO], conducted from 1993 to 1999). The study focused on providing 
educational information on the risk of transmission of HIV and STDs among crack-
cocaine users and drug injectors in St. Louis (Cottler et al., 1998). Dr. Cottler was a 
member of the NIDA consortium of CA-funded researchers who developed the 
original RBA.  
 
  92
concurrent validity as demonstrated by the urine test (Dowling-Guyer et al., 1994; 
Edwards et al., 2007; Needle et al., 1995; Weatherby et al., 1994).   
Over the past few years and in response to specific study requirements, Dr. 
Cottler and the EPRG team at Washington University have made several revisions to 
the original RBA to increase its utility with female drug users, heavy drinkers, and 
offenders; as well as male and female inhalants users and club drug users. For the 
CDSLAM study the RBA was significantly modified based on the findings from 
focus group discussions (qualitative phase of the CDSLAM study) and refined later 
through several rounds of pilot-testing, as described earlier. 
The RBA has always been used to enrich the data provided in the SAM, 
which serves primarily a diagnostic purpose. The RBA for Club Drugs (RBA-CD) 
focused not only on HIV risk-taking behaviors, as they relate to drug use and sexual 
behaviors, but also on situations and events that could shed more light on the abuse 
and dependence liability of each club drug; such as bingeing, concomitant use of 
over-the-counter drugs (like 5HTP) to “come down,” school or work performance, 
and parental monitoring history. Additional information on the reasons for drug use, 
rave party attendance, religion and music preferences, and perception of harms were 
also added. The original sections on IDU habits (needle sharing) and sex practices 
were replaced with more relevant questions about sex practices while under club 
drugs influence as well as sharing drugs at parties.  
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The RBA-CD assessment also included questions to gather a wide range of 
economic data; such as drug availability, dealer access and user network, lifetime 
quantity of each club drug used and other detailed information on past 30 day 
consumption, actual price paid last time using a particular drug as well as 
respondent’s own expected price, employment, current income and other relevant 
information detailing sources of income. The RBA-CD has been found to have good 
test-retest reliability (Shacham & Cottler, 2009). 
The Center for Epidemiological Studies Depression Scale (CES-D) – The 
CES-D is a 20-item self-report scale developed by the NIMH based on previously 
validated scales for depression (Radloff, 1977). The CES-D scale covers several 
aspects of depression within the past week (last 7 days). The items include depressed 
mood, lack of concentration, feeling of guilt, sadness and worthlessness, crying 
spells, loss of appetite, and sleeping disturbance, among others. All 20-symptoms are 
scored on a 4-point scale, ranging from rarely to almost always and four items are 
reverse coded for scale consistency. Validation studies with clinical populations have 
established well defined total scoring ranges: less than 15, indicating no endorsement 
of major depressive symptoms; 15-21, mild to moderate depression; and over 21, 
indicating major depression. The CES-D has been extensively used as a screening 
tool for assessing current depressive symptomatology in clinical as well as research 
settings using general population samples. Several branches at the NIH have used the 
CES-D questionnaire in their large, multi-site studies of diverse populations due to its 
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excellent psychometric properties among general population samples (Beals et al., 
1995; Golding & Aneshensel, 1989). The CES-D has been shown to have very high 
internal consistency and adequate psychometric properties among youth and young 
adults. 
Interview-Time Requirements -- Time-1 interview sessions required between 
two and three hours. The CD-SAM took approximately 60 minutes, the RBA-CD 
took a minimum of 20 minutes, and the CES-D about 10 minutes. In addition, each 
participant spent about 20 minutes on average providing locator information to 
facilitate tracking during follow-up interviews (Time-2 & 3). It was also estimated 
that respondents traveled 30 minutes on average to get to the interview site. 
Participants in the CDSLAM quantitative data collection were able to receive up to a 
maximum of $120 U.S. dollars in monetary compensation for their participation in 
three different time period interviews. The incentive included compensation for 
assistance with recruitment.  
Study Sample -- The use of multiple sampling techniques (described earlier) in 
combination with the PI’s weekly-meeting monitoring-system for recruitment 
progress proved to be a highly effective recruitment strategy. A total of 1084 
individuals from the community responded to the targeted outreach efforts (e.g., 
flyers, newspaper ads as well as electronic advertisements, to name a few strategies) 
and respondent’s referrals. As was described above, an initial eligibility screening 
was performed over the phone. Of the 1084 subject contacts, 157 (14%) respondents 
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were immediately found ineligible through the telephone screen. The remaining 927 
callers were invited to enroll in the study upon a final in-house determination of their 
eligibility. At this point, an additional 9 respondents were eliminated. As a result, 918 
individuals consented and were enrolled in the study across all three sites [439 (48%) 
subjects in St. Louis, 317 (34%) in Miami, and 162 (18%) in Sydney]. Out of the 918 
enrolled respondents, 269 (29%) never showed up to their Time-1 interview and 649 
were interviewed, yielding slightly more than a 70% overall recruitment response 
rate.  
Additionally, 5 (0.5%) respondents were eliminated for various reasons; 
including relocation too far for staff to conduct cost-effective interviews, the 
participant withdrew from the study or was noticeably intoxicated on some substance 
during the interview. Among the remaining 644 surveyed respondents at Time-1, 4 
did not have complete information on all the study variables needed for this 
investigation and were therefore eliminated, leaving a final analysis sample of 640 
participants [296 (46%) subjects from St. Louis, 186 (29%) from Miami, and 158 
(25%) from Sydney]. 
Measurement Specification 
Data for the present modeling efforts were gathered from 83 questions that 
appeared in five sections (Socio-demographics, Ecstasy use, Ecstasy abuse and 
dependence, depression, and HIV-related sexual risk behaviors) of the three 
assessment batteries described earlier (SAM-CD, RBA-CD, and CES-D). All of the 
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questionnaire items were used in the construction of measured indices (or multi-item 
scales). For some measures a single questionnaire item was used. When multiple 
indicators were used to reflect latent constructs, these indicators were generally 
constructed with several items averaged, or in some cases a summed unit-weighted 
index was created. The three different approaches to creating measures are briefly 
described below. 
Ecstasy Use -- Four measured indicators reflected a latent construct of Ecstasy 
“Consumption,” one of the two main outcomes or dependent measures used in this 
study (labeled ‘Ecstasy Use’). These included: 
• A measure of lifetime number of pills used [The RBA-CD asks (QNTYLT): 
“If you were to add up all of the Ecstasy pills you have used since you first started 
using Ecstasy, about how many pills would that be?”], with response values recoded 
in increments of 10 pills ranging from ‘Less than 10 pills’ (coded as “1”) to ’greater 
than 100 pills’ (coded as “11”);  
• Number of times using Ecstasy in the past 30-day period [The RBA-CD asks 
(TMSP30DAY): “How many days have you used Ecstasy or MDMA in the last 30 
days?”], with responses coded in terms of total number of days used;  
• Frequency of Ecstasy use per day in the past 30-day period [The RBA-CD 
asks (FRQP30DAY): “During these days {when you used}, how many times a day 
did you usually use Ecstasy or MDMA?”], with responses coded in terms of number 
of times Ecstasy was consumed per day;  
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•  A measure of recency of Ecstasy use [The SAM-CD asks (RECENT): “When 
was the last time you used {Ecstasy}?”], with response categories ranging from 
‘within past 30 days’ (coded as “1”), ‘not in the past 30 days but during the last 12 
months (coded as “2”) to ‘more than 12 months ago’ (coded as “3”).  
Descriptive statistics revealed highly skewed distributions for the last two 
items (recent use and frequency). The data were accordingly transformed. Categories 
2 and 3 for recent Ecstasy use were recoded to “0” to avoid sparse numbers in the 
cells. The frequency of Ecstasy use per day in the past 30-day period showed that 
responses ranged from 0 through 12, which was then truncated (due to low frequency 
of response for number of times greater than 4) to range between 0 and 4.  
Ecstasy Dependence -- Standard DSM-IV abuse and dependence criteria were 
used to mimic the diagnostic classification techniques used with other illicit drugs. 
For this investigation, only the items reflecting dependence were modeled as the 
second outcome measure.45 A latent construct of “Dependence” was assessed using 
the seven adopted DSM-IV diagnostic criteria. The criteria included: (1) tolerance, 
                                                 
45Actually, diagnostic criteria for both abuse and dependence were included initially 
in the modeling procedure, as indicators of two separate latent constructs measuring 
the addictive potential of Ecstasy use. However, we were unable to obtain a 
satisfactory latent-variable model positing distinct constructs of abuse and 
dependence. The statistical artifact of an almost perfect correlation between the two 
constructs necessitated modeling only one construct. We also considered collapsing 
items from the two latent constructs into a single latent construct; however this 
procedure might go against the grain of certain diagnostic models. As a result the 
modeling efforts posited only the dependence construct. This also provides some 
clarity with respect to the consequences of Ecstasy consumption, and incorporates a 
construct possessing greater reliability (alpha for the Abuse construct was .91, 
whereas alpha for the Dependence construct was .96).       
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(2) withdrawal, (3) increased use of larger amounts over a longer period of time than 
intended, (4) persistent desire or unsuccessful efforts to cut down or control use, (5) 
great deal of time spent in activities to obtain substance, use substance, or recover 
from its effects, (6), giving up or reducing important social, occupational or 
recreational activities because of substance use; and (7) continued use despite 
knowledge of persistent or recurrent physical or psychological problems caused or 
exacerbated by the substance. Each one of these criteria (referred to in the model as 
DEP-1 through DEP-7) was coded as “1” if endorsed by the subject and as “0” 
otherwise.  
Economic Predictors -- Three conceptually distinct measures of economic 
importance were created through data transformations including: income, unit price, 
and opportunity cost. An index of income status (labeled ‘Income Index’) consisted 
of work status in the past 12 months [The SAM-CD asks (WRKP12M): “In the past 
12 months, how many months did you work for pay full time?”], sources of income 
in the past year [The RBA-CD asks (SRCINCP12M): “In the last 12 months, what 
were your sources of income?”], reported earnings [The RBA-CD asks (TINCP12M): 
“Considering all sources of your income, how much money did you make altogether 
in the last 12 months?”], and current employment status [The RBA-CD asks 
(CEMPSTS): “Which of these best describes your current work situation?”]. Sample 
work situation items included “unemployed,” “working full or part time,” 
“homemaker,” “student,” and “disabled.” Based on sound judgment, these categories 
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were reduced to dichotomous categories including: “Employed and having an 
income” (coded as “0”) versus “Unemployed and not having a visible means of 
support” (coded as “1”). The measure of sources of income included 12 different 
response categories, which were further dichotomized into those representing legal 
means (e.g., paid job, welfare, social security, and alimony) coded as “0” and those 
representing illegal means (e.g., dealing drugs, prostitution, or sex) coded as “1.” 
Reported earnings contained response categories in $5,000 increments, ranging from 
$0-3,999 through $25,000 and thereafter in $10,000 increments through $65,000, and 
then $65,000-$100,000). The index was reduced to a binary variable approximating 
the federal income poverty level (less than $15,000 for a family of three: Department 
of Health and Human Services, 2005) coded as “1” and those earning in excess of this 
amount coded as “0”. The resultant ‘Income Index’ comprised of the four unit-
weighted composites assessed ‘social anomie’ and ranged from 0 through 4 with 
higher scores indicating participants with lower earning potential and experiencing 
economic displacement. 
Another important measure of economic influence is the cost to acquire an 
illicit drug. In economics, such a cost is referred to as the "full price" which generally 
includes a monetary price paid for a unit of the drug purchased, a value of the time 
and effort spent to get the drug, and an expected cost for future health consequences 
as well as potential penalties for illegal use of psychoactive substances.  In this study, 
only the first two components (unit price and time spent obtaining Ecstasy) were 
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considered.46 The unit price of Ecstasy (labeled ‘Monetary Cost’) was self-reported 
[The RBA-CD asks (UPRICE): “How much did you pay for one pill of Ecstasy the 
last time you bought it?”], with response categories recoded as ‘under $10’, ‘$10-
$20’, ‘$21-$30’, and ‘greater than $30’. These categories were then dichotomized to 
‘$20 or less’ coded as “1” and ‘greater than $20’ coded as “0”. 
Users’ time spent procuring Ecstasy (labeled ‘Opportunity Cost’) was also 
self-reported [The RBA-CD asks (TIME2GETX): “If you wanted to get Ecstasy right 
now, how long would it take you to get it?”], with response categories coded in 
minutes, hours, days, and weeks. This measure assesses the cost of passing up other 
opportunities, which can serve as a monetary motivation in the drug user’s decision 
process. Based on inspection of the resulting distribution of this cost measure, we 
converted all responses to a daily metric and then further refined it to a binary form 
representing ‘a day or less’ coded as “1” and ‘greater than one day’ coded as “0.”  
Other Explanatory Measures -- The possibility of spuriousness and 
confounding relations makes it important to control for psychosocial functioning in a 
model detailing the unique role of economic measures to account for variation in 
consumption. A latent construct of “Motivation” for Ecstasy use was reflected by 
indicators assessing opportunities for obtaining Ecstasy [The RBA-CD asks 
(WAYS2GTX): “We are interested in all the ways people get ecstasy, have you ever 
                                                 
46The last two components of the economic cost (the future cost of health care and 
potential penalties) were not assessed in the parent study and the use of other sources 
was considered inappropriate, as explained earlier in this chapter. 
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gotten ecstasy from …,” with response formats including “spouse, family member, 
roommate, stranger, and dealer” then forming an additive index ranging from 0 to 5]; 
places to use Ecstasy [The RBA-CD asks (PLACES): “We are also interested in all of 
the places people take or use Ecstasy. Have you ever taken or used it in …,” with 
responses including a myriad of places including rave clubs, bars, and fraternities, to 
name a few, which were dichotomously coded (‘yes/no’) and summed into an 
additive index); a unit-weighted index of people to share Ecstasy with [The RBA-CD 
asks (PEOPLE): “Have you ever used Ecstasy with …”, listing different people 
including spouse, friends, roommates, dealer, to name a few]; and a unit-weighted 
index assessing various affect regulation and positive enhancement motives for using 
[The RBA-CD asks (MOTIVE): “have you ever taken Ecstasy for …,” with response 
categories including “stress relief, bonding, pressure, spiritual experience, and 
curiosity,” among others, which were all coded ‘yes/no’ (1/0) and summed]. 
A latent factor of depression (labeled “Depression”) was reflected by four 
five-item random parcels capturing the behavioral (e.g., “I talked less than usual”), 
somatic (e.g., “I did not feel like eating, my appetite was poor”), affective (e.g., “I 
had crying spells”), and cognitive (e.g., “I had trouble keeping my mind on what I 
was doing”) components of depression. Random parcels represent an excellent means 
of preserving scale integrity, homogeneity, and capturing the underlying 
multidimensional structure of depression (e.g., Radloff, 1977; Bagozzi & Heatherton, 
1994; MacCallum et al., 1992; Little et al., 2002). Items were distributed evenly 
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across the four parcels (CESD-1 through CESD-4) with consideration of content 
balance and reliability. 
Additionally, we included a unit-weighted index of HIV sexual risk-taking 
(labeled “Sex-Risk”), including dichotomously scored items (‘yes/no’ coded 1/0) 
assessing frequency of vaginal intercourse [The RBA-CD asks (EHADVSEX): “have 
you ever had vaginal sex?”], repeated identically for oral and anal sex; age of onset 
[The RBA-CD asks (AOSEX): “How old were you the first time you had sex of any 
kind?”], coded as ‘younger than 15’ (coded as “1”) and ‘older than 15’ (coded as 
“0”); number of sex partners in the last three months [The RBA-CD asks 
(SEXPARTNRS): “In the last three months, how many different sex partners have 
you had?”], dichotomized as more than three sex partners versus less (‘yes/no’); 
forced sexual contact with a dating partner [The RBA-CD asks (FRCDSEX): “Have 
you ever been forced to have sex with a dating partner?”],  coded ‘yes/no’ (1/0); 
frequency of condom use [The RBA-CD asks (CNDMVP12M): “In the last 12 
months, how often have you used a condom or other barrier protection when having 
vaginal sex?” which was repeated for oral and anal sex] with response categories 
coded as ‘Never’ (coded as “0”) through ‘Always’ (coded as “4”), which were further 
divided into ‘Never and Rarely’ (coded as “1”) and ‘More Frequent Use’ (coded as 
“0”) (designating lower risk with more frequent condom use), and having sex under 
the influence [The RBA-CD asks (SEXUNDER): Having ever been under the 
influence of Ecstasy while having any kind of sex” (‘yes/no’)]. The sexual behaviors 
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used to index drug users’ risk-taking in this study are consistent with Center for 
Disease Control and Prevention (1991) guidelines for “high risk” activity related to 
HIV and other morbid conditions (STD). 
Control Variables -- The model also contained several exogenous measures to 
control for potential subject differences. These included demographic characteristics, 
including gender (male coded as “1”), race [White (coded as “1”) and racial 
minorities and others (coded as “0”)], age [‘less than 21’ (coded as “1”) versus 
‘older’ (coded as “0”)], and education [‘less than high school’ (coded as “1”) and 
‘beyond high school including vocation and technical education’ (coded as “0”)]. 
These subject characteristics were modeled into a single structural equations model 
and then further used to examine subgroup differences through more refined tests of 
moderation. 
3. Statistical Modeling Method 
As previously stated, the present study applied Structural Equations Modeling 
(SEM) analyses to test the hypotheses regarding a psycho-economic model of Ecstasy 
consumption and Dependence. For this purpose, all statistical computations including 
model parameters estimation and fit indices were performed using the EQS 6.1 for 
Windows statistical program (Bentler, 2004). EQS was specifically chosen for this 
investigation because it offers distinctive advantages, including its built-in robust 
statistics function to correct for non-normally distributed data (i.e., reducing Type I 
error in parameter estimates; Byrne, 1994). 
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Preliminary descriptive, bivariate correlation, reliability, and other standard 
statistical data analyses were carried out using the SAS® 9.2 software package for 
Windows (SAS Institute Inc., 2009). The rest of this section provides the basic 
underlying principles behind SEM and describes how this statistical modeling 
procedure was specifically utilized in the analyses.  
Basics of SEM --- The SEM technique has been in use since the early 1970s, 
but its origin can be traced back to 1904, when Charles Spearman first used “factor 
analysis” to identify common factors underlying the association among manifest 
indicators. Also, Sewall Wright made a substantial contribution in 1921 as he was 
credited with testing the first path model (with observed measures). Early historical 
reviews of the development of SEM have been provided by Bentler (1986), Jöreskog 
(1982), and Mueller (1996). Economists have also adopted this approach (Duncan, 
1975; Goldberger, 1972; Kline, 2005); however, SEM was “greatly misused” and 
“inadequately formalized” by economists very early on and never became a standard 
practice in causal economic modeling (Freedman, 1987). 
In general, SEM provides a statistical tool for validating the psychometric 
properties of multi-item scales and also for testing causal multivariate processes. In 
the economic and social science literatures, SEM has been exclusively applied to 
analyze consumer behavior with regard to travel choice (see, for example, Golod, 
2001; Kim, 2008; and Rangaswamy et al., 2008), decision making as well as 
participation in organizations and management (Rosa Diaz, 2002; Salo & Karjaluoto, 
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2007; Shook et al., 2004).  It has also been used to estimate the determinants and size 
of underground (hidden or shadow) sectors in the economy (Brambila-Macias, 2008; 
Dell’Anno & Schneider, 2009; Schneider, 2007; Vuletin, 2008). 
What is SEM? -- SEM is a second generation, multivariate technique for 
analyzing theory-driven and complex interrelations among directly observable and 
latent variables in a predictive framework (Bollen, 1989; 2002). SEM is widely 
recognized as a powerful model-building and theory testing methodology because it 
combines different aspects of various traditional multivariate statistical procedures 
including factor analysis, regression, and path analysis (Cudeck, du Toit, & Sörbom, 
2001). Although these procedures have high utility individually, by integrating them 
together into a single procedure, SEM provides a superior statistical framework for 
testing and validating theories (Bentler, 1978; Kline, 2005). Lomax (1989) even 
suggested that SEM has been “the single most important contribution of statistics to 
the social and behavioral sciences during the past twenty years” (p. 171).   
Typically, when elaborating SEMs, a researcher is required to specify a priori 
a given theoretical model (Bentler, 1978). The implied model is then tested against 
the sample data and evaluated with several absolute and inferential measures of fit 
(Bentler, 1990; Bentler & Bonnet, 1980; Kline, 2005). The idea behind SEM is to 
minimize the difference between the observed variance/covariance matrix based on 
the actual sample data and the implied or hypothesized population matrix. No one 
single fit index adequately determines the overall fit of a SEM model or its 
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correspondence with theory. Rather several fit indices are used to gauge model fit 
including the standardized factor loadings (determining how well the latent factors 
were hypothesized), the large sample chi-square test (minimizing the discrepancy 
function between the sample and implied population variance-covariances), and the 
magnitude of the off-diagonal residual covariances (indexing poorness of fit) (Hu & 
Bentler, 1999; Kline, 2005). 
One other indication of model “fit” relies on an assessment of model 
“parsimony” or the ability of the specified model to account for structural relations 
with the fewest parameters (Bentler & Mooijaart, 1989). The Law of Parsimony is 
achieved through an iterative process of model specification, estimation, and 
validation.  
What is the Structure of a Typical SEM Model? -- A typical SEM contains 
two components: a measurement model detailing the psychometric properties of the 
various latent constructs, and a second component detailing the structural relations 
(regressions) between measures and latent constructs. The measurement component 
specifies relations between latent (unobservable or hypothetical) variables and their 
respective manifest (observed) indicators. Typically, this component corresponds to a 
confirmatory factor analysis (CFA) in which each latent construct is operationally 
defined by a set of measures and then the fit of this configuration tested. A 
measurement model can be specified in several ways, but usually the latent factors 
are allowed to freely covary (restrictions can be imposed and tested against the more 
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“relaxed” model). An observed measure can be posited to load on only one “factor” 
as with simple structure or allowed to load on more than one factor as with a complex 
factor loading. Errors that reflect variance net of prediction (a factor is hypothesized 
to predict the manifest variable) can also be correlated to represent “measurement or 
time-specific variance.” These model modifications are made using empirical 
specification searches that can improve the overall fit of a model (Chou & Bentler, 
1990). Usually a researcher desires a more pure (and replicable) model so the simple 
structure approach without correlated errors is most commonly used. 
In order to deal with problem of “identification,” the latent variables are 
assigned a unit of measurement either by fixing the loading of a reference indicator to 
one or standardizing the factor variance. This provides a “metric” and helps identify 
the model and yields its measurement properties. From the CFA portion of the model 
a researcher can learn about the reliabilities of various measures and from the pattern 
of their inter-correlation with other factors or measures learn about their construct, 
divergent, and convergent validity. 
The structural component of a SEM expresses the hypothesized inter-
dependence and causal relations between latent factors and in certain cases with other 
observed variables. This part of the model represents the simultaneous estimation of 
several regressions at once, including direct effects, indirect effects (mediated by 
intervening variables), and associations (or correlations) among both exogenous and 
endogenous variables (indicators or latent constructs). Depending on the desired 
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specification, a structural regression model can be regarded as: a) saturated (where all 
possible relations are included), b) independent [no relations among measured 
variables or latent variables ([i.e., null model)], or c) constrained. A “constrained” 
model can be tested or contrasted with a more “relaxed” model that has fewer 
parameter constraints and the difference in model Chi-square (χ2) compared with the 
nested likelihood test (yielding the χ2 difference per degrees of freedom). A final 
structural equation model may include parameters that are fixed (set at some 
designated value usually zero) and/or freely estimated. When the number of freely 
estimated parameters equals (or exceeds) the number of variables in the data, the 
SEM model is said to be “just identified” (or “over justified”) [i.e., the model has a 
unique estimate (or more than one potential value) for each parameter]. 
What are the Strengths and Weaknesses of SEM? -- There are a number of 
strengths and weaknesses associated with SEM techniques. Perhaps the most 
important and appealing feature of SEM, making it a perfect tool for these analyses, 
is its ability to model hypothesized latent constructs in a regression framework. The 
psycho-economic model includes four hypothesized latent constructs; including 
Ecstasy Consumption, Dependence, Motives, and Depression. Each construct is 
reflected by multiple indicators (and indicators are constructed from multiple items), 
thus creating a more parsimonious representation of the data and increasing power.  
Another significant feature of SEM is its ability to account for measurement 
error (or “noise”) that occurs at the level of manifest or measured variables. This 
  109
specific feature alone gives SEM an advantage over other simpler, relational 
modeling techniques (such as path or ordinary least-squares regression analysis), 
which assume that all variables are measured without error.  
There is one other noteworthy feature of SEM that distinguishes it from other 
traditional modeling procedures (such as simultaneous [or system] equations [SE]). 
Indeed, like SE techniques, SEM provides estimates for all direct and indirect effects 
based on theoretical specification of causal effects. Unlike SE however, SEM also 
estimates associations (non-directional relations) between dependent variables net of 
prediction and allows models to have correlated errors of measurement (Bollen, 
2002). In other words, if there are several predictors and two dependent or outcome 
measures in an equation, SEM will estimate the effects of the predictors on both of 
the dependent measures and then estimate the association between the dependent 
measures net of prediction. This extra step provides a more accurate estimation of the 
model, drains meaningful variation from the covariance matrix, and provides a more 
optimal fit between the sample data and the implied population model. Related to this 
last point, SEM estimates the entire set of regression equations simultaneously. It can 
test whether one regression parameter is different (null model) from another as a 
whole system. In other words, SEM examines the entire architecture of the 
underlying relations in the model of interest rather than invoking a “straw-man” 
alternative (Jöreskog et al., 1999; Tomarken & Walker, 2005).  
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There are also several weaknesses associated with SEM procedures. SEM is 
mainly a confirmatory technique, which requires a priori theoretical specification of a 
model. Thus, a researcher must have a fairly good indication of the theoretical 
linkages (i.e., postulates, syntax, and axioms) before the model is tested. SEM does 
not compensate a researcher for a poorly generated model or unreliable constructs. In 
other words, SEM is highly recommended for theory testing in a confirmatory 
framework and not considered the optimal approach for testing preliminary models in 
their developmental stages. Overall, these limitations should not however decrease 
the importance of using SEM for this study. Their mention merely emphasizes the 
need for thorough knowledge of theory, a complete specification of the model, and a 
systematic process for analyzing and assessing the model results using the best 
psychometric tools available (Bentler & Mooijaart, 1989). 
Model Estimation and Testing Strategy --- Estimation of SEM proceeds in a 
systematic fashion. This process includes model identification, estimation, evaluation 
of fit, and then possible re-specification (i.e., fine-tuning) followed by estimation 
again (Bollen & Long, 1993; Kline, 2005). Furthermore, SEM is a two-step 
procedure with the psychometric [confirmatory factor analysis (CFA)] part of the 
model tested prior to its structural component (Anderson & Gerbing, 1988). Any 
changes in the CFA that provide insight to the psychometric properties of measures 
and latent constructs are considered prior to estimation of structural regression 
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effects. This iterative process was thoroughly followed in this investigation. A 
description of the adopted estimation and evaluation strategies are presented next. 
Model Estimation Procedure -- The EQS approach to SEM analysis works by 
providing parameter estimates that minimize the discrepancy between the model-
implied population covariance matrix and the actual (observed) covariance matrix 
based on the sample data. In particular, the observed covariance matrix is assumed to 
be based on a random sample drawn from the entire population. EQS offers a number 
of estimation methods based on different fitting functions. These include full-
information maximum likelihood (ML), weighted least squares (similar to ML under 
full data normality), and asymptotic distribution-free estimators (no distribution 
required) among others (Bentler & Wu, 1995). 
The ML estimation technique is the most commonly applied method for 
estimating SEM models. It proceeds iteratively and estimates all model parameters 
simultaneously. The ML technique has been shown to provide consistent, efficient 
(having minimum standard error variance) estimates, assuming multivariate normally 
distributed continuous variables (Kline, 1998). The EQS program provides several 
remedies for dealing with violations of normality (i.e., when data violate 
requirements for multivariate normality or when the underlying distributions of the 
data represent a mixture of categorical and continuous scales). The EQS program 
provides adjustments for non-normality, offering distribution-free estimation methods 
and statistical means to test for these violations (Satorra & Bentler, 2001). 
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Additionally, EQS provides “robust” standard errors of the estimates to account for 
the extent of non-normality (Bentler, 2004). For all these reasons, the EQS ML 
method option was adopted for estimation of the models tested in this study. 
Sample Size Requirement – Because the covariance structure (SEM) method 
of analysis is based on large sample theory, the correct sample size becomes an 
important issue for the estimation of stable parameter values (Kline, 2005). In 
particular, parameter estimates and overall χ2-test of model fit are sensitive to sample 
size. Therefore, the greater the number of free parameters specified in a model, the 
larger the sample size that is required to achieve a desired level of statistical power. 
There is, however, a lack of general agreement about how large is large enough to 
obtain reliable model estimates. Some researchers have suggested a range of sample 
sizes for the use with ML estimation methods; including less than 100 observations 
defined as a small sample, between 100 and 200 as a medium size sample, and more 
than 200 as a large sample (Kline, 2005). Parameter estimates should be reliable and 
stable with small standard errors given the relatively large sample size of this study.  
Other researchers have recommended a “rule of thumb” to determine the 
minimum sample size for SEM model. The rule stipulates that an adequate sample 
should include at least 10 to 20 cases (or observations) for each independent variable 
included in a model (Hair et al., 1998). Applying this rule, and given the number of 
independent measures, the psycho-economic model would require a minimum of 220 
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to 440 case; thus, the dataset we are using is more than adequate and sufficiently 
powered to detect effects.  
Bentler (1995) has suggested using the number of estimated parameters rather 
than the independent variables for power computation. Following this suggestion, 
reliable estimates for the present model would require a sample size varying between 
550 and 1100 observations. Since a saturated model will not be the goal of this 
analysis, the actual sample of N = 640 is determined to be adequate. Moreover, EQS 
offers test statistics to evaluate whether the size of the sample applied is appropriate 
(Bentler & Yuan, 1999).  
Model Testing Strategy -- An initial CFA model tested the overall statistical 
reliability of the hypothesized latent factors (Consumption, Dependence, Depression, 
Motives). The psychometric model indicates whether the latent constructs were 
conceptualized correctly. In addition, the CFA model provided a means to inspect the 
error-free correlations among the latent constructs and between latent constructs and 
any measured variables. Following the CFA model we conducted a series of 
structural models that incrementally tested the effects of economic indicators first on 
Ecstasy Consumption and then on Dependence. Additionally, given the cross-
sectional nature of the data the relation between Dependence and Ecstasy 
Consumption was estimated freely as a correlation rather than estimating a causal 
effect. Subsequent models estimated relations between latent constructs of 
Depression and Motives and their prediction of Ecstasy Consumption and 
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Dependence controlling for the economic predictors. This model is one of several in a 
series that tests the unique influence of economic indicators on the two endogenous 
constructs controlling for psychosocial risk. A “fully conditioned model” specified 
the contents of the previous model containing the two endogenous constructs 
(Ecstasy Use and Dependence) along with the predictor constructs (Depression and 
Motives), and added the observed measure of sexual risk and the economic measures. 
The latter fully conditioned model was then re-estimated using empirical 
specification searches to capture any nonstandard effects (details on these methods 
are explained below) that were not hypothesized a priori. In light of the obtained 
mean differences based on race, age, education, and site we added these measures to 
the final model to examine whether obtained parameter estimates dramatically 
changed following their inclusion.  
Goodness-of-fit criteria – Evaluation of the fit of SEMs involves several 
model fit indices. One measure of goodness-of-fit, the discrepancy function or large 
sample χ2 examines the difference between the observed and implied population 
covariance matrices. A non-significant χ2 value (p > .05) indicates the model fits well 
and there is very little residual covariation in the matrix after imposing the model on 
the sample data. As a measure of fit, the χ2 is sensitive to large sample sizes and the 
complexity (degrees of freedom) built into the model. Under such considerations, the 
χ2 measure has been shown to increase the risk of Type II error, or the probability of 
rejecting a true model (Kline, 2005). As a result, additional goodness-of-fit indices 
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have been proposed that provide additional model fit information (Hu & Bentler, 
1998). These indices can be grouped into: 1) Measures of absolute fit [such as the 
chi-square divided by its degree of freedom (χ2/df, also called normed χ2), Goodness-
of-fit index (measuring the overall degree of fit), and Root Mean Square Error 
Approximation (RMSEA: measuring an error in approximation; Browne & Cudeck, 
1993)], 2) Incremental fit measures [such as Normed Fit Index (NFI: comparing the 
proposed model with a null model; Bentler & Bonnet, 1980) and Comparative Fit 
Index (CFI: similar to NFI but incorporating degrees of freedom and non-centrality 
parameter evaluation for the both models; Bentler, 1990;  Benter & Yuan, 1999)], and 
3) Measure of parsimony [Akaike information criterion (AIC: a composite measure 
of badness of fit and complexity of the model; Akaike, 1987)]. For model evaluation 
the χ2/df, NFI, CFI, RMSR and RMSEA were applied in this investigation. Standard 
benchmarks for these model fit indices include: χ2/df less than 447, NFI, CFI and 
AGFI with values between .90 and 1.0, and an RMSEA and RMSR less than .08 (Hu 
& Bentler, 1998). 
In sum, this chapter presented the study methodology, including the methods 
for data acquisition and measurements formulation, as well as the statistical modeling 
approaches used. The chapter also introduced the basic tenets of SEM and outlined 
the principles of model estimation and the validation strategy adopted. These tools 
were fully implemented and the results are presented next. 
 
47Acceptance criterion for χ2/df varied in the literature, ranging from less than 2 
(Ullman, 2001) to less than 5 (Schumacker & Lomax, 2004). 
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CHAPTER IV:  RESULTS 
 
This chapter presents the results of the statistical analyses conducted. In order 
to integrate the voluminous material, the chapter is organized into three sections. The 
first section describes the demographic characteristics of the participants as well as 
their history of illicit-substance use and problems associated with drug use. This 
descriptive material includes their lifetime use and current (past 30-days) patterns 
(quantity and frequency) of Ecstasy consumption. Differences in the sample 
characteristics, patterns of substance use and complications are also described by site 
and gender.  
Section two presents summary statistics for all of the variables used in the 
model, including measures of central tendency (i.e., mean standard deviation, 
skewness, and kurtosis). These descriptive statistics provide a means to check 
violations of normality assumptions required for conducting the covariance structure 
analyses. Additional information includes the results of variance decomposition of 
the key measures presented by gender and site. Additionally, Pearson product 
moment correlations between all the latent constructs and measured variables/indices 
used in the model were examined to check for multicollinearity, possible suppression, 
and confounding. Information from the correlation matrix was used to examine 
interrelationships among the latent constructs and also associations between 
constructs and measured variables (Hair et al., 1998). All of these preliminary 
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descriptive analyses were carried out using the SAS® 9.2 software package for 
Windows (SAS Institute Inc., 2009). 
Section three presents results of a series of measurement and structural 
equation models implemented to test the specific research hypotheses. Briefly, the 
psycho-economic model was assessed using a two-step procedure (Anderson & 
Gerbing, 1988): First a “measurement model” was tested using confirmatory factor 
analysis (CFA) procedure. This portion of the model assesses the psychometric 
properties of the hypothesized latent constructs and provides a means to examine 
“error-free” associations among the four hypothesized latent constructs. The four 
latent constructs included Depression, Motivation, Consumption, and Dependence. 
Each construct was reflected by multiple indicators (observed measures), as described 
in the previous chapter. 
The CFA model provides two distinct pieces of information: the reliabilities 
(i.e., accuracy of measurement) of the indicators used to reflect the latent constructs 
and also information detailing the statistical associations among the latent constructs 
and between measured variables and composite measures posited in the model. The 
reliabilities are computed based on methods for structural composites (Werts, Linn, & 
Jöreskog, 1974). The relations between the four latent constructs as well as the free-
standing measured variables (e.g., income, unit price, and opportunity cost) and 
composites are indicated by Pearson product moment correlations. In the case of the 
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factor-to-factor relations, these associations are disattenuated for error of 
measurement. 
 A second step included testing and refining the “structural model” (referred 
to here as the SEM). The SEM procedure assesses the fit of the hypothesized psycho-
economic model in the sample data against the implied population model. The SEM 
was tested in a stepwise manner, starting with the economic measures to derive their 
unbiased parameter estimates and then adding the psychological measures (i.e., 
Motivation) and other selected risk factors (i.e., Depression and sexual risk) in an 
incremental fashion until all the measures and constructs were incorporated. The final 
model-parameter estimates (standardized regression coefficients) are adjusted for all 
the variables included in the model. This forward “inclusion” procedure was chosen 
to arrive at an acceptable model and eliminate any potential confounder bias, 
spuriousness, and inconsistent effects (Nachtigall et al., 2003). The final and most 
parsimonious model was then used to examine possible gender as well as site 
differences. The suitability of a particular model was determined using several overall 
fit indices, including Chi-square (χ2(df)), Normed Fit Index (NFI), Comparative Fit 
Index (CFI), Standardized Root Mean Square Residual (SRMR), Root Mean Square 
Error of Approximation (RMSEA), and the Adjusted Goodness of Fit Index (AGFI). 
All of the CFA and SEM models were tested using the EQS software program for 
Windows Version 6.1 (Bentler & Wu, 1995). The chapter concludes with a brief 
summary of the findings. 
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1. Descriptive Data Analysis 
As previously described in the methodology chapter, this investigation used 
data from a NIDA funded “Tri-City Study of Club Drug use, Abuse and 
Dependence,” referred to as the “CDSLAM.” The CDSLAM study was designed to 
examine club drug (including Ecstasy, Ketamine, GHB, and Rohypnol) use behaviors 
between 2002 and 2005 at three sites [St. Louis (Missouri, US), Miami (Florida, US), 
and Sydney (New South Wales, Australia)]. These particular sites were selected 
based on epidemiological evidence suggesting an increased incidence of Ecstasy use. 
The study’s main eligibility criteria required that participants must have used Ecstasy 
more than five times in their lifetime, with the most recent use being within the 12 
month period prior to the CDSLAM survey. The parent study included test-retest 
reliability (Time-1 & 2) and validity (Time-3) components. For the present analyses, 
only Time-1 interview data was used. The selected sample was further limited to 
current Ecstasy users who had complete data for all the variables of interest to this 
investigation. The final analysis sample consisted of N=640 participants. This first 
section provides brief background information describing the study participants and 
their pattern of drug use, including their consumption of Ecstasy and other 
substances. 
Participants’ Demographic Profile --- Table 4.1 shows descriptive statistics 
for the total sample (N=640) and by site. A total of 46% of the participants were from 
St. Louis (N=296), 29% were from Miami (N=186), and 25% were from Sydney, 
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Australia (N=158). Table 4.1 also contains numerical frequencies and percentages for 
categorical variables and means and standard deviations (SD) for continuous 
measures. Comparisons across sites for categorical measures were conducted using 
the chi-square test of independence and for continuous measures using variance 
decomposition techniques (single-factor analysis of variance, also known as one-way 
ANOVA).  
For all three sites combined (N=640), 58% of the participants were male 
(N=369), and 42% were female. All three sites had more male than female 
participants (54% at St. Louis, 61% at Miami, and 59% at Sydney). However, there 
were no statistically significant differences in the proportion of male or female 
participants across sites. 
A variable coding participant’s age at study time was categorized into three 
age groups: “Minors,” defined as being 20 years or younger, “Young Adults,” 
included 21 to 24 years old, and “Adults,” defined as being 25 years old or older. The 
overall mean age of the participants in the sample was 23.3 years [Range=16 – 45 
years (not shown) and Standard Deviation (SD) = 5.01]. A total of 214 participants 
(33%) were “Minors,” 246 participants (38%) were “Young Adults,” and 180 
participants (28%) were “Adults.” Although there were more individuals classified as 
“Young Adults” among St. Louis participants than in either Miami or Sydney, there 
were no significant differences in mean age or distribution of the three levels across 
the three sites. 
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Table 4.1  Socio-Demographic Characteristics of the Study Sample  
Total Site
Sample St. Louis Miami Sydney
(N =640) (N =296) (N =186) (N =158)
Characteristic  n(%) % % %
Gender
Female 271(42%) 46% 39% 41%
Male 369(58%) 54% 61% 59%
Age
Minors(20 years or younger) 214(33%) 32% 33% 35%
Young Adults(21 - 24 yrs) 246(38%) 42% 35% 35%
Adults(25 years or older) 180(28%) 25% 32% 29%
Mean Age(SD) 23.3(5.01) 23.2(5.08) 23.6(4.98) 23.2(4.94)
Race/Ethnicity
White/Caucasian 400(62%) 73% 31%    80%***
Black 55(9%) 16% 4% 0%
Hispanic 113(18%) 3% 55% 1%
Others 72(11%) 8% 10% 19%
Marital Status
Currently married 19(3%) 4% 4% 0%
Separated/Divorced/Widowed 23(4%) 4% 4% 1%
Never married 598(93%) 92% 91% 99%
Education Level
Elementary 42(7%) 6% 4%      9%**
Secondary(High School) 402(63%) 69% 57% 58%
Post-Secondary 196(31%) 24% 39% 33%
Current Work Status
Working Full/Part-time 187(29%) 27% 25% 37%
Student Working Full/Part-time 280(44%) 44% 45% 41%
Unemployed and Looking for work 100(16%) 17% 17% 12%
Unemployed, not Able/Looking for work 73(11%) 12% 13% 10%
Total Income in the Last 12 Months
$3,999 or less 120(19%) 23% 19%   10%**
$4,000 - $6,999 78(12%) 11% 16% 10%
$7,000 - $10,999 100(16%) 17% 16% 13%
$11,000 - $14,999 67(11%) 10% 8% 15%
$15,000 - $18,999 88(14%) 16% 11% 14%
$19,000 - $24,999 62(10% 8% 14% 8%
$25,000 - $34,999 58(9%) 8% 8% 12%
$55,000 - $44,999 29(5%) 3% 4% 8%
$45,000 or more 38(6%) 5% 5% 9%
Notes:  1. Percents might not add up to 100% in some cases due to truncation
           2. Sites comparisons were assessed with t-test for categorical variables and   
              ANOVA for continuous variables. Statistically significant levels are indicated by 
               * for p  ≤ .05, ** for p  ≤ .01, and *** for p  ≤ .001  
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When participants were asked to indicate their race (or ethnicity), 62% 
(N=400) identified themselves as “White” (or “Caucasian”), 18% (N=113) self-
identified as “Hispanic,” and 9% (N=55) classified themselves as “Black” (or 
“African American,” all of these individuals were from the US). The remaining 11% 
of the sample (N=72) opted to choose “Other” as their racial designation. Included in 
the “Other” group, 30 participants (about 5%) were Asian and 42 (about 7%) 
participants were from various ethnic groups, including 1 Alaskan Native, 2 
American Indians, 6 Middle Easterners, 3 Pacific Islanders, 18 Biracial, and 12 
Multiracial. The Pearson chi-square test indicated statistically different racial 
composition across the three sites, χ2(6)=296.4, p<.0001. Indeed, while most Whites 
[N=343 out of 400 (86%)] were from St. Louis [N=217 (54%)] and Sydney [N=126 
(31%)], nearly all of the Hispanics [N=102 out of 113 (90%)] were from Miami.  
Table 4.1 also shows that 93% (N=598) of the participants reported they were 
“Never Married;” only 3% (N=19) were “Currently Married,” and 4% (N=23) 
indicated they were “Separated,” “Divorced” or “Widowed.” Proportional tests of 
independence indicate no statistically significant differences for marital status across 
the three sites. This most likely resulted from the high proportion of “single” 
participants at each site (92%, 91%, and 99%, respectively at St. Louis, Miami, and 
Sydney).  
When asked about their educational status 63% (N=402) of the participants 
reported that they received a “High School Diploma” or a “G.E.D.” certificate, and 
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approximately 31% (N=196) indicated that they held a college degree (“Bachelor” or 
“Master” degree). On the other hand, only 42 participants (about 7%) had an 
“Elementary or Junior High” level of education. Participants’ education was 
significantly different across the three sites, χ2(4) =15.25, p = .0042. There were 
relatively more college level participants in both Miami (39%) and Sydney (33%) 
than in St. Louis (24%). On the other hand, St. Louis had more participants that were 
high school graduates (69%) than Miami (57%) or Sydney (58%). 
Participants were also asked to describe their “current work situation.” For all 
three sites combined, 29% (N=187) of the participants reported they were currently 
working [Either “Working full-time (35 hours a week)” 17% (N=112) or “Working 
part-time (less than 35 hours a week)” 12% (N=75), not shown in Table 4.1] and 44% 
of the total sample (N=280) reported they were students, including 143 participants 
who were “Full-time students and working part-time,” 51% (N=29) were “Full-time 
students and working full-time” (10%), and the remainder, 39% (N=108), were full-
time students and not currently employed. The remaining participants consisted of 
16% (N=100) that indicated they were “Unemployed or laid off and looking for 
work” and 11% (N=73) who were “Unemployed or laid off and not looking for 
work.” Overall, the participants’ current working situation was not statistically 
different across the three study sites.    
Participants were also asked to add up all money they collected from all 
sources of income in the past 12 months and to report their total by income ranges or 
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brackets. Not surprising, given the participants’ somewhat youthful age and the high 
proportion that were students at all three sites (see Table 4.1), the distribution of a 
measure of their purchasing power (total income) was positively skewed. More than 
half of the sample (57% or N=365) earned less than $15,000 during the past 12 
months period prior to their interviews.48 The remaining 43% (N=279) earned 
substantially more money, including 38 participants (6%) reporting a total income of 
$45,000 or more. Specifically, the positive tail of the distribution included 16 
participants (about 3%) (Not shown in Table 4.1) that reported total income between 
$65,000 and $100,000 or more. By contrast, the low income side of the distribution 
included 120 participants (19%) who reported total income less than $4,000 in the 12 
month time frame. Moreover, there was a significant difference in the distribution of 
the participants’ total income across the three sites, χ2(18)=38.75, p=.0031. While a 
majority (51%) of participants from St. Louis and Miami earned less than $11,000 a 
year and the rest of the participants had higher income stretching out to more than 
$100,000, participants from Sydney were more evenly spread out from the lowest 
income bracket “$3,999 or less” to the highest bracket “$45,000 or more.”  
Although not shown in Table 4.1, participants were also requested to indicate 
their sources of income over the past 12-month time frame from a list of 16 
categories. The income question provided a response format indicating “Anything 
 
48Fifteen thousand dollars was defined as the threshold for the US federal income 
poverty level (less than $15,000 for a family of three). Source: Department of Health 
and Human Services, 2005. 
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else?” and if the respondent selected “YES,” they were asked to further “SPECIFY: 
…” the source. The list included legal sources of income (such as “Paid job, salary, or 
business,” “Welfare, public assistance, or AFDC,” “Social Security, disability, or 
Workman’s Compensation,” “Student Loan,” and “Selling or trading goods, or 
bartering”) as well as illegal sources of income (such as “Dealing drugs,” “Winnings 
from gambling or betting,” and “Prostitution or trading sex”). Approximately one 
third (33%, N=209) of the participants reported using one or more illegal activities as 
additional sources of income. Cross-tabulation of the measure of income distribution 
and sources of income (legal vs. illegal) indicated that individuals from lower income 
brackets ($15,000 and under) resorted more to illegal sources of income than 
participants with higher income brackets, χ2(2)=10.04, p=.007. 
Consumption Patterns of Ecstasy --- Table 4.2 includes descriptive 
information indicating levels of involvement with Ecstasy and other illicit drugs. The 
Table also provides psychiatric diagnostic information used to designate whether a 
participant met criteria for abuse or dependence; i.e., addicted on a particular drug. 
The first column in Table 4.2 shows descriptive statistics for the overall sample 
(N=640), while the remaining columns describe the sample by gender (second and 
third columns) and site (fourth, fifth and sixth columns). The statistical information 
includes numerical frequencies and percentages for categorical variables, and means 
with their standard deviations (SD) for continuous variables. Statistical analysis of 
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categorical measures relied on the chi-square (χ2(df)) statistic, while t-tests or one-
way analysis of variance (ANOVA) was used for continuous measures. 
Age of Onset of Ecstasy Use -- Participants were asked to indicate the earliest 
age when they began using Ecstasy. The average reported age of first use (see Table 
4.2) for the entire sample (N=640) was 19 years (SD=4.11), and ranged from 13 to 44 
years (not shown in the table). Males were slightly older than females when they 
began to use Ecstasy, t=-3.21, p=.0014 [MM=19.42 (SD=4.42) with a range of 13 to 
44 years; MF=18.39 (SD=3.57) with a range of 13 to 40 years, for males and females, 
respectively]. Age of onset differed significantly across the three sites, F(2)=3.43, 
p=.0329. In particular, participants in St. Louis were on average significantly older 
than those from Sydney when they first tried Ecstasy [St. Louis Mage=19.43 
(SD=4.47) vs. Sydney Mage=18.42 (SD=3.22)]. 
To assess whether these differences were consistent across the age ranges of 
participants’ first use of Ecstasy, the age of onset variable was categorized, using 5-
years date bands. Overall, nearly 80% of participants reported initiating their use of 
Ecstasy before the age of 21, corresponding to the minimum legal drinking age in the 
United States. In particular, 16 participants (2% of total sample) started using Ecstasy 
while they were 14 years old or younger and 491 participants (77%) used Ecstasy 
when they were between the ages of 15 and 20 years. In contrast, 87 participants 
(14% of the total sample) reported initiating their use of Ecstasy when they were 
 
  127
Ta
bl
e 
4.
2 
 E
cs
ta
sy
 U
se
 P
at
te
rn
 a
m
on
g 
St
ud
y 
Pa
rt
ic
ip
an
ts
 b
y 
G
en
de
r a
nd
 S
ite
 (N
=6
40
)
To
ta
l
   
   
   
   
   
G
en
de
r
S
ite
S
am
pl
e
Fe
m
al
e
M
al
e
S
t. 
Lo
ui
s
M
ia
m
i
S
yd
ne
y
(N
 =
64
0)
(N
 =
27
1)
(N
 =
36
9)
(N
 =
29
6)
(N
 =
18
6)
(N
 =
15
8)
C
ha
ra
ct
er
is
tic
 
n(
%
)
%
%
%
%
%
A
ge
 o
f O
ns
et
 o
f E
cs
ta
sy
 U
se
15
 y
ea
rs
 o
r y
ou
ng
er
 6
6(
11
%
)
14
%
   
8%
*
9%
15
%
  1
0%
*
16
 - 
20
 y
ea
rs
43
8(
68
%
)
70
%
67
%
66
%
67
%
76
%
21
 - 
24
   
25
 y
ea
rs
  8
7(
14
%
)
11
%
15
%
17
%
12
%
9%
25
 y
ea
rs
 o
r o
ld
er
46
(7
%
)
5%
9%
9%
7%
4%
M
ea
n 
A
ge
 o
f O
ns
et
(S
D
)
19
.0
(4
.1
1)
18
.4
(3
.5
7)
19
.4
(4
.4
2)
**
*
19
.4
(4
.4
7)
18
.8
(4
.1
3)
18
.4
(3
.2
2)
*
Ye
ar
s 
S
in
ce
 1
st
 E
cs
ta
sy
 U
se
2 
ye
ar
s 
or
 le
ss
10
3(
16
%
)
18
%
15
%
17
%
14
%
   
 1
7%
**
*
3 
- 4
 y
ea
rs
20
7(
32
%
)
32
%
33
%
42
%
22
%
28
%
5 
- 6
 y
ea
rs
17
1(
27
%
)
27
%
26
%
23
%
34
%
25
%
7 
ye
ar
s 
or
 m
or
e
15
9(
25
%
)
23
%
26
%
18
%
31
%
30
%
M
ea
n 
ye
ar
s(
S
D
)
5.
3(
3.
21
)
5.
1(
2.
91
)
5.
4(
3.
41
)
4.
7(
2.
83
)
5.
7(
3.
25
)
5.
8(
3.
67
)*
**
Li
fe
tim
e 
U
se
 o
f E
cs
ta
sy
 
M
ea
n 
nu
m
be
r o
f p
ill
s(
S
D
)
22
7.
7(
54
3.
7)
20
8.
4(
48
9)
24
1.
8(
58
0.
8)
18
4.
7(
52
6.
1)
25
5.
3(
60
8.
5)
27
5.
6(
48
9.
9)
C
ur
re
nt
 U
se
 o
f E
cs
ta
sy
W
ith
in
 p
as
t 3
0 
da
ys
27
0(
42
%
)
44
%
41
%
30
%
31
%
   
 7
9%
**
*
M
or
e 
th
an
 3
0 
da
ys
 a
go
, b
ut
 in
 p
as
t 1
2 
m
on
th
s
37
0(
58
%
)
56
%
59
%
70
%
69
%
21
%
   
 P
as
t 3
0 
D
ay
s 
U
se
 o
f E
cs
ta
sy
 (N
 =
27
0)
   
 N
um
be
r 
of
 D
ay
s
   
   
1 
- 3
 d
ay
s
20
0(
74
%
)
72
%
76
%
82
%
86
%
   
 6
3%
**
*
   
   
4 
or
 m
or
e 
da
ys
  7
0(
26
%
)
28
%
24
%
18
%
14
%
37
%
   
   
M
ea
n 
nu
m
be
r o
f d
ay
s(
S
D
)
2.
8(
2.
69
)
2.
8(
2.
69
)
2.
8(
2.
69
)
2.
6(
3.
01
)
2.
0(
1.
95
)
3.
3(
2.
64
)*
   
 N
um
be
r 
of
 T
im
es
 p
er
 D
ay
 o
f E
cs
ta
sy
 U
se
   
   
1 
tim
e
15
7(
58
%
)
58
%
58
%
70
%
65
%
   
 4
6%
**
*
   
   
2 
or
 m
or
e 
tim
es
11
3(
42
%
)
42
%
42
%
30
%
35
%
54
%
   
   
M
ea
n 
nu
m
be
r o
f t
im
es
 a
 d
ay
(S
D
)
1.
8(
1.
46
)
1.
8(
1.
57
)
1.
8(
1.
38
)
1.
5(
1.
24
)
2.
1(
2.
19
)
1.
9(
1.
14
)
N
ot
es
: 1
. P
er
ce
nt
s 
m
ig
ht
 n
ot
 a
dd
 u
p 
to
 1
00
%
 in
 s
om
e 
ca
se
s 
du
e 
to
 tr
un
ca
tio
n
   
   
   
  2
. S
ite
s 
co
m
pa
ris
on
s 
w
er
e 
as
se
ss
ed
 w
ith
 C
hi
-S
qu
ar
e 
fo
r c
at
eg
or
ic
al
 v
ar
ia
bl
es
 a
nd
 t-
Te
st
 fo
r  
 
   
   
   
   
  c
on
tin
uo
us
 v
ar
ia
bl
es
. S
ta
tis
tic
al
ly
 s
ig
ni
fic
an
t l
ev
el
s 
ar
e 
in
di
ca
te
d 
by
 
   
   
   
   
   
* 
fo
r p
 ≤
 .0
5,
 *
* 
fo
r p
 ≤
 .0
1,
 a
nd
 *
**
 fo
r p
 ≤
 .0
01
 
  128
between 21 and 25 years old, and only 46 participants (7%) were 26 years old or older 
when they first experimented with Ecstasy. 
Table 4.2 also depicts essentially the same distributional patterns regarding 
the age of onset by gender (columns 2 and 3) and site (columns 4, 5 and 6). Indeed, a 
vast majority of both female (84%) and male (75%) were younger than 21 years old 
when they first used Ecstasy. There was, however, a statistically significant 
difference between the ranges of age of onset for each gender, χ2(3)=8.92, p=.0304. 
In particular, the distributions for age of onset indicate that females initiated their use 
of Ecstasy at a younger age than males. Participants also differed with respect to their 
age of onset across the three sites, χ2(6)=12.80, p=.0464. While the reported age of 
onset patterns for Miami and Sydney are quite comparable, individuals in the St. 
Louis site began their use of Ecstasy at an older age than their counterparts in the 
other sites. 
Years since First Ecstasy Use -- The number of years since participants used 
Ecstasy for the first time was computed as the arithmetic difference between current 
age and age of onset of Ecstasy use for each participant. Table 4.2 summarizes these 
results. The overall mean number of years since study participants first used Ecstasy 
was 5.3 years [Range = 1–25 years (not shown) and SD=3.21]. A total of 16% of the 
sample (N=103) reported using Ecstasy for 2 or less years, 32% (N=207) used it for 3 
to 4 years, 27% (N=171) used it for 5 to 6 years, and 25% (N=159) used Ecstasy for 7 
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or more years. No significant gender difference was found for the mean number of 
years since participants first tried Ecstasy.  
One-way analysis of variance indicated significant differences in the mean 
number of years since Ecstasy was first used by study participants across the three 
sites, F(2)=7.99, p≤.001. On average, participants in St. Louis reported fewer years 
since their first Ecstasy use [Myears=4.7 (SD=2.83)] than participants in Miami 
[Myears=5.7 (SD=3.25)] or Sydney [Myears=5.8 (SD=3.67)]. Additionally, variability in 
the number of years since first use differed between St. Louis participants compared 
to those in Miami or Sydney, χ2(6)=30.99, p<.0001. In particular, Ecstasy users in St. 
Louis were relatively new to this drug. As shown in Table 4.2, more than half of the 
participants (59%) in St. Louis were observed to have not more than four years since 
they first tried Ecstasy, while more than half of the participants in Miami (65%) and 
Sydney (55%) reported five or more years of Ecstasy use since they first 
experimented. The source of difference is most likely due to the fact that participants 
in St. Louis were on average older and started using Ecstasy at a much later age than 
participants from the other two sites.  
Lifetime Use of Ecstasy -- Participants were asked “if you were to add up all 
of the Ecstasy pills you have used since you first started using Ecstasy, about how 
many pills would that be?” The overall mean number of pills consumed was 227.7 
(SD=543.7). Males and females did not differ significantly in their reported lifetime 
use [MM=241.8 (SD=580.8) with a range of 6 to 5200 pills and MF=208.4 
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(SD=489.0) with a range of 6 to 4000 pills]. There was a trend for site differences in 
the mean number of pills used, F(2)=2.67, p≤.071, with mean levels of Ecstasy use 
relatively higher for Sydney and Miami compared to St. Louis [MSYD=275.58 pills 
(SD=489.88)] and MMI=255.34 pills (SD=608.49), and MSL=184.72 pills 
(SD=526.08)].   
Current Use of Ecstasy -- In addition to their lifetime and past year Ecstasy 
use, participants were also asked “How many days have you used Ecstasy in the past 
30 days?” The combination of past year and past 30 day pattern of use indicated that 
42% (N=270) of the total sample used Ecstasy within the past 30 days, while 58% 
(N=370) used it more than 30 days ago, but within the past 12 months. The 
distribution of current users was not statistically different for male (41% used Ecstasy 
within the past 30 days and 59% used it more than 30 days ago) and female (44% and 
56%, respectively) participants. However, there were significant site differences in 
current use of Ecstasy, χ2(2)=117.33, p≤.0001. Specifically, participants in Sydney 
reported more recent use than those in St. Louis and Miami (79% vs. 30% and 31% 
for the three sites, respectively). 
Participants were also asked about the intensity of their Ecstasy use (number 
of times a day they used the drug) and the number of days they used Ecstasy in the 
past 30 days (frequency of use). Gathering information on quantity and frequency is 
consistent with previous studies seeking to clarify ‘regular’ and more moderate 
patterns of use (Cottler et al., 2000, Degenhardt, Barker, & Topp, 2003; Forsyth, 
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1996; Topp et al., 1999; Sherlock & Conner, 1999; Riley et al., 2001). The category 
of ‘Regular’ users was defined as those who take Ecstasy at least once a week on a 
regular basis (partying on weekends) and ‘moderate patterns of Ecstasy use’ was 
defined as taking one or two Ecstasy pills per occasion/episode. Based on these 
definitions, Table 4.2 shows the responses to the two quantity-frequency questions 
assessed among the 42% (N=270) of the participants who consumed Ecstasy within 
the past 30 days prior to their interview (hereinafter, referred to as “recent users”).  
Overall, recent Ecstasy users reported using the drug for an average of 2.81 
days (SD=2.69), ranging from 1 to 15 days a month. There were no observed gender 
differences in the patterns of recent (30-day) Ecstasy use, as both males and females 
reported using the drug on average 2.80 days (SD=2.69). In contrast, there were 
significant site differences for the average number of days participants used Ecstasy, 
F(2)=5.45, p=.0048. In particular, Ecstasy users in Miami reported less drug-use days 
on average per month [MMI=1.96 (SD=1.95)] than participants from the other two 
sites [MSL=2.63 days (SD=3.01) in St. Louis and MSDY=3.32 days (SD=2.64) in 
Sydney].  
Table 4.2 also depicts additional information on the pattern of Ecstasy use 
days. Of the 270 participants who used Ecstasy within the past 30 days, 74% (N=200) 
reported taking it 1 to 3 days, whereas 26% (N=70) used the drug on four or more 
days (about once a week, on average) during the same 30-day period. This suggests 
that only one quarter of the current sample of users can be qualified as “regular 
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users.” Furthermore, there was no statistically significant gender difference in the 
days of Ecstasy consumption over the past 30 days (76% of male used Ecstasy 
between one and three days and 24% used it four or more days vs. 72% of female 
used Ecstasy between one and three days and 28% used it on four or more days). 
There were, however, significant site differences in the number of Ecstasy use 
days in the past 30 days, χ2(2)=14.64, p=.0007. Although about the same pattern of 
Ecstasy use days was observed in St. Louis and Miami, Sydney had relatively fewer 
participants (63% vs. 82% in St. Louis and 86% in Miami) who used Ecstasy one to 
three days and more participants (37% vs. 18% in St. Louis and 14% in Miami) who 
used it for four or more days. This observed difference suggests that there are 
relatively more “regular users” in the sample recruited from Sydney than from either 
one of the two U.S. sites. 
Participants were also asked about the “number of times per day” they used 
Ecstasy. Table 4.2 shows that on average, the 270 participants who used Ecstasy 
within the past 30 days reported taking it about two (1.82) times a day (SD=1.46). 
Mean comparisons by gender and across sites showed no statistically significant 
differences for the average number of times per day study participants used Ecstasy 
over the designated study period. 
As a point of further clarification, 157 or 58% of the 270 “recent” users used 
Ecstasy one time a day, while 113 (42%) used it two or more times a day. These 
proportions did not differ by gender, which suggests that the study sample included 
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users with moderate consumption habits. However, site comparisons indicated 
significant differences in the daily intake-frequency of use (a proxy measure of 
quantity) among recent users, χ2(2)=13.64, p<.0011. Whereas about a third of the 
participants in St. Louis (30%) and Miami (35%) used Ecstasy two or more times per 
occasion, more than half (54%) of Sydney participants did the same.  
Taken together, these findings suggest that study participants in Sydney report 
strikingly different Ecstasy consumption habits than their counterparts in St. Louis 
and Miami. Specifically, there are more “regular” Ecstasy users with more frequent 
pattern of use in Sydney than in the other two sites. This may explain why Sydney 
users reported taking more Ecstasy pills lifetime than those in St. Louis or Miami.  
Consumption Patterns of Other Substances --- Recent evidence suggests that 
Ecstasy is used alone or in combination with other licit and/or illicit drugs (Cottler et 
al., 2001; Wu el al., 2009). To examine further the patterns of drug use habits in the 
current sample, CDSLAM participants were asked about their consumption of 
alcohol and a variety of other drugs. Self-reported prevalence rates of lifetime (more 
than 5 times) use of some of these substances among the study sample are reported in 
Table 4.3. The results show that most participants have used a number of other 
substances over time. Alcohol, in particular, was very common, as almost 100% of 
the sample reported having consumed alcohol beverages in the past and that they 
started drinking at the age of 14. This was a consistent finding regardless of the 
participant’s gender or site. 
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Table 4.3 also shows that consumption of other drugs is quite prevalent in this 
sample. When asked about their use of other “club (or party) drugs,” 34% (N=219) of 
the participants reported using Ketamine, 18% (N=112) used GHB, and 12% (N=76) 
used Rohypnol, all three examples of other popular “club drugs.” There were, 
however, statistically significant differences by gender and site with regards to the 
use of each one of these drugs. Males were significantly more likely to report using 
one or more of these drugs than female participants, χ2(1)=14.36, p=.0002 (49% for 
males and 39% for females, respectively). On the other hand, with the exception of 
Ketamine, which was used by about a third of the participants in each site, more 
Ecstasy users in Miami reported having used GHB and Rohypnol than those in St. 
Louis and Sydney. Also, the participants’ earliest exposure to any of these party-
drugs was between the age of 19 and 20 years regardless of their gender or site, 
suggesting that Ecstasy was the first substance to be used among all four common 
club-drugs.  
Measures of drug consumption also included questions about lifetime use of 
other illicit drugs from a list of nine commonly known drug categories (Cottler, 
2000). Table 4.3 shows the top four most prevalently used drugs. Marijuana was the 
primary drug reported by most (98%) participants, followed by (64%) hallucinogens, 
(63%) stimulants, and (61%) cocaine. Both males and females were equally likely to 
use marijuana (97% vs. 98% for females and males, respectively). The prevalence of 
use of the other listed drugs differed, however, significantly by gender. More males 
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than females reported having used hallucinogens, χ2(1)=11.81, p=.0006 (70% vs. 
56%), stimulants, χ2(1)=7.21, p=.0072 (67% vs. 57%), and cocaine, χ2(1)=7.01, 
p=.0081 (65% vs. 55%).  
Although study participants did not differ significantly in their use of 
marijuana, the reported prevalence rates of hallucinogen use were highest among 
Miami participants (76%) compared to St. Louis (66%) and Sydney (46%), 
χ2(2)=36.25, p<.0001. Likewise, the prevalence of cocaine use was significantly 
higher among participants in Miami (72%) and St. Louis (66%) than Sydney (40%), 
χ2(2)=40.81, p<.0001. Also, while most of the participants in Sydney (91%) reported 
having used stimulants, significantly lower proportions reported doing the same in St. 
Louis (58%) and Miami (47%), χ2(2)=75.16, p<.0001.  
Additionally, while the overall mean age-of-onset of the first illicit drug used 
was 14.8 years (SD=2.97) and did not differ by gender, the mean age for participants 
first trying any illicit drug differed significantly across sites, F(2)=37.48, p=.0143, 
with the age of onset slightly older in Sydney (15.3 years, SD=2.43) than in St. Louis 
(14.5 years, SD=2.82) and Miami (15.0 years, SD=3.35). 
Examination of the age-of-onset when any illicit drug was used in comparison 
to the age of first time use of Ecstasy revealed that only 14 (2%) participants started 
using Ecstasy before using other drugs. On the other hand, a vast majority (N=497, 
78%) of the participants started using Ecstasy and other drugs at the same age. The 
remaining (N=129, 20%) participants started using Ecstasy after using a variety of 
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other drugs. There was no significant difference by gender in the order of first use of 
drugs, as a large majority of both female and male were found to have used Ecstasy 
for the first time either at the same age (77% & 78%, respectively) or a few years 
after using other drugs (20% of each gender). There were however significant site 
differences, χ2(2)=24.15, p<.0001. Specifically, while about 85% of the participants 
in Sydney and Miami initiated their Ecstasy use before or at the same age they 
experimented with other illicit drugs, almost 100% of St. Louis study participants 
started using Ecstasy either at the same age or years after using various drugs. 
DSM-IV Diagnostic Information --- Table 4.4 contains the lifetime substance 
use diagnoses for Ecstasy, alcohol, other club-drugs, and other licit and illicit drugs. 
This information is based on diagnostic algorithms from the DSM-IV (Diagnostic and 
Statistical Manual of Mental Disorders, 4th Edition). Participants are asked a variety 
of questions about symptoms or problems that may result from their drug use. These 
symptoms are then clustered into “criteria” based on defined algorithms. The 
diagnostic results for Ecstasy use indicated that 25% (N=163) of the participants 
received no diagnosis, 15% (N=97) met criteria for DSM-IV “abuse,” and 59% 
(N=380) of the sample met DSM-IV threshold (3 or more criteria experienced 
simultaneously within a 12 month period) for “dependence.” Similar proportions 
were observed for female (23% no diagnosis, 13% abuse, and 64% dependence) and 
male (27%, 17%, and 56%, respectively) participants. There were also no significant 
site differences for diagnosis of abuse (17%, 16%, and 12%, respectively for St. 
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Louis, Miami and Sydney), but there was a significant difference for diagnosis of 
dependence, χ2(2)=10.56, p=.0320 (66%, 63%, and 53%, respectively for Sydney, 
Miami, and St. Louis).  
A diagnosis of “dependence” represents the most severe level of substance 
use disorder. In this respect, Table 4.4 shows that an overwhelming majority (N=520 
or 81%) of the participants were diagnosed with alcohol dependence. There was no 
significant gender difference in diagnosis of alcohol dependence. There were, 
however, statistically significant differences by site, χ2(2)=9.00, p=.0111. Ecstasy 
users in Miami and St. Louis were found to be more alcohol dependent that those in 
Sydney, as 85% and 82% vs. 73% of the participants in those three sites were 
diagnosed with alcohol dependence, respectively. 
Similar patterns where observed for dependence with other club-drugs as well 
as other illicit drugs. Although the prevalence of DSM-IV dependence was lower for 
“any other club drug” (i.e., Ketamine, GHB, and Rohypnol) (N=132 or 21% of the 
sample) than for “Any other licit or illicit drug” (i.e., marijuana, stimulants, sedatives, 
cocaine, heroin/opioids, PCP, hallucinogens, and inhalants) (N=573 or 90%), there 
were statistically differences by gender and site. More males were found dependent 
on “Any other licit or illicit drug” (24%) and “Any other licit or illicit drug” (92%) 
than females (16% and 86% for each group of drugs respectively). Additionally, more 
individuals from Miami were diagnosed as “other club drug” dependent (31%) than 
among participants in Sydney (17%) or St. Louis (16%). On the other hand, while the 
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prevalence rates of dependence among Ecstasy users in Miami (92%) and St. Louis 
(90%) were very comparable, more participants were dependent on “other licit or 
illicit drug” in Sydney than their Miami and St. Louis counterparts (85%).  
To summarize the descriptive information, the analyses indicated that 
although Ecstasy users in this sample were a homogenous group with respect to 
several key demographic measures, they differed across sites on numerous facets of 
their lifetime and current drug consumption patterns, including patterns of Ecstasy 
use and dependence.  
2. Exploratory Data Analysis 
Prior to empirically testing the proposed psycho-economic model, the raw 
data was further scrutinized for potential violations of the basic assumptions of 
multinormality and non-multicollinearity (or singularity) required for the maximum 
likelihood estimation procedure used for the SEM parameters estimation (Bagozzi & 
Yi, 1998). Failure to address these two conditions may bias SEM parameter 
estimates, produce unreliable standard errors, and more importantly violate basic 
assumptions underlying the χ2 statistic as a measure of overall fit the SEM (Hair et 
al., 1998). The results from this preliminary exploratory analysis are discussed in the 
present section.  
Tests of Normality --- As a necessary, but not sufficient, condition for 
multivariate normality of data, the univariate normal distribution should be checked 
for each individual variable in the model. This was accomplished by examining the 
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skewness and kurtosis as measures of central tendency for each observed variable. 
Both statistics provide univariate point-estimates of deviation from normality. A 
common rule-of-thumb dictates that the skew should be within the range of -2 to +2 
and the kurtosis should be within the range of -3 to +3 for a variable to be described 
as normally distributed (Hair et al., 1998). Kline (2005) advocates that skewness 
greater than 3 in absolute value and kurtosis values greater than 10 in absolute value 
should be described as extreme non-normality conditions. In this study, the most 
commonly used rule-of-thumb required cutoff values within ±2 range for skewness 
and ±3 range for kurtosis. 
Accordingly, the 85 separate questionnaire items were regrouped into five 
major conceptual domains: Demographics (gender, age, race, education, and site), 
outcome measures (measures used to reflect Ecstasy Consumption and Dependence), 
economic factors [income index (as a measure of social anomie), unit price of Ecstasy 
pill, and opportunity cost of acquiring Ecstasy], psychological factors (indicators of 
Motivation), and other risk factors [indicators of Depression and a composite of sex 
risk (measuring risk-taking)]. Within each domain, and when possible, the observed 
items were parceled into groups of theoretically related-items to form reliable scales 
(unit weighted “index” measures or composites), as already discussed in the 
methodology chapter. 
A summary of descriptive statistics (e.g. mean, standard deviation (SD), skew, 
and kurtosis) provided by SAS® UNIVARIATE procedure for all of the individual 
  142
items and index scales used in the model (except for the demographic variables) are 
shown sequentially in Tables 4.5. Overall, the skewness and kurtosis values for a vast 
majority of the observed variables (80% or 64 out of the 80 items reported) fell 
within the commonly acceptable ranges, fairly suggesting univariate normality of the 
data. The exceptions included sixteen (20%) variables identified as having values 
(highlighted in the tables, using italic font and underlined) outside the desired first-
order moment ranges indicating low to moderate non-normality. Transformation 
(both logarithm and square root) of these items alone and in combination with the 
removal of outlier values did not substantially lower the magnitude of skewness and 
kurtosis for most of these variables. Thus, violation of the normality assumption may 
be caused by the true skewness reflected in the consistent response of the participants 
rather than from the contribution of distinct outliers. 
Furthermore, it should be noted that, with the exception of three items (e.g. 
‘number of days used Ecstasy in past 30 days,’ ‘continued to use despite knowledge 
of potential problems,’ and ‘average time it would take to get Ecstasy’), the highly 
skewed or kurtotic variables were transformed and parceled into aggregate 
composites, as described earlier. Such practice of item parceling is often 
recommended to summarize a large number of homogeneous or conceptually similar 
variables and reduce the influence of their restricted variances (Bandalos, 2002; Hau 
& Marsh, 2004; Little et al., 2002). In this study, parceling not only reduced the 
number of observed variables from 80 to 23 (making the model more parsimonious), 
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but also resulted in more normally distributed measures than the original items. 
Indeed, as shown in Table 4.5, the univariate skewness of each of the 12 created item-
parcels varied between -0.68 and 1.59, while their respective kurtosis varied between 
-1.86 and 2.18, both of which are well within their acceptable (±2 & ±3) ranges. The 
improvements in central tendency and close approximation of normality argued 
convincingly for using parcels and composite indicators without data transformations 
(e.g., logarithm, spline, square root, or inverse weighting) or deleting specious 
outliers (Liang et al., 1990). Furthermore, the EQS Maximum likelihood estimation 
procedure provides the Satorra-Bentler scaling corrections for the χ2-statistic (SB χ2) 
to adjust for any overall bias in estimation from multivariate non-normality (Chou & 
Bentler, 1995; Satorra & Bentler, 1988). 
In addition to the descriptive statistics, Table 4.5 also includes gender (fifth 
column) and site (sixth, seventh, and eighth columns) mean differences for all the 
observed items and scales used in the model estimation. Overall, the results indicate 
there were several gender differences. For example, female Ecstasy users were more 
likely to endorse the “adopted” DSM-IV Dependence Criteria for Ecstasy than males. 
However, although females were more likely than males to endorse six out of the 
seven dependence criteria, only three out of the six mean differences were at an 
acceptable statistically significant level (p≤.05). The remaining three criteria 
indicated a trend (.05< p ≤ .10, not shown in Table 4.5) for females to indicate they 
experienced problems from their Ecstasy use. 
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Also, with the exception of these noted differences in the “adopted” Ecstasy-
use-disorder criteria, there was no consistent pattern in the observed gender 
differences. Gender had a significant effect on most of the measures lumped into the 
Economic Factors domain. Females were more likely to report being “unemployed, 
last 12 months,” MF-M=.12, t=3.13, p=.002, and have a “total income below poverty 
level, last 12 months,” MF-M=.12, t=3.09, p=.002. Males, on the other hand, were 
more likely to report that they “had an illegal source of income, last 12 months,” MF-
M=-.21, t=-6.04, p<.0001.  
Similar results were observed for the measures constituting the Psychological 
Factors domain. For instance, females were more likely than males to report getting 
Ecstasy “from spouse or partner,” MF-M=.27, t=7.12, p<.0001, and sharing it “with 
spouse or partner,” MF-M=.10, t=3.16, p=0.002, while they were less likely than males 
to acquire Ecstasy “from dealing,” MF-M=-.14, t=-3.77, p=.0002, or “as a payment for 
service,” MF-M=-.16, t=-4.53, p<.0001. 
For the measures categorized as Other Risk Factors,  males were more likely 
than females to report that they “talked less than usual,” MF-M=-.15, t=-2.21, p=.0277. 
Conversely, females were more likely than males to report that they “had crying 
spells,” MF-M=.41, t=7.58, p<.0001. Males and females also differed with regard to 
the Sex Risk domain. In particular, while males were found to be more likely than 
females to have “had 3 or more sex partners, in the last 3 months,” MF-M=-.10, t=-
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3.56, p=.0004, females were more likely than males to have “ever experienced forced 
sexual contact,” MF-M=.14, t=4.95, p <.0001. 
Taken together, the above findings suggested that male and female Ecstasy 
users may differ with regard to their Ecstasy consumption patterns and its 
consequences as well as over the behaviors that may place them at risk. However, it 
is unlikely these gender differences were preserved once aggregate scales were 
formed. As can be seen in Table 4.5, most of the composite indices employed in this 
study showed no statistically significant differences by gender. One exception is the 
psychological motivation subscale labeled “opportunity to get Ecstasy.” This 
composite score was calculated based on four alternative ways to get Ecstasy other 
than paying money for it. Analyses indicated that males were more likely than 
females to report using three out of the four ways: “by stealing it,” MF-M=-.03, t=-
2.03, p=.0423, “as a payment for service,” MF-M=-.14, t=-3.77, p=.0002, and “From 
dealing,” MF-M=-.16, t=-4.41, p<.0001. On the other hand, females more frequently 
obtained Ecstasy “for free” but not significantly more than males, MF-M=.04, t=1.34, 
p=.1797. As a result, males scored significantly higher than their counterpart females 
on the overall subscale, MF-M=-.30, t=-3.92, p<.0001.  
Table 4.5 also shows slightly more site than gender differences for most of the 
variables just discussed. As shown, there were some marked site differences in all of 
the consumption pattern measures. Participants from Sydney were more likely to 
report greater number of Ecstasy pills used lifetime than their counterparts from St. 
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Louis, MSL-SDY=-1.98, t=-5.10, p<.0001, and Miami, MMI-SDY=-0.97, t=-2.30, p=.022, 
whereas Miami participants reported more lifetime number of pills used than those 
from St. Louis, MSL-MI=-1.0, t=-2.66, p=.008. Moreover, while participants from St. 
Louis and Miami were comparable on the rest of the consumption measures, Sydney 
participants reported significantly more Ecstasy-use days in the past 30 days than 
those in St. Louis, MSL-SDY=-1.85, t=-8.19 and p<.0001, and Miami, MMI-SDY=-2.02, 
t=-8.88, p<.0001. Participants from Sydney also reported significantly more number 
of times they used Ecstasy in the past 30 days compared to St. Louis, MSL-SDY=-1.02, 
t=-11.27, p<.0001, and Miami, MMI-SDY=-0.92, t=-7.90 and p<.0001. Furthermore, 
Sydney Ecstasy users were more likely to be more recent in their use of Ecstasy than 
those in St. Louis, MSL-SDY=-.47, t=-11.10, p<.0001, and Miami, MMI-SDY=-0.45 with 
t=-9.43 and p<.0001. 
There was also a clear site differences in the prevalence rates of DSM-IV 
criteria for Ecstasy dependence. Overall, Ecstasy users from Miami and Sydney were 
more likely to endorse a greater number of symptoms of Ecstasy-use disorder than 
their counterparts in St. Louis, while users at the Miami and Sydney sites did not 
show striking differences for endorsement of Ecstasy-related symptoms. Among the 
most noted site differences, participants from Sydney were more likely than 
participants from St. Louis to report tolerance, MSL-SDY=-.12, t=-2.54, p=.0113, 
withdrawal, MSL-SDY=-.13, t=-2.93, p=.0036, spend a great deal of time to acquire, 
use, and/or recover from Ecstasy, MSL-SDY=-.14, t=-2.81, p=.0052, and reduce or give 
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up social, occupational, and/or recreational activities because of their Ecstasy use, 
MSL-SDY=-.14, t=-3.09, p=.0022. Likewise, Ecstasy users from Miami were more 
likely than St. Louis users to report tolerance, MSL-MI=-.13, t=-2.84, p=.0047, to use 
Ecstasy in larger amounts or over a longer period of time than was intended, MSL-MI=-
.11, t=-2.25, p=.0248, and spend great deal of time to acquire, use, and/or recover 
from Ecstasy, MSL-MI=-.14, t=- 3.04, p=.0025. On the other hand, users at the Miami 
site were significantly different from only those in Sydney reporting withdrawal, 
MMI-SDY=-0.10 with t=-2.01 and p=.0454, and reducing or giving up important 
activities because of their use of Ecstasy beach, MMI-SDY=-0.10, t=-.2.05, p=.0409. 
There were also significant site differences with respect to economic and 
psychological measures as well as in the levels of Other Risk Factors reported. More 
importantly, however, is the fact that these site differences appeared at both the item 
and composite score levels. Since only the aggregate indices (scales & subscales) 
were modeled in the SEM, the discussion will be limited from now on to these 
composite measures. 
With regard to the economic measures, Sydney participants were at an 
advantage in terms of the resources available to them when compared to participants 
from St. Louis and Miami. Income (an index of social anomie), serving as a proxy 
measure of “purchasing power” or marginalization differed across sites. Ecstasy users 
from Sydney were more likely to be at a lower level of anomie than their counterparts 
in St. Louis, MSL-SDY=.22, t=2.04, p=.0421, and Miami, MMI-SDY=.18, t=2.0, p=.0513. 
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There was also no significant difference in the income index level between St. Louis 
and Miami sites. Additionally, substantial differences in the “monetary cost” (or unit 
price) per Ecstasy pill used were observed across the different sites. The unit price of 
a pill paid (in USD) in Sydney was significantly lower than the price paid in St. 
Louis, MSL-SDY=.49, t=12.77, p≤.0001, and Miami, MMI-SDY=.85, t=29.20, p≤.0001. 
On the other hand, the monetary cost per Ecstasy pill for Miami residents was 
significantly higher on average than the rate paid in St. Louis, MSL-MI=-.36, t=11.41, 
p≤.0001. However, Ecstasy was less likely to be available for users in Sydney than 
for their counterparts in both St. Louis and Miami. Sydney participants were found to 
spend significantly more time and therefore paid higher “opportunity cost” to acquire 
Ecstasy than those participants from St. Louis, MSL-SDY=-.18, t=-4.13, p≤.0001, and 
Miami, MMI-SDY=-.12, t=-2.41, p=.0163. No significant difference was found between 
the “opportunity costs” incurred by Miami or Sydney participants. 
Findings were somewhat mixed when examining site differences for the 
components of the Psychological Domain. Overall, Ecstasy users from St. Louis were 
less likely to report Motivation for their consumption based on “opportunities to get 
Ecstasy” than their counterparts from Miami, MSL-MI=-.19, t=-2.15, p=.0321, or 
Sydney, MSL-SDY=-.12, t=-1.84, p=.0448. Also, St. Louis participants reported 
significantly less motivation based on “places and/or people to get Ecstasy from” than 
those from Miami, MSL-MI=-1.05, t=-5.27, p≤.0001, and Sydney MSL-SDY=-1.07, t=-
4.97, p≤.0001. There was however no significant differences in the reported 
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“opportunities to get Ecstasy” or “places and/or people to get Ecstasy from” between 
Miami and Sydney participants. Additionally, all three sites did not differ 
significantly in their “specific motivation to use Ecstasy.”  
Table 4.5 shows significant differences in the reported depressive symptoms 
across sites. In particular, three out of the four CESD depression parcels suggest that 
Ecstasy users from Sydney tended to endorse significantly lower levels of depression 
than their counterparts from the other two sites. Specifically, Sydney participants 
were less likely to report behavioral depressive symptoms than participants from St. 
Louis, MSL-SDY=.28, t=3.22, p=.0014, and Miami, MMI-SDY=.36, t=3.55, p=.0004. 
Likewise, Ecstasy users from Sydney were less likely to report affective and 
cognitive depressive symptoms than those from St. Louis [MSL-SDY=.28, t=3.11, 
p=.0020, and MSL-SYD=.34, t=3.46, p=.0006, respectively] or Miami [MMI-SYD=.23, 
t=2.31, p=.0215, and MMI-SYD=.39, t=3.61, p=.0004, respectively]. Conversely, no 
significant differences were found between St. Louis and Miami participants’ scores 
for the same three depression subscales or for the fourth subscale tapping somatic 
depressive symptoms.  
The proxy measure sexual risk captures individual differences in risk-taking 
and was comprised of 10 items. These items tap the propensity to engage in high-risk 
behaviors without planning or forethought including having sex without protection, 
multiple partners, having “forced” sex, and using drugs while having sex. Significant 
site differences were observed with participants from Sydney being more likely to 
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engage in sexual risk than participants from St. Louis, MSL-SDY=.32, t=2.09, p=.0374, 
and Miami, MMI-SDY=.31, t=1.95, p=.0536. There were however no statistically 
significant differences in the mean levels of sexual risk-taking between the 
participants from St. Louis and Miami. 
Tests of Multicollinearity ---A commonly used approach to check for the 
presence of multicollinearity relies on the strength or magnitude of bivariate 
associations (or inter-correlations) between each pair of variables in the data. Large 
magnitude of association between any given pair would indicate not only empirical 
overlap, but also conceptual overlap, suggesting the two variables measure the same 
phenomenon. It is usually suggested that an absolute value of Pearson’s |r| less than 
.10 is “trivial,” between .10 and .35 is “small” (or low), between .35 and .70 is 
“moderate,” and greater than .70 is substantially “large” (or high). Based on this 
interpretation, multicollinearity should be a very serious concern when the inter-
correlation between a pair of independent variables is large, |r| >.70, which generally 
means that there is considerable redundancy between the two items (Ferketich, 1991). 
On the other hand, construction of a well-defined and psychometrically reliable 
construct requires that the relations between its indicators (items, parcels or multi-
item scales) be moderate to large (r = .45 to .60).  
Given the type of data used in this study, both parametric (Pearson) and non-
parametric (Spearman’s rank-order) inter-correlations between all the measured 
variables and/or latent constructs developed within the five domains defined above 
  156
were examined for the full sample. With very few exceptions, the Pearson’s 
correlations and Spearman’s correlations for each pair of variables were identical. For 
this reason, only the former [Pearson’s product-moment correlation coefficients (r)] 
and their corresponding level of significance are presented in Table 4.6. Also, 
because the correlation matrix is symmetric, only the upper triangle is presented. 
Additionally, the table includes “Adjusted Item-to-Total Correlation,” measuring the 
correlation of each item with the total construct score based on the rest of the items 
contained in the same domain. This latter statistic should be reasonably large in 
magnitude to indicate sufficient conceptual overlap between the components, with 
some unique variability as well.  
As Table 4.6 depicts, there are overall small to relatively moderate but 
significant inter-correlations between all the variables selected for the model. In 
particular, the inter-correlations between each pair of the indicators used to reflect the 
hypothesized latent construct Consumption were significantly positive (all ps≤.001), 
ranging from a low correlation value of r=.26 to a high correlation value of r=.68 
which is moderate but still in the acceptable range to imply little redundancy among 
the observed measures. On the other hand, the adjusted item-to-total correlations for 
the outcome construct Consumption ranged from a low of r=.53 to a high of r=.70, 
suggesting satisfactory magnitude of associations for the indicators of Consumption. 
 
 
  157
Ta
bl
e 
4.
6 
 C
or
re
la
tio
ns
* A
m
on
g 
th
e 
23
 O
bs
er
ve
d 
Va
ria
bl
es
 &
 C
on
st
ru
ct
s 
U
se
d 
in
 th
e 
Ps
yc
ho
Ec
on
om
ic
 M
od
el
 (N
=6
40
)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
O
ut
co
m
e 
M
ea
su
re
s
 C
on
su
m
pt
io
n
  1
. Q
ua
nt
ity
 o
f E
cs
ta
sy
 u
se
d 
lif
et
im
e
‐
.2
6†
.3
3†
.2
6†
.4
0†
.2
3†
.3
4†
.2
1†
.3
8†
.3
1†
.2
0†
-.1
9†
-.0
1
.2
2†
.4
8†
.5
2†
.5
2†
.2
9†
.1
1
.0
6
.0
2
.0
9
.2
0†
  2
. X
 u
se
 d
ay
s 
in
 p
as
t 3
0 
da
ys
-
.5
8†
.6
0†
.1
3†
.1
1
.1
0
.1
1
.0
8
.1
8†
.0
8
.0
3
-.2
1†
.2
2†
.1
5†
.1
9†
.2
1†
.1
2
.1
2
.0
5
.0
5
.0
9
.0
9
  3
. T
im
es
 p
er
 X
 u
se
 d
ay
 p
as
t 3
0 
da
ys
-
.6
8†
.2
0†
.1
1
.1
3†
.0
9
.1
4†
.2
0†
.1
2
-.0
6
-.1
9†
.1
7†
.1
6†
.2
4†
.2
5†
.0
9
.0
9
-.0
1
-.0
1
.0
5
.0
8
  4
.  
re
ce
nc
y o
f X
 u
se
-
.1
2†
.1
1
.0
9
.0
9
.0
8
.1
6†
.1
1
-.0
5
-.2
0†
.1
4†
.1
0
.2
0†
.2
0†
.0
5
.0
3
-.0
4
-.0
3
-.0
1
.0
4
D
ep
en
de
nc
e 
  5
. T
ol
er
an
ce
-
.2
7†
.3
3†
.2
6†
.3
7†
.3
5†
.1
8†
-.0
3
.0
1
.0
7
.2
8†
.3
1†
.2
5†
.2
5†
.0
5
.0
9
.0
9
.0
8
.0
6
  6
. W
ith
dr
aw
al
-
.3
1†
.2
5†
.3
4†
.2
6†
.2
1†
-.0
4
-.0
4
.0
5
.1
8†
.2
0†
.1
7†
.2
4†
.0
8
.1
0
.1
2†
.1
4†
.0
4
  7
. I
nc
re
as
ed
 u
se
 o
ve
r l
on
ge
r p
er
io
d 
-
.3
8†
.4
3†
.3
3†
.2
0†
-.0
2
-.0
1
.1
0
.2
4†
.2
7†
.2
6†
.2
4†
.0
7
.1
3†
.0
5
.1
0
.0
7
  8
. D
es
ire
 o
r i
na
bi
lit
y 
to
 c
ut
 d
ow
n 
-
.2
9†
.3
3†
.1
6†
-.0
2
-.0
3
.0
4
.1
6†
.1
6†
.1
9†
.2
4†
.1
4†
.1
7†
.1
5†
.1
5†
.0
4
  9
. G
re
at
 d
ea
l o
f t
im
e 
sp
en
t 
-
.4
0†
.2
3†
.0
4
.0
3
.1
0
.2
8†
.3
0†
.3
1†
.2
9†
.1
2†
.1
5†
.0
9
.1
1†
.1
0
10
. R
ed
uc
e 
or
 a
vo
id
 im
po
rta
nt
 a
ct
ivi
tie
s
-
.1
8†
-.0
04
-.0
7
.0
7
.2
8†
.2
8†
.3
3†
.3
4†
.1
3†
.1
6†
.1
2†
.1
3†
.1
5†
11
. C
on
tin
ue
 to
 u
se
 d
es
pi
te
 p
ro
bl
em
s
-
.0
4
.0
01
.0
3
.0
9
.1
8†
.1
7†
.1
9†
.0
2
.1
0
.0
4
.0
3
.0
4
Ec
on
om
ic
 F
ac
to
rs
12
. S
oc
ia
l A
no
m
ie
 (I
nc
om
e 
In
de
x)
-
.0
9
.0
1
-.0
3
-.0
6
-.0
7
.0
03
.0
3
.0
5
.0
5
.0
6
-.0
9
13
. U
ni
t p
ric
e 
of
 E
cs
ta
sy
 p
ill
-
-.0
4
.1
1
.0
1
-.0
5
.0
4
-.0
3
.0
1
.0
3
.0
3
.0
6
14
. O
pp
or
tu
ni
ty
 c
os
t 
-
.1
6†
.2
1†
.1
4†
.0
4
.1
4†
.1
1
.0
5
.0
8
.0
3
Ps
yc
ho
lo
gi
ca
l F
ac
to
rs
M
ot
iv
at
io
n
15
. O
pp
or
tu
ni
ty
 to
 g
et
 E
cs
ta
sy
-
.4
5†
.4
6†
.3
0†
.1
0
.0
7
.0
9
.1
4†
.2
0†
16
. P
la
ce
s/
Pe
op
le
 to
 g
et
 E
cs
ta
sy
 fr
om
-
.6
2†
.3
4†
.1
0
.1
5†
.1
0†
.1
5†
.2
8†
17
. P
eo
pl
e 
to
 g
et
/s
ha
re
 E
cs
ta
sy
 w
ith
-
.3
4†
.1
4
.1
5†
.1
4†
.1
6†
.3
0†
18
. M
ot
iv
e 
to
 u
se
 E
cs
ta
sy
-
.1
9†
.2
6†
.2
1†
.2
3†
.1
6†
O
th
er
 R
is
k 
Fa
ct
or
s
D
ep
re
ss
io
n
19
. B
eh
av
io
ra
l 
-
.5
9†
.6
4†
.6
9†
.0
7
20
. S
om
at
ic
-
.7
0†
.6
6†
.1
3†
21
. A
ffe
ct
ive
-
.7
2†
.1
0
22
. C
og
ni
tiv
e
-
.0
9
R
is
k 
Ta
ki
ng
23
. S
ex
 ri
sk
‐
Ite
m
-to
-T
ot
al
 C
or
re
la
tio
n*
.5
3
.6
1
.7
0
.6
7
.4
6
.4
3
.5
2
.4
3
.5
5
.4
9
.3
0
.1
2
-.0
6
.2
4
.5
1
.5
9
.6
3
.4
0
.7
1
.7
2
.8
1
.8
2
-
* 
Th
is
 is
 a
 m
ea
su
re
 o
f i
nt
er
as
so
ci
at
io
n 
of
 e
ac
h 
ite
m
 w
ith
 th
e 
to
ta
l c
or
re
la
tio
n 
ad
ju
st
ed
/c
or
re
ct
ed
 fo
r t
he
 it
em
s 
(a
ll 
st
an
da
rd
ize
d)
 in
 th
e 
do
m
ai
n.
† 
St
at
is
tic
al
ly 
si
gn
ifi
ca
nt
 le
ve
ls
 a
t p
 ≤
 .0
01
 (2
-ta
ile
d)
  158
Turning first to the measures of Consumption, the largest association was 
observed between times used per day in the past 30 days and recent use (r = .68) and 
the smallest association was observed between lifetime quantity and both number of 
days used in the past 30 days and recent use (r’s = .26). Overall, the moderate 
associations between the different measures of consumption and the information from 
the adjusted item-to-total correlations (ranging from .53 to .70) indicate these 
different measures of use are likely tapping an underlying frequency/quantity 
dimension.  
The inter-correlations between the seven indicators (i.e., DSM-IV diagnostic 
criteria) of Dependence were all positively correlated with one another and highly 
significant (all ps ≤ .001). Their values ranged from a low of r = .16 to a high of r = 
.43, again reinforcing that the values were in the small to relatively moderate range 
and confirmed the absence of empirical redundancy. The adjusted item-to-total 
correlations were also moderate, ranging from a low of r = .30 to a high of r = .55, 
suggesting that each criterion measure is a suitable representation of the hypothesized 
latent construct. 
Turning next to the economic measures, there are three measures including 
economic well-being or “social anomie” (labeled income index), “unit price” 
indicating how much is actually paid for an Ecstasy pill, and “opportunity cost”, 
assessing the amount of time required to obtain and use Ecstasy. It was not expected 
that there would be considerable overlap between these items as they tap distinct 
  159
economic facets driving drug consumption. Indeed, the inter-correlations between 
these items were very small in magnitude and none were significant. They ranged 
from a low of r = .01 between “income and opportunity cost” to a high of r = .09 
between “income and unit price,” and all of these associations were in the expected 
direction. In particular, the Pearson product moment correlation between unit price 
and opportunity cost was negative, indicating that users might have to search longer 
and expend more time traveling to obtain less expensive Ecstasy pills (The more time 
spent searching for Ecstasy, the higher the chance to buy it at lower price). The 
relatively small magnitude of association between the economic indicators supports 
the assumption of minimal redundancy among the three items (or measures) 
comprising this domain. Additionally, the adjusted item-to-total correlation for each 
of these measures was also small and further indicates there is no “latent” dimension 
underlying these associations. 
A latent construct of Motivation from the “Psychological Factors” domain 
was hypothesized based on the assumed inter-relationships between four indicators: 
“opportunity to get Ecstasy,” “places/people to get Ecstasy from,” “people to 
get/share Ecstasy with,” and “motives to use Ecstasy.” The correlations between 
these indicators were positive and highly significant (all ps≤.001). The absolute 
magnitude of these associations ranged from a low of r = .30 between “opportunity to 
obtain Ecstasy and motive to use Ecstasy” to a high of r = .62 between “people and 
places to get Ecstasy and “people to get/share Ecstasy with,” suggesting a moderate 
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amount of conceptual overlap but limited empirical redundancy. Adjusted item-to-
total correlations were also within an acceptable moderate range from a low of r = .40 
to a high of r = .63, reinforcing the hypothesis that there is some conceptual similarity 
within the four indicators that reflect an underlying “impetus” for consuming Ecstasy. 
A latent construct of Depression in the domain labeled “Other Risk Factors” 
for using Ecstasy was reflected by four indicators tapping “behavioral,” “somatic,” 
“affective,” and “cognitive” symptoms. Inter-correlations between these four 
indicators ranged from a low of r = .59 between “behavioral and somatic” to a high of 
r = .72 between “affective and cognitive” and were significant (all ps ≤ .001). The 
parcel containing affective symptoms was moderately related with both the indicator 
containing somatic symptoms (r = .70) and the one containing cognitive symptoms (r 
= .72). As far as benchmarks go, these values are respectively at the low end of the 
spectrum for “large” associations, suggesting that there may be a modest amount of 
conceptual overlap between the items used to construct these different indicators. 
Adjusted item-to-total correlations ranged from a low of r = .71 to a high of r = .82, 
indicating considerable overlap between the indicators and the hypothesized latent 
construct of Depression. 
Cross-Domain Associations -- Overall, the cross-domain item-paired 
correlations [see highlighted (shaded) areas in Table 4.6] were generally small to 
moderate, but varied in magnitude, direction, and statistical significance, depending 
on the particular association that was examined. Relations between the three 
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measures from the economic domain [“social anomie” (or income index), “unit 
price,” and “opportunity cost”] differed with the indicators of the two outcome latent 
constructs (Consumption and Dependence). Specifically, most of the associations 
between the three economic measures and the four indicators of Consumption were 
moderately small, significant, and in the expected direction. The associations between 
opportunity cost and the four indicators reflecting Consumption were consistent in 
magnitude ranging from a low of r= .14 for recent use to a high of r = .22 for quantity 
lifetime and number of days used past 30 days. Next largest in magnitude were the 
relations between unit price and the four consumption indicators, ranging from a low 
of r = -.01 for lifetime quantity to a high of r = .21 for number of days used past 30 
days. Relations between social anomie and the four consumption indicators were 
much smaller in magnitude with the exception of quantity (r = -.19), the remainder 
were all quite small and none was significant. 
The relations between the economic measures and the dependence indicators 
were all relatively small and none were significant. The largest magnitude was 
observed between increased use over a longer period and opportunity cost (r = .10). 
Only three of the possible 12 relations between economic measures and the indicators 
of motivation to use Ecstasy were significant, and all involved opportunity cost with 
“places and people to get Ecstasy” (r = .21), “opportunity to get Ecstasy” (r = .16), 
and “people to get and share Ecstasy” (r = .14). 
  162
With few exceptions, associations between the indicators of Motivation and 
indicators of Consumption were modest in size and significant. The non-significant 
relations were between motives to use Ecstasy and all three measures of recent use 
(but not lifetime use). The magnitude of relations between the indicators of 
Dependence and Motivation were similar in size and only one (“continued use despite 
problems” with “opportunity to get Ecstasy”) did not achieve significance.  
Relatively speaking, the bivariate associations between the components of 
“Other Risk Factors” (“Depression” and “sexual risk”) and the indicators of 
Consumption and Dependence were smaller in absolute size and there was no 
observable pattern in their signs. The relations between indicators of Depression and 
Consumption were quite small and none achieved significance. The same relations 
between indicators of Depression and Dependence, respectively, were considerably 
larger in magnitude and 14 of the 28 achieved significance. Among the significant 
associations they ranged in magnitude from a low of r = .11 between “cognitive 
symptoms” and “great deal of time spent in activities looking for drug” and r = .17 
between “somatic symptoms” and “persistent desire or unsuccessful efforts to cut 
down” (all ps < .0001). 
On average the composite unit-weighted index of sexual risk-taking had a 
greater magnitude of association with indicators of Dependence compared to 
Consumption. The largest relation overall was between quantity (lifetime) and sexual 
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risk (r = .20) and this was followed by “reduce or avoid important social, occupation, 
or recreational activities” and sexual risk (r = .15), both ps < .001.  
In contrast to these relatively small associations, sexual risk taking was more 
moderately associated with the indicators of Motivations. These associations ranged 
from a low of r = .16 for “motive to use Ecstasy” to a high of r = .30 for people to 
get/share Ecstasy with” (all ps <.0001). 
To summarize, the preliminary statistical tests contained in this section helped 
verify that the data comforts with the underlying assumptions of normality and the 
absence of multicollinearity required for robust estimation of SEMs. In particular, 
univariate measures of kurtosis and skewness indicated non-significant departures of 
the item and scale distributions from normality. Additionally, the moderate 
associations of items or indicators within certain domains supported the hypothesized 
latent constructs. In the case of the four measured indicators of Depression, the 
associations among these measures are moderate and consistent suggesting they tap 
an underlying tendency of participants to consistently report a wide range of somatic, 
behavioral, cognitive, affective problems they experience when they feel depressed. 
Likewise the magnitude of association between items from the different domains, 
reinforces that the domains do not overlap conceptually and suggests there is a 
modest amount of conceptual “divergence” in the way these measures were 
constructed. Having established the suitability of the data using the traditional 
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approach of item level of analysis, the next step proceeded with the multivariate 
analyses intended to examine the fit of the sample data to the hypothesized model. 
3. SEM Testing Results 
This section contains two interrelated parts: (1) steps taken to construct and 
refine the conceptual model; and (2) empirical analyses of the hypothesized model. 
Construction and Refinement of the Conceptual Model --- The research 
hypotheses address the potential importance of combining economic and 
psychological domains to predict Ecstasy Consumption and problems associated with 
consumption (labeled Dependence). Figure 2.1 (from Chapter II) provided a basic 
overview of the conceptual framework for the proposed psycho-economic model. The 
framework highlights the main relations between relevant economic measures, select 
measures of psychological risk (both observed and latent constructs), and the two 
outcome constructs (Consumption and Dependence). The steps taken to construct the 
model consisted of identifying measures (indicators) that suitably assess the latent 
constructs (“measurement component”) and then specifying the hypothesized 
predictive relations among all the variables (“structural component”). Figure 4.1 
presents the latent-variable structural framework, referred to as the refined conceptual 
psycho-economic model. 
The measurement and structural portion of the model is separated by the 
stippled lines. The inner section in the upper portion of the Figure labeled 
“Measurement Component” details the framework for testing the hypothesized latent 
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constructs (indicated by large ovals) including Depression, Motivation, Ecstasy Use 
(or Consumption), and Dependence. Each latent construct is reflected by manifest 
(observed) indicators, shown by the rectangular boxes. To illustrate the model 
construction procedures, there are four observed indicators that reflect Depression 
(i.e., CESD-1=Behavioral, CESD-2=Somatic, CESD-3=Affective, and CESD-4 
=Cognitive), four that reflect Motivation (i.e., MOTIVE-1=Ways to get Ecstasy, 
MOTIVE-2=Places to use or get Ecstasy from, MOTIVE-3=People to share Ecstasy 
with, and MOTIVE-4=Motives to use Ecstasy), four used to indicate Ecstasy Use 
[i.e., USE-1=When last time used Ecstasy (Recency), USE-2=Number of days past 
30 days used Ecstasy (Frequency), USE-3=Number of pills per day (Quantity), and 
USE-4=Total number of Ecstasy pills used lifetime (“Addictive stock”) ], and seven 
for Dependence (i.e., DEP-1=Experienced tolerance, DEP-2=Experienced 
Withdrawal, DEP-3=Used Ecstasy for a longer time than intended, DEP-4=Had the 
desire or was unable to quit, DEP-5=Spent great deal of time acquiring or using 
Ecstasy, DEP-6=Avoided important activities to use Ecstasy, and DEP-7=Continued 
to use despite the knowledge of problems related to Ecstasy use).  
Both Depression and Motivation are considered “exogenous” constructs (and 
they can also be termed “predictors”) and Ecstasy Use (Consumption) and 
Dependence are posited as endogenous constructs (or “outcomes”). The term 
exogenous and endogenous are used to indicate the hypothesized process through 
which one measure or latent construct influences or contributes to another (or 
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accounts for predictive variance). This causal flow is indicated by the single-headed 
arrows on straight lines leading from left to right in the figure. Stated differently, 
Depression and Motivation are hypothesized to contribute unique predictive variance 
to the endogenous latent constructs of Ecstasy Use and Dependence. 
In contrast to the inner measurement component, the outer stippled box 
(encompassing the measurement component) in the Figure depicts the full 
“structural” portion of the model. The structural portion includes the measurement 
portion and then estimates the “effect” or influence of predictors on outcomes. The 
left-hand side of the model includes the manifest (observed) measures of economics, 
sexual risk, gender, age, race, education, as well as the two exogenous latent 
constructs (Depression and Motivation). The influence of these measures is estimated 
on the two latent construct outcomes (Ecstasy Use and Dependence). This model then 
becomes the formal statement of “theory” and is tested by positing these relations and 
comparing the fit between the sample variance/covariance matrix and the implied 
population model. 
Outside of the designated stippled areas are measured (observed) variables 
that are used as indicators of the latent constructs in the measurement portion of the 
model. In the measurement model, each latent construct is hypothesized to 
statistically “cause” the association among the observed indicators. In the case of 
Depression, the four indicators assess behavioral, somatic, affective, and cognitive 
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Ecstasy Use
Sex Risk
Gender
Age
Race
CESD-1δ11
Income Index
Monetary Cost
Opportunity Cost
ζ1
Dependence
Depression
Motivation
Site
Measurement Component
Structural Component
CESD-2δ12
CESD-3δ13
CESD-4δ14
MOTIVE-1δ21
MOTIVE-2δ22
MOTIVE-3δ23
MOTIVE-4δ24
USE-1 ε11
USE-2 ε12
USE-3 ε13
USE-4 ε14
DEP-1 ε21
DEP-2 ε22
DEP-3 ε23
DEP-4 ε24
DEP-5 ε25
DEP-6 ε26
DEP-7 ε27
ζ2
Figure 4.1 The revised conceptual psycho-economic model
Education
 
symptoms, but together they are all posited to tap Depression. Consistent with a 
standard equation for an ordinary least square model, there is an element of “error” 
associated with the prediction. These error terms are designated by the Greek symbol 
“theta” (δ) on the left-hand side of the model and “epsilon” (ε) on the right-hand side 
of the model. These respective error terms for the predictor latent factor indicators 
and those corresponding to the outcome or endogenous indicators capture non-factor 
determined variance or the residual variance in the indicator net of prediction by the 
factor. The usual interpretation given to a residual term for an indicator predicted by a 
latent construct is “measurement specific” variance that does not reflect the 
underlying factor. For instance, in the case of an indicator of Depression that assesses 
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looked at its entirety, Figure 4.1 also graphically portrays the 
hypoth
own in the upper “measurement portion” of the model are curved lines 
with do
affective symptoms, the residual term would reflect symptoms that are not 
behaviorally isomorphic with feeling blue, sad, or moody, but are still reported by 
participants.  
When 
esized “causal” model linking predictor variables (e.g., sexual risk) and latent 
constructs (e.g., Depression) on the left-hand side with two endogenous latent 
constructs. The flow of the model is portrayed using single-headed arrows on straight 
lines from the left-hand side pointing toward the right-hand side of the model. These 
are “paths” or regression effects and are estimated as beta (β) parameters or 
standardized regression coefficients. Each path coefficient reflects the influence of an 
independent variable or latent construct on a dependent construct and should be 
interpreted as the amount of “change” in the designated outcome for a unit change in 
the predictor.  
Also sh
uble-headed arrows indicating correlations between constructs. To illustrate 
the meaning of this parameter, the curved line between Depression and Motivation 
reflects their association net of the contribution of the remaining manifest variables 
(e.g., income, monetary cost, etc.) that are on the left-hand side of the model. 
Likewise, the curved line between Ecstasy Use and Dependence reflects their 
association net of prediction from all of the measured variables and constructs on the 
left-hand side of the model. In addition, the straight lines coming from each latent 
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bance” term that 
reflects
 Psycho-Economic Model
construct pointing toward a single rectangular box (observed or manifest indicators) 
are also regressions, but they are standardized factor loadings and designated 
“lambda” (λ) parameters in the model construction. These parameters indicate the 
strength of an item as a reflection of the underlying latent construct. 
Each of the endogenous latent constructs also has a “distur
 residual or net variation after prediction (ζ1 and ζ2). In the model, these are 
allowed to covary freely as estimates of the relation between Consumption and 
Dependence after all the effects of all exogenous predictors have been accounted. 
When squared and subtracted from 1.0, these terms indicate the proportion of 
variance accounted for in the particular construct. 
Empirical Analysis of the Hypothesized  --- As 
mentio
el that 
incorpo
ned previously, the model testing procedure followed a two-step process 
recommended by Anderson and Gerbing (1988). The first step includes specification 
of the psychometric model. This portion of the model is used to ascertain if the latent 
constructs are statistically reliable and are hypothesized correctly in terms of their 
respective indicators. In addition, the CFA model provides a means to inspect the 
error-free correlations between the latent constructs, a procedure that would not have 
been available using exploratory factor analytic techniques (Hair et al., 1998). 
The CFA model is then followed by a structural path regression mod
rates the findings from the measurement portion of the model. The structural 
model tests whether measures and constructs on the left-hand side (Figure 4.1) can 
  170
ortion of the model was also tested in a series of integrated 
steps. T
 latent 
constru
account for significant variance in the designated constructs on the right-hand side. 
This portion of the model is a direct test of the research hypotheses and provides a 
means to evaluate the unique contribution of economic measures to the outcomes and 
also their unique predictive variances when controlling for psychological measures 
(and latent constructs). 
The structural p
he first structural model examined the effects of economic measures (income 
index, monetary cost, and opportunity cost) on Ecstasy Use. Conceptually speaking, 
this is termed the ‘unbiased’ model, because it provides a picture of whether the 
economic measures are even statistically related to Ecstasy consumption in a 
multivariate framework (when their contributions are considered simultaneously) in 
the absence of any other measures. The same model was then estimated with the 
addition of the latent construct of Dependence (and the association between the two 
endogenous constructs is also estimated). Specification of an association between 
disturbance terms for the endogenous latent constructs is appropriate for a cross-
sectional model where any efforts to infer causation would be at best tenuous. 
The next series of models in the sequence incrementally specified
cts tapping Motivation, and then Depression, and this was followed by the 
inclusion of sexual risk-taking as predictors of Ecstasy Consumption and 
Dependence. This model retained the economic measures and addresses whether the 
economic measures maintain their predictive variance while controlling for the 
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 procedure, and in light of the obtained mean 
differen
ted 
using t
domain of psychological risk. At this point in the sequence, the model testing 
procedure included empirical specification searches to capture any nonstandard 
relations that were not hypothesized a priori. Nonstandard relations (sometimes called 
“uniquenesses”) capture relations between measured variable predictors (i.e., 
economic measures or sexual risk taking) and indicators of endogenous latent 
constructs as well as indicators of exogenous predictor constructs and indicators of 
endogenous constructs. These were not part of the original model nor are they 
“theory-driven” but their inclusion can approximate the “true model” (MacCallum, 
1986). Failing to include these associations would lead to model misspecification and 
produce a biased or poor fitting model. 
At this point in the model testing
ces in the preliminary descriptive analysis, other control measures were 
added. These measures include gender, age, race, and education, and study site.  
Estimation of the models specifying demographic characteristics provides an 
opportunity to examine whether the obtained parameter estimates for the economic 
and psychological factors dramatically change with the inclusion of these controls. 
All of the control measures were dichotomously scored for comparison purposes [for 
site the comparison include the US (St. Louis and Miami combined) vs. Sydney]. 
The parameters in both the measurement and structural models were estima
he Maximum Likelihood estimation (MLE) method for SEM provided in the 
EQS statistical program (Bentler, 1995). MLE has been shown to be robust especially 
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in the presence of normality violations (Newcomb & Bentler, 1988). Several statistics 
were employed to gauge the overall performance of each model. The large sample 
chi-square (χ2) statistic was examined to determine how well the estimated sample 
covariance matrix in the hypothesized model reproduced the population covariance 
matrix. As discussed earlier, Satorra-Bentler χ2-statistic (SB χ2) was applied instead 
of the traditional χ2 to adjust for any possible multivariate non-normality. A smaller 
χ2 indicates a better model fit, and the corresponding shrinkage in χ2 when contrasting 
nested models indicates superior fit as well. Several other commonly used goodness-
of-fit indices that were discussed earlier were also used to evaluate model fit. These 
included the comparative fit index (CFI: Bentler, 1990), the root mean square error of 
approximation (RMSEA: MacCallum, Browne, & Sugawara, 1996; Steiger & Lind, 
1980), and the Adjusted Goodness of Fit Index (AGFI: Arbuckle, 1997). The 
benchmark or “threshold” level conventionally required for “acceptable” model fit 
using these statistical measures are:  CFI ≥ .9 (range 0 to 1.0), indicating how much 
variance and covariation is accounted for in the sample data by the implied 
population model, an RMSEA ≤ .08 (where close to .05 indicates a good model fit), 
and an AGFI ≥ .9 (Bentler, 1992; Hu & Bentler, 1998; Jöreskog & Sörbom, 1996). 
Results of the Measurement Model --- As noted earlier, the CFA model 
consisted of 19 observed items (or indicators) used to measure four latent constructs: 
Depression, Motivation, Consumption (or “Ecstasy Use”), and Dependence. The first 
three constructs (Depression, Motivation, and Consumption) were measured by four 
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different indicators each, while Dependence was reflected by seven indicators. A 
first-order factor structure was estimated to assess the statistical reliability of each 
construct and obtain the standardized loadings for the entire sample.  
First-Order Factor Model -- In the first-order CFA, simple structure was 
specifie
 for the constrained and unconstrained models. 
The ba
d allowing only one non-zero loading per factor and thus no cross-factor 
loadings (an indicator for Depression could not load on Motivation) and the latent 
constructs were allowed to correlate freely. This means all six relations between the 
four latent constructs were estimated without any constraints. After this model was 
estimated, a constrained model was tested that fixed the latent construct correlations 
to unity (r = 1.0). The constrained model (compared to the maintained or less 
restrictive model) assesses whether the relations between the constructs are “perfect” 
and there is total conceptual overlap (this provides a test of construct validity). The 
nested likelihood χ2 difference test comparing the constrained to the less restricted or 
unconstrained model indicates the suitability of the constraints (i.e., whether the 
correlations are different from 1.0).   
Table 4.7 contains fit indices
se measurement model, provided an adequate fit to the data, χ2 (146) = 555.13, 
p ≤ .001, NFI=.877 (not reported in Table), CFI=.906, GFI=.922, AGFI=.899, 
SRMR=.080 and RMSEA=.063. The base model posits four latent constructs, but 
allows them to freely correlate. Another way to structure this model is to fix the 
correlations between latent constructs to r = 1.0 and test the adequacy of this fit 
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ount of the population variability 
predict
against the less constrained model by a nested likelihood difference test. The nested 
χ2 difference test indicates the unconstrained model provides a better fit, ?χ2(6) = 
2022.19, p > .001. The CFI is .906 for the unconstrained model and .442 for the 
constrained model. The higher the value of the CFI, the better the fit (.906 means the 
hypothesized model accounts for 90% of the variances and covariances in the sample 
data). The SRMR, which measures the average difference across the residual 
variances and covariances between the predicted and observed covariance matrices, is 
.138 in the constrained model and .08 in the unconstrained model. Again, smaller 
numbers indicate a better fit (8% of residual variation is left in the off-diagonal of the 
covariance matrix by the hypothesized model). 
The AGFI, which shows the relative am
ed by the covariance matrix specified by the model after adjusting for the 
degrees of freedom, is .574 in the constrained model and .899 in the unconstrained 
model (higher values are better). The ratio of χ2/df for the unconstrained model is 
3.80 whereas the same comparison for the constrained model is 16.95. In general, this 
ratio, as a gross measure of fit, should be closer to 2.0 (where < 4.0 is acceptable).  
Taken together, these findings provided ample evidence that the correlations between 
latent constructs are different from one. Therefore, the constrained specification of 
the measurement model was rejected. 
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Table 4.7  Comparative fit of The Measurement Model (N=640)
Four First-Order Degree of Chi-Square Chi-Square
Factor Structure Chi-Square Freedom Test Difference
Model χ2 df χ2/df ∆χ2 (∆df ) CFI GFI AGFI SRMR RMSEA
Constrained 2577.32 152 16.96 N/A .442 .659 .574 .138 .158
Unconstrained 555.13 146 3.8 2022.19(6)** .906 .922 .899 .080 .063
Note: 1. CFI = Comparative Fit Index;   GFI = LISREL Goodness of Fit Index; 
             AGFI = LISREL Adjusted Goodness of Fit Index;   
             SRMR = Standardized Root Mean-Square Residual
             and RMSEA = Root Mean-Square Error of Approximation.
          2. **Statistically significant at p  ≤ .01  
 
Although the unconstrained model provided a superior fit, it is worth pointing 
out tha
2001).  
t the χ2-statistic for the base model was statistically significant, implying poor 
overall fit of the model. This should not be unexpected when testing SEMs because 
the large sample χ2 statistic is sensitive to sample size and does not adjust for model 
complexity (Marsh et al., 1988). It is well known that large sample sizes can have 
excessive Type I error rates (Bollen, 1989; Browne & Cudeck, 1989; Marsh, 1994). 
Thus, trivial deviations between the sample data and the implied population model 
will cause the model to produce a significant χ2 statistic. Bollen (1989), among others 
(Bentler 1992; Byrne, 1994) suggest using a modified version of this statistic that 
takes into account the sample size, such as the ratio of χ2 points to the model degrees 
of freedom (χ2/df). Therefore, while the χ2-statistic was significant, the relative (or 
normed) χ2 was still within the acceptable threshold of less than 4 times the degrees of 
freedom established for this study, χ2/df =3.80 (Schumacker & Lomax, 2004; Ullman, 
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Second-Order Factor Model -- Even though the CFA findings indicated there 
was acceptable support for the unconstrained model, several of the goodness-of-fit 
indices
ctor loadings corresponding to the first-order latent constructs 
Depres
 exceeded their respective benchmarks. In particular, both the RMSR=.08 and 
RMSEA=.06 exceeded the .05 threshold. There are several model modifications that 
can be used to “tighten” up a model and enhance its overall fit. One such 
modification involves testing a higher-order structure based on the moderate 
associations between the first–order latent constructs. In other words, this model 
posits whether a single “second-order” latent construct can statistically account for 
the moderate associations among the first-order latent constructs (Gribbons & 
Hocevar, 1998). The fit of this model was adequate, χ2(148, N=640) = 559.245, p ≤ 
.001 (or χ2/df =3.78), NFI=.876, CFI=.905, GFI=.922, AGFI=.900, RMSR=.082 and 
RMSEA=.066 but did not improve on the fit of the first-order model, ?χ2(2) = 
4.115, p > .05.  
A careful examination of the second-order model findings shows that the 
standardized fa
sion, Motivation, Consumption, and Dependence were .265, .881, .430, and 
.724, respectively. Such a wide range of estimates indicates lack of communality 
shared among the first-order factors. As a result, the first-order factor structure with 
its freely estimated factor inter-correlations provided the best fit of all the alternative 
models tested. Importantly, implementations of any further model refinements (e.g., 
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elimination of weak items or freeing cross-construct loadings) were reserved for a 
later point in the model testing procedure with the fully conditioned SEM.  
Factor Reliability – The loadings of the various indicators on their respective 
latent constructs provide another indication of the suitability of the model. These 
standardized factor loadings indicate the “strength” of the observed measures as an 
indicator of the hypothesized latent construct. This provides, in many respects, an 
alternative means to assess the internal consistency (reliability) of the four latent 
constructs. The reliability of any indicator is defined as the square of its loading on 
the latent factor (Bollen, 1989). In other words, the loading of any item is the square 
root of its reliability. Ideally, for construct reliability, the factor loading estimates 
should be above .5 to be reliable. Furthermore, the product of factor loadings of any 
two items on the same construct defines their inter-correlation. Cronbach’s alpha (α) 
is essentially an average of the inter-item correlations underlying a construct. 
However, Cronbach’s alpha assumes that the observed items are perfectly measured 
without error. In order to separate measurement errors from model structural errors, 
Werts, Linn and Jöreskog (1974) proposed instead an error-disattenuated 
(measurement-error-free) formula for computing alpha. A disattenuated coefficient 
alpha of .7 or higher is commonly recommended for an adequate internal consistency 
of construct. 
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tandardized Parameter Loadings
Depression
Motivation
USE-1
USE-2
USE-3
USE-4
CESD-1
CESD-2
CESD-4
CESD-3
DEP-1
DEP-2
DEP-3
DEP-4
DEP-5
DEP-6
DEP-7
Ecstasy Use
MOTIVE-1
MOTIVE-2
MOTIVE-4
MOTIVE-3
.765
.754
.883
.894
.598
.489
.766
.770
.408
.715
.807
.830
.562
.501
.623
.668
Dependence
.604
.334
.514
.237***
.048
.219***
.388***
.632***
.316***
Figure 4.2 Measurement model depicting four hypothesized latent factors.
***Statistically significant at p ≤ .001
α =.89
α =.74
α =.51
α =.70
 
S  – As depicted in Figure 4.2, with minor 
exception, standardized parameter loadings from the CFA model were significant and 
above the .5 critical threshold. Loadings for the Depression construct ranged from a 
low of λ = .754 for behavioral symptoms (CESD-1) to a high of λ = .894 for 
cognitive symptoms (CESD-4), with an average λ = .824. Loadings for the 
Motivation construct ranged from a low of λ = .489 for “motive to use Ecstasy” 
(MOTIVE-1) to a high of λ =.770 for “places where Ecstasy is used” (MOTIVE-4), 
with an average λ = .656. Loadings for the Ecstasy Use (i.e., Consumption) construct 
ranged from a low of λ = .408 for “lifetime quantity of Ecstasy pills used” (USE-4) to 
a high of λ = .830 for “number of times used Ecstasy per day past 30 days” (USE-3), 
with an average λ = .691. Loadings for the Dependence construct ranged from a low 
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of λ = .334 for “continued use despite persistent physical or psychological problems” 
(DEP-7) to a high of λ = .668 for “great deal of time spent obtaining, using, or 
recovering from substance use” (DEP-5), with an average λ = 544.  
Interfactor Correlations – Of the six possible estimated correlations only the 
one bet
at each of the four latent constructs was 
statistic
 Structural Model
ween Depression and Ecstasy Use failed to achieve significance (r = .048). Of 
the remaining associations, Depression was associated with higher Motivation (r = 
.237, p ≤ .001) and more Dependence (r = .219, p ≤ .001). Motivation was associated 
with higher levels of Ecstasy Use (r = .388, p ≤ .001) and more Dependence 
symptoms (r = .632, p ≤ .001). Ecstasy Use and Dependence were moderately and 
positively associated (r = .316, p ≤ .001). 
Overall, these results indicated th
ally reliable. The coefficient alphas, ranging from .51 to .89, showed that the 
indicators adequately represented the underlying factors of Depression (α =.89), 
Motivation (α =.74), and Dependence (α =.70). The reliability for Ecstasy Use was 
somewhat lower (α =.51) after adjusting the measurement errors in its indicators. 
Overall, however, the findings of the CFA provided support for the proposed 
measurement model. 
Results of the  --- Having obtained a suitable measurement 
model that provided adequate psychometrics for the four specified latent constructs, 
the next step in the analysis involved testing the theorized psycho-economic model. 
As shown in Figure 4.1, the structural model specified the predictive relations as 
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pathways from the left-hand side of the model to the two outcome latent constructs 
(Consumption and Dependence). The predictors included two latent constructs 
(Depression and Motivation), two composite variables (income index and sexual risk-
taking), two ‘single” item economic measures (monetary cost or unit price and 
opportunity cost), and five “control” measures (gender, race, age, education, and 
site). The process of testing the SEMs involved a series of sequential models (not 
nested) that specifically addressed the research hypotheses. Each model was reviewed 
and evaluated first by examining the sign, magnitude, and statistical significance of 
the estimated path coefficients and second by the various model fit indices. For 
purposes of comparison, summary model fit statistics from the different SEMs are 
presented in Table 4.8. Table 4.9 contains the corresponding standardized parameter 
estimates for the different models tested in the sequence. 
Economic Model -- The first SEM examined the hypothesized economic 
compon
st step the model 
include
ent of the conceptual psycho-economic framework, using the three economic 
measures (income, opportunity cost, and unit price) as predictors of the latent 
construct outcomes (referred hereafter as the “Economic Model”). 
The Economic Model was tested in two steps. In the fir
d the three independent economic measures (income index, monetary price, 
and opportunity cost) as predictors of Ecstasy Consumption only. Even though this 
model is considerably pared down from the hypothesized psycho-economic model 
(and not nested with any more complex or subsequent models), it provides an 
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ng only the economic measures (referred to 
above 
other hand, “time spent obtaining Ecstasy” (assessing opportunity 
cost) w
opportunity to examine unbiased parameter estimates resulting from the regression of 
Ecstasy Use on the economic indicators. 
By all indications, a model positi
as ‘unbiased’ model) did not provide an optimal fit to the data (results not 
shown in Tables), χ2(11) = 69.40, p ≤ .001 (χ2/df = 6.31), NFI = .922, CFI = .932, 
SRMR = .049, RMSEA = .091, and AGFI = .924. Specifically, the χ2 was large and 
statistically significant and the χ2/df = 4 exceeded the upper bounds of acceptable 
upper limits for this fit index. Furthermore, although the Comparative Fit Index (CFI 
≥ .9) and the Adjusted Goodness of Fit Index (AGFI ≥ .9) meet the criteria for 
adequate model fit, the RMSEA was greater than .05, indicating there was substantial 
variation left in the sample data unaccounted for by the hypothesized model. Turning 
to the model parameters, the index of social anomie (income index) did not 
significantly predict Consumption (β=-.041, p > .10). Monetary (or unit price) was 
negatively associated with Consumption (reflecting the basic law of demand), β = -
.226, p ≤ .001.  
On the 
as positively associated with Consumption (i.e., more time is required for less 
expensive Ecstasy that leads to more use), β=.212, p ≤ .001. Correlations among the 
exogenous predictors indicated that higher levels of income (reflecting social power, 
available discretionary income or the opposite of anomie) was positively associated 
with lower levels of unit price (r = .085, p ≤ .05). Stated in different terms, it would 
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ce as a second endogenous 
constru
ied correlations (both for the exogenous and endogenous 
parts of
appear that lower income drug users search for lower Ecstasy prices. As a follow-up 
test, and as a means of testing for suppression (this also has been termed 
‘interpretational confounding’ by Burt, 1973; 1976), the Economic Model was also 
specified and tested just modeling the income index as a predictor of Consumption 
(essentially constraining to zero the effects associated with opportunity cost and 
price). This model also showed that neither unit price nor opportunity cost was 
“masking” the relation between income and Consumption. The estimated path 
coefficient maintained roughly the same magnitude, there was no reversal of sign, 
and the parameter was not significant, β=-.036, p > .10. 
The next Economic Model specified Dependen
ct along with Consumption and included the three exogenous economic 
indicators (referred to as “SubModel 1”). Model fit statistics (see Table 4.8) also 
showed a less than optimal fit by several criteria, χ2(70) = 274.09, p ≤ .001 (χ2/df = 
3.92), NFI = .875, CFI = .890, RMSR = .071, RMSEA = .068, and AGFI = .919. Of 
all three exogenous predictors (see Table 4.9), “time spent locating Ecstasy” (i.e., 
opportunity cost) significantly predicted Ecstasy Use (β = .214, p ≤ .001) and 
Dependence, β = .126, p ≤ .01, while unit price (i.e., monetary cost) predicted Ecstasy 
Use, β = -.226, p ≤ .001.  
Among the specif
 the model), the positive association between income and unit price remained 
intact (r = .085, p ≤ .05) and as expected higher Consumption was associated with 
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hological Model
more reported problems from Ecstasy use (i.e., Dependence criterion), r = .30, p ≤ 
.001. Overall, the economic component of the structural model explained about 14% 
of the variance of Consumption (R2 = .135) and 12% of the variance in Dependence 
(R2 = .117). The income index was not a significant predictor of either outcome latent 
constructs. 
Psyc  -- The next SEM specified pathways (see Figure 4.1 
above)
≤ 
.001 (χ
 indicating all possible predictive relations between the hypothesized non-
economic “Risk Factors” and the two endogenous outcome constructs: Consumption 
and Dependence. This model does not include the economic measures and also 
provides an opportunity to examine the influence of psychological risk on 
Consumption and Dependence. The domain labeled “Risk Factors” included 
psychological functioning (Depression), situational motivations to use drugs, and 
sexual risk-taking, the latter serving as a proxy of the Ecstasy user’s risk taking 
behavior. This model was referred to as the Psychological Model. Results of this 
model are reported in Table 4.8 and Table 4.9 under the heading of “SubModel 2.”  
The Psychological Model showed a fairly adequate fit, χ2(161) = 565.13, p 
2/df = 3.51), NFI = .877, CFI = .908, SRMR = .078, RMSEA = .063, and 
AGFI = .902. In particular, the χ2 was large and statistically significant, and the χ2-
ratio was lower than 5.0 but still larger than the acceptable level of 2.0 indicating 
superior model fit (χ2/df = 4). With the exception of the NFI, the overall goodness of 
fit measures (CFI and AGFI) exceeded their critical thresholds of .90, but only 
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slightly. Although the RMSEA was below its acceptable level, SRMR was just near 
its cut-off value of .08. 
 
Table 4.8  Goodness of Fit for The Structural Model (N=640)
Degree of Chi-Square
Competing Model for Chi-Square Freedom Test
Ecstasy Use & Dependence χ2 df χ2/df NFI CFI GFI AGFI SRMR RMSEA
  SubModel 1  274.09 70 3.92 .875 .890 .946 .919 .071 .068
  SubModel 2  565.13 161 3.51 .877 .908 .925 .902 .078 .063
  Full Model 671.23 206 3.26 .860 .898 .923 .897 .071 .059
  Refined Model  607.70 200 3.04 .879 .916 .932 .906 .065 .055
  Conditioned Model 1042.51 272 3.83 .829 .869 .901 .868 .081 .071
 Notes: 1. SubModel 1 = Model with economic measures only (Income, Price, & Opportunity Cost)
                  SubModel 2 = Model with psychological factors only (Motivation, Depression, & Sex-Risk)
                  Full Model = SubModel 1 and SubModel 2 combined
                  Refined Model = Full Model + allowing for nonstandard effects 
                  Conditioned Model = Full Model + controling for demographics (Gender, Age, … etc) and site
             2. NFI = Normative Fit Index;   CFI = Comparative Fit Index;
                 GFI = LISREL Goodness of Fit Index;   AGFI = LISREL Adjusted Goodness of Fit Index;
                 SRMR = Standardized Root Mean-Square Residual;  and 
                 RMSEA = Root Mean-Square Error of Approximation.
     Goodness of Fit Measures
 
 
An examination of the standardized parameters estimated for this model (see 
Table 4
Dependence (β = .654, p ≤ .001).  
.9) showed that not all path coefficients were significantly different from zero 
(p > .05). Neither Depression nor sexual risk-taking significantly predicted Ecstasy 
Use (Consumption). However, Depression was significantly associated with 
Dependence, β = .078, p ≤ .001. Sexual risk-taking was not significantly associated 
with Consumption but negatively and significantly associated with Dependence (β = -
.110, p ≤ .01). It is worth noting also that of all the psychological risk measures 
Motivation had the largest influence on both Consumption (β = .417, p ≤ .001) and 
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Furthermore, there were several significant associations among the predictor 
measur
e Full Model
es and constructs. Depression was significantly associated with sexual risk-
taking (r = .110, p ≤ .05), as was Motivation with sexual risk-taking (r = .362, p ≤ 
.001), and Motivation was significantly associated with Depression (r = .231, p ≤ 
.001). The psychological component of the structural model explained (see Table 4.9) 
about 16% of the variance in Consumption (R2 = .155) and 41% of the variance in 
Dependence (R2 = .414). 
Specification of th  -- The next in the series of SEMs tested the 
influen
ptable fit was obtained when the model included both the economic 
and psy
ce of both the economic and psychological domains in fully saturated model 
(and predicting both latent constructs of Ecstasy Use and Dependence). Estimates of 
the “Full Model” path coefficients were derived in an ordered sequence, starting with 
the Economic Factors (income index, monetary price, and opportunity cost) and 
adding incrementally the three risk factors (Motivation, Depression, and sexual risk-
taking). Running the model incrementally helps to identify problems with 
convergence and optimization as well as detect any suppression. The sequential 
nature of model testing also provides a means to compare the direct effects of each 
risk factor from a specific domain before and after controlling for measures from 
other domains. 
An acce
chological components, χ2(206) = 671.23, p ≤ .001 (χ2/df = 3.26), NFI = .860, 
CFI = .898, SRMR = .071, RMSEA = .059, and AGFI = .897. Despite the fact that 
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ution of combining key economic and 
psycho
model that constrained these paths to zero.  
the χ2 was statistically significant, the χ2/df ratio achieved an acceptable level (χ2/df ≤ 
4). Also, while both the CFI and the AGFI statistics did not clearly meet their 
required criteria (CFI ≥ .90 together with AGFI ≥ .90), they were still both well 
within their acceptable .90 range. On the other hand, the SRMR and RMSEA were 
both below their recommended benchmark of .08. Furthermore, the fully saturated 
structural model accounted for 22% of the variance in Consumption and 41% of the 
variance in Dependence (see Table 4.9). 
To further assess the contrib
logical measures  to account for Ecstasy Use and Dependence, two additional 
models were directly compared with the Full Model (referred to in this test as “Parent 
Model”), using the χ2 nested difference test. The importance of the three economic 
factors (income, price, and opportunity cost) was tested first. In this test, the “Parent” 
Model with its freely estimated parameters was compared to a structural model that 
constrained the paths corresponding to the economic measures to zero. This model 
essentially posits there are null effects for the economic measures when juxtaposed 
against measures of psychological risk and structurally nested with the Parent Model. 
The nested comparison of these two models was significant, Δχ2 = 2610.21 - 671.23 
= 1938.98 (Δdf = 209 - 206 = 3), p ≤ .001, indicating that at least some of the 
constraints were not tenable. In other words, specifying paths from the economic 
measures to Consumption and Dependence improves the fit of the model over a 
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the effects of the psychological factors to 
be zero
s 
betwee
ructs 
(Consu
Following this test, the Parent Model was compared to a nested model that 
constrained the path coefficients estimating 
. These constraints resulted in a significantly poorer fit than when the same 
parameters were freely estimated, Δχ2(Δdf =3) = 2191.76, p ≤ .001, suggesting that 
the psychological factors were also needed to explain the use of Ecstasy and its 
related consequences. On the basis of the above findings, it was apparent the 
integration of economic and psychological factors was deemed essential. 
The Final Model parameter estimates are reported in Table 4.9 and displayed 
in path diagram in Figure 4.3. Because the estimated factor loadings, correlation
n constructs, and error terms were almost identical to those reported for the 
measurement model in Figure 4.2, they are not presented here. Also, for purposes of 
clarity, only the structural components of the Full Model with statistically significant 
coefficients corresponding to paths and correlations are illustrated in Figure 4.3. 
As shown in Figure 4.3, among all the hypothesized relations between the 
exogenous economic and psychological predictors and the endogenous const
mption and Dependence), the income index did not significantly predict either 
Ecstasy Use (β = -.028, p > .10) or Dependence (β = .013, p > .10). However, 
opportunity cost (time spent seeking drugs) was significantly related to Ecstasy Use 
(β = .137, p ≤ .001) and monetary cost (unit price) was inversely and significantly 
associated with Ecstasy Use (cheaper prices were associated with more consumption: 
β = -.234, p ≤ .001). Among the psychological risk factors, Motivation was associated 
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with greater consumption (β = .384, p ≤ .001) and also with more problems from 
consumption (β = .661, p ≤ .001). Interestingly, and in contrast to the previous model 
findings (see SubModel 2 results), Depression was not significantly related to either 
of the two endogenous constructs, albeit there was a trend for more depressive 
symptoms to be associated with more problems from consumption (β = .076, p = 
.051). Sexual risk-taking was inversely and significantly associated with association 
with Dependence (β = -.11, p ≤ .05). 
 
Ecstasy Use
Sex Risk
Income Index
Monetary Cost
Opportunity Cost
Dependence
Depression
Motivation
.110**
.098*
Figure 4.3 Final SEM depicting influence of both economic and psychological factors 
on Ecstasy use and dependence (Only significant paths are showing). 
***Statistically significant at p ≤ .001
**Statistically significant at p ≤ .01
*Statistically significant at p ≤ .05
.076*
.384***
.661***
-.234***
.137***
-.107*
.250***.236***
.336***
.220***
.068*
-.095*
.085*
 
 
The Full Model also contains significant correlations between several of the 
exogenous predictors. The largest of these includes an association between 
Motivation and sexual risk-taking (r = .336, p ≤ .001), followed in order of decreasing 
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magnitude by associations between Depression and Motivation (r = .236, p ≤ .001, 
Motivation and opportunity cost (r = .220, p ≤ .001), Depression and sexual risk-
taking (r = .110, p ≤ .01), Depression and opportunity cost (r = .098, p ≤ .05), and 
income with sexual risk-taking (r = -.095, p ≤ .05: more financial displacement is 
associated with higher risk-taking), monetary cost (r = .085, p ≤ .05), and Depression 
(r = .068, p ≤ .05). Overall, these eight correlations help clarify the overlap between 
the economic measures and psychosocial risk. The only other parameter remaining of 
interest is the association among disturbance terms for the two endogenous constructs 
(Ecstasy Use and Dependence), which reflects their association net of all predictor 
effects (r = .25, p ≤ .001). 
Post-Hoc Specifications and Model Refinement – At this point it made sense 
with all of the specified predictors included in the model to run empirical 
specification searches to detect any additional ‘nonstandard’ effects (or associations 
in this case, given the cross-sectional nature of the data) that may help improve the 
overall model fit. Theoretically speaking, the full model specified very general 
predictive relations; however, there are other less obvious relations that exist within 
the data that may be sample specific, but were not hypothesized as part of the psycho-
economic model. These also help to uncover the “true” model. The specification 
searches include any “indicators” of a predictor construct that influence either an 
endogenous latent construct or the indicator corresponding to an endogenous 
construct. In addition, nonstandard relations can include exogenous constructs that 
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am produces modification indices (MIs) that indicate the 
magnit
were checked for theoretical consistency 
(addres
influence indicators of endogenous constructs and that were not specified a priori. 
[See Leamer (1978) for a thorough discussion of specification searches in the context 
of economic theory].  
Although post-hoc empirical specification searches are conducted “after the 
fact” they are tested in a very systematic fashion. The Lagrange Multiplier test in the 
EQS statistical progr
ude and direction of an expected parameter change and corresponding change 
in likelihood ratio χ2 value for the model that accompany freeing an individual 
parameter (Bentler, 1995). Inclusion and specification of nonstandard parameters 
essentially takes a parameter fixed at zero and freely estimates this parameter in the 
context of other obtained nonzero relations. 
Specification searches were conducted in a very straightforward and 
methodical manner to assure model consistency (e.g., Silvia & MacCallum, 1988). 
First, each recommended parameter change 
sing whether the proposed change in model parameterization was consistent 
with prior reported empirical findings) and then the sign of the parameter was 
examined in the context of the given zero-order bivariate relations. If a recommended 
change involved specification of a path involving a factor, the signs of the proposed 
parameter were checked against all of the indicators reflecting the factor. This 
procedure protects against suppression and inconsistent models. Given the primary 
interest rests with the significance of economic indicators in the context of important 
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 to the Full Model. These 
include
psychosocial measures, the search for nonstandard relations concentrated on 
identifying effects from economic predictors on observed indicators of the two 
endogenous constructs (Consumption and Dependence).  
Based on the systematic search outlined above, six nonstandard relations 
involving the three economic indicators and two endogenous constructs were 
detected, satisfied the criteria for inclusion, and added
d a path between the income index and number of pills used/day past 30 days 
(β = .07, p ≤ .05) and a path from opportunity cost (time spent obtaining Ecstasy) and 
number of pills used/day past 30 days (β = .09, p ≤ .01). In addition, opportunity cost 
was significantly associated with lifetime quantity (β = .15, p ≤ .001) and the index of 
income was significantly associated with lifetime quantity (β = -.18, p ≤ .001). 
Coding of the income index indicated that less financial means were associated with 
less lifetime Ecstasy use. In addition, monetary cost (unit price) was associated with 
lifetime quantity (β = .11, p ≤ .01) and with an indicator of dependence (β = -.07, p ≤ 
.05). The latter relation indicated greater cost was associated with less dependence. 
The Revised Model with the addition of these paths fit the data reasonably well, 
χ2(200) = 607.70, p ≤ .001 (χ2/df = 3.04), NFI = .879, CFI = .916, RMSR = .07, 
RMSEA = .05, and AGFI = .932. Specifically, the χ2/df ratio was smaller and below 
the critical 4.0 threshold. All three relevant model fit indices met their joint critical 
thresholds of “good fit” (CFI ≥ .9 together with a RMSEA ≤ .08 or with an AGFI ≥ 
.9). The Revised Model explained 24% of the variance in Consumption (R2 = .237) 
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and 43% of the variance in Dependence (R2 = .428). At this point, there were no more 
post-hoc additions that reflected unequivocal influence of economic indicators on the 
endogenous components and the overall model change in χ2 points was not 
appreciable enough to warrant inclusion of additional specific relations. 
Simulation and Bootstrap Analyses – On the basis of the above findings (see 
Table 4.9), a bootstrap analysis was undertaken to determine whether the obtained 
parameter estimates were stable or consistent. Bootstrapping is a nonparametric 
method
ue” (or population) values of the parameters and 
 usually used for both inferential and descriptive purpose based on the data-
driven sampling distribution of estimates (Efron & Tibshirani, 1994). In this study, 
the bootstrap procedure consisted of re-sampling from the available data repeatedly 
and re-estimating the model parameters. One thousand random “bootstrap samples” 
with a subset of 500 observations each were drawn with replacement from the actual 
sample data. The model selection for these bootstrap simulations was the Full Model 
as it was the most conceptually relevant specification of the proposed psycho-
economic model. From the empirically estimated sampling distribution, the parameter 
mean estimates, standard errors, and the ratio of the mean parameter estimate to its 
standard errors were computed and reported along with the actual Full Model 
parameter estimates in Table 4.10. 
The bootstrap approach assumes that the model is theoretically correct, but 
that the estimates drawn through re-sampling sample data are not precisely accurate. 
They are approximation of the “tr
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given t
ases) and also relatively small standard errors (this 
indicat
he hypothesized model. The ratio of the mean parameter estimate and standard 
error functions as a t-test or critical z-ratio statistic indicating the significance of the 
estimate. It should be noted that for a good approximation of the “true” parameter 
value, the ratio should be greater than two (1.96 is formally the critical z-ratio limit 
for a two-tailed hypothesis test). 
Table 4.10 contains the results of the bootstrap procedure. Overall, the mean 
bootstrap estimates and the Full Model parameter values were very close with very 
trivial deviations (.001 in many c
es the estimates are quite efficient). Across the 1000 replications, Motivation (t 
= 6.326), monetary cost (t = -5.167), and opportunity cost (t = 2.906) were the more 
consistent predictors of Consumption, while Motivation (t = 8.691), Depression (t = 
2.250) and sexual risk-taking (t = -2.167) were the more consistent predictors of 
Dependence. The income index was not a consistent predictor of either endogenous 
constructs (Consumption or Dependence). Of particular interest was the parameter 
estimates for the association between sexual risk-taking and Ecstasy Use. The 
absolute value of this parameter was very small but between the sample and bootstrap 
model’s flipped signs. Of the 1000 bootstrap simulation results, 58% of its values 
were positive and the remainder was negative perhaps indicating suppression. 
Therefore, although the results from this bootstrap analysis confirmed that in general 
the parameters of the full hypothesized model were stable (and efficient) over the 
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1000 replications, variables such as income, Depression and sexual risk-could 
perhaps be dropped to improve the fit of the model. 
Table 4.10  Sample and Bootstrap of Model Parameter Estimates (1000 Replication, N=640)
Predictors Sample Bootstrap SE t-Value
             Ecstasy Use              Dependence
Sample Bootstrap SE t-Value
Economic Factors
Income Index -.004 -.003 .015 -.221 .007 .008 .012 .612
Monetary Cost -.181 -.182 .035 -5.167 -.019 -.021 .026 -.816
Opportunity Cost  .110 .109 .037 2.906 -.014 -.016 .028 -.584
Psychological Factors
Motivation .145 .146 .023 6.326 .186 .189 .022 8.691
Other Risk Factors
Depression -.020 -.018 .0186 -.968 .021 .022 .010 2.250
Sex Risk -.006 .012 .0119 1.008 -.019 -.020 .009 -2.167
 Notes: 1. The model used in these simulations was the originally hypothesized "Full" model and 
               did not include any non-standard effects/associations 
           2. Sample = ML non-standardized solution, Bootstap = Mean bootstrap results,
           SE = Estimated standard errors for bootstrap estimates, and 
           t-Value = Mean bootstrap estimates to estimated SE (z-critical ratio)  
The Conditioned Full Model -- The final step in the model testing procedure 
involved estimation of the Full Model with demographic control variables. Inclusion 
of these control measures was based partly on the findings from the earlier 
descriptive and variance decomposition analysis that had reinforced clear gender, age, 
and site differences in model variates. Usually, the best way to evaluate the influence 
of exogenous “control” measures requires splitting the sample for each variable and 
conducting multiple group comparisons. In the case of gender, for example, a sample 
variance/covariance matrix would be generated separately for male and female 
participants and various equality constraints tested across these models. However, 
splitting the sample would result in highly uneven groups for most of the control 
measures (particularly race, age, education, and site), the comparison would be highly 
underpowered, and strain the robustness of the statistical methods. An alternative 
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approach is to dummy code the control measures (male=1, female=0) and add them 
to the “Full” model as exogenous control measures (their influence is treated as 
“covariates” and the model assesses whether these measures “condition” the 
parameter estimates). 
Demographics Control – An initial conditioned model included gender (male 
coded as “1”), race (white coded as “1” and ‘racial minorities’ coded as “0”), age 
(‘less than 21’ coded as “1” ’21 and older’ coded as “0”), and education (‘less than 
high school’ coded as “1” and ‘high school and beyond’ coded as “0”) to examine 
whether they dramatically change the model fit and its parameter estimates. A model 
specifying these control measures indicated a “decrement” in fit from the “Full” 
model previously reported, χ2(296) = 1063.19, p ≤ .001 (χ2/df = 3.59), NFI = .814, 
CFI = .849, RMSR = .07, RMSEA = .06, and AGFI = .895. Although the χ2/df was 
still acceptable (χ2/df = 4), the remaining model fit indices did not met their joint 
critical thresholds (CFI ≥ .9 together with a RMSEA ≤ .08 or with an AGFI ≥ .9). 
Also, of all the demographic variables added to the model only education marginally 
predicted Consumption (β = .10, p = .05). On the other hand, gender (male 
participants reported less problems than females, β = -.10, p ≤ .05) and age (younger 
users reported more problems than older ones, β = .16, p ≤ .01) significantly 
predicted Dependence. 
Site Comparisons – A second conditioned model added all the demographic 
measures along with site into the Full model (participants from Australia coded as 
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“1” and
onsumption and Dependence. Although this model showed a better fit 
than th
 those from St. Louis and Miami coded as “0”). Again these additions led to a 
decrement in model fit, χ2(321) = 1356.42, p ≤ .001 (χ2/df = 4.23), NFI = .760, CFI = 
.803, RMSR = .09, RMSEA = .07, and AGFI = .841. Furthermore, there was also 
additional evidence of “suppression” because certain parameter estimates (income 
index and monetary cost) reversed signs predicting both Consumption (β = .01, p > 
.10 and β = .30, p > .10, respectively) and Dependence (β = -.01, p > .10 and β = -.02, 
p > .10, respectively). Indeed, based on earlier bivariate analysis, both race and 
education were strongly associated with site (see Table 4.1). Since neither variable 
reached the nominal alpha level for significance, they were candidates for 
elimination. 
A third and final conditioned model examined the effect of gender, age and 
site on both C
e two previous models, it was only marginally acceptable (reported in Tables 
4.8 and 4.9), χ2(272) = 1042.51, p ≤ .001 (χ2/df = 3.83), NFI = .829, CFI = .901, 
RMSR = .08, RMSEA = .07, and AGFI = .868. Of all three control variables added to 
the model, only site was a strong and significant (β = .479, p ≤ .001) predictor of 
Ecstasy use or Consumption, indicating that, holding all else constant, Ecstasy users 
in Australia consumed more pills that their counterparts in St. Louis and Miami. On 
the other hand, gender (β = -.11, p ≤ .01) and age (β = .15, p ≤ .001) were the only 
significant predictors of Dependence. At this point there were no further statistical 
tests that could be applied to ascertain the validity of the research hypotheses. 
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The chapter begins with a review of the purpose of the study, continues with 
discussion of the study rationale, and then summarizes the findings with respect to the 
main research hypotheses. The chapter also revisits ways in which the current study 
improves upon and refines existing research on drug consumption. The chapter then 
discusses the strengths as well as the limitations of the data noting in particular its 
source, data collection methods, data manipulations, and transformations. The chapter 
concludes by discussing the potential implications of these findings and provides 
recommendations for future research. 
1. Purpose of the Study 
For centuries, philosophers have engaged considerable debate over whether 
man acts in a rational or irrational manner in making certain decisions. For the most 
part, these different views of “thought” have fueled considerable discussion with 
different disciplines weighing in at different times. Among the many disciplines 
investigating human behavior, economists take the view that humans are entirely 
rational and their behavior can therefore be examined through traditional market-
price mechanisms (i.e., invisible hand). The success of this approach has gained 
earnest respect and models have been developed to explain production and 
consumption of goods and services, as well as many other aspects of day-to-day 
economic activity. Interestingly, drug use is one of many activities engaged by 
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humans; however, it has not come under scrutiny by economists until recently. This is 
most likely becau roduct of 
irrational behavior.” 
assume explicitly or implicitly the “ceteris 
onstant) as pure market factors are used to 
account for behavior. T
se most economists would regard drug use as the end p
“
This seeming neglect changed entirely with the publication of the Rational 
Addiction Model (RAM) by Nobel laureate Gary Becker. According to Becker, man 
is purely rational, forward thinking, and seeks to maximize his utility (or satisfaction) 
subject to a budget constraint. In dramatic fashion, Becker then argued this approach 
can be used to account for drug use, which can readily be explained by “market 
factors.” As powerful an argument as this may seem there are considerable issues that 
need to be addressed when behavior is approached from the RAM perspective. One in 
particular is that economists traditionally 
paribus” clause (i.e., hold all other factors c
he idea that one can artificially control important influences 
may present an impoverished view of behavior because in real life there are many 
factors that drive consumption and that go beyond price, opportunity cost, and 
income. In fact, people are dynamic and quite complex, always deliberating about a 
host of factors when making decisions. It is thus overly simplistic to suggest that 
price alone dictates choices over consumption when other “factors” also seem 
relevant. 
Psychology is one of several alternative disciplines that have spent 
considerable time attempting to explain behavior and looking into the role of these 
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 From this brief accounting it should be apparent that 
econom
“other factors.” Some of the more prominent concepts used to explain drug use 
behaviors have included motivation, desire, craving, urges, attitudes, beliefs, and 
affective experiences.
ists and psychologists have two very unique approaches to explain behavior 
and while both seem necessary neither explanation alone is sufficient. After all, drug 
users consume drugs not only because they are cheap, but also because of their own 
desire and interest in the drug and their anticipated effects. It should be apparent then, 
that both arguments provide valid explanations for drug use behavior and should 
perhaps be considered together. The purpose of this study is to assess the theoretical 
importance of combining key factors from economic and psychological theories into 
a model of Ecstasy use and dependence. 
Contribution of this Study --- There are several ways in which the current 
study improved upon previous research. First, as powerful as Becker’s model of drug 
consumption may seem, it has mostly been applied with legal or “licit” substances 
like alcohol and cigarettes. In fact, no extensions of the RAM have ever fully been 
tested with “illicit” drugs. In the present study, the existing RAM was applied to an 
“illicit” substance that may not be bound by the same market factors used to explain 
licit drug use.  
Second, the existing RAM did not consider factors that may influence drug 
consumption from outside the economic domain. Thus only market factors were 
considered as vital predictors of consumption. In the present study, additional 
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nly consumption as a reflection of drug 
behavio
e for the Study
“psychological” measures were included that may enhance the prediction of drug 
consumption. These measures represent key etiological risk mechanisms that have 
been linked with various forms of drug use but are especially important in the 
consumption of Ecstasy. 
Third, the psycho-economic model also incorporated hypothesized “latent 
constructs.”  Reliance on “unobserved” constructs as opposed to measured or 
“manifest” variables attenuate measurement error and improve model precision. The 
latent constructs modeled reflected both predictors and outcomes and enabled a more 
parsimonious test of whether economic measures remained vital predictors of 
consumption when juxtaposed against psychological risk mechanisms. 
Fourth, the RAM considered o
r. However, many drug users experience side effects or consequences from 
their drug use that can influence or regulate their consumption. These subtle relations 
have not been traditionally modeled in economic models of consumption and have 
also been neglected when modeling psychological risk. The present study modeled a 
latent construct of “problems from Ecstasy use” reflecting currently diagnostic 
nosology, termed Dependence, in addition to consumption. 
Rational  --- Any time youth become involved in psychoactive 
drugs there is considerable cause for alarm. Not only are psychoactive drugs illegal, 
they interfere with successful role socialization, impair cognitive functioning, and 
detract from living fully. Illicit drugs are also responsible for neurological problems, 
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n upsurge in use by all ages across the lifespan, but mostly 
among 
that Ecstasy is 
the “lov
lude hyperthermia, jaw 
clenchi
physical harm, and can derail youth from achieving their full potential. For these and 
other reasons concern is raised when new drugs become available and appear 
attractive to youth. One drug in particular that has raised considerable concern is 
Ecstasy, which has seen a
youth. Ecstasy is known for its hallucinogenic properties and for its ability to 
break down interpersonal inhibitions or social barriers. Users of Ecstasy report 
feeling interpersonally close, able to read other people more accurately, and warm to 
sensations and emotional feelings they don’t normally have. Many people use Ecstasy 
to electrify their sexual experiences, hoping the drug will open portals of perception 
during physical contact. This has led several writers to coin the phrase 
e drug.”  
Considerable field work now shows that many young people use Ecstasy in 
combination with other substances while attending raves, all night dances held in 
large open spaces or warehouses where they can experience the constant grind and 
rhythm of music. The effects of the Ecstasy can last several hours. Both laboratory 
and naturalistic studies of Ecstasy users indicate serious medical and psychological 
complications from even limited use. Side effects inc
ng, racing heart and elevated pulse, some cognitive impairment including 
memory loss, and potentially harmful and often irreversible bodily effects. 
Special Features of the Data --- There are several strengths to the data used for 
this research that should be noted. First, the parent NIDA-funded study (CDSLAM) 
  203
 secondary analysis provides a cost-effective opportunity to learn 
more a
Data were 
obtaine
was intended to examine the utility of DSM-IV diagnostic criteria for substance use 
disorders and their extension to club drugs, including Ecstasy use. As a result, 
extensive self-report information was collected that detailed the prevalence and 
patterns of Ecstasy consumption including consequences that arise from use and 
factors that regulate its consumption. Second, participants were extensively probed 
regarding their consumption patterns of not only Ecstasy but other licit and illicit 
drugs. This included their use and the effects of club drugs other than Ecstasy and 
what factors may have prompted their drug involvement. Fourth, participants were 
also asked questions about whether they engage a wide range of other high risk 
behaviors that may relate to drug use. The ability to collect such extensive and rich 
data and conduct
bout drug etiology (and test the psycho-economic model) without expending 
large financial resources to collect the information needed for this study.  
Furthermore, the parent study was conducted by a team of highly respected 
and well qualified researchers, guided by Dr. Linda Cottler and the EPRG group. This 
led to the development of excellent and reliable measures, as well as strict adherence 
to research protocols, minimizing any bias in the data from uncontrolled sources. The 
data was also obtained from areas that had been identified by epidemiological 
surveillance methods with indications of high prevalence for Ecstasy use. 
d from a relatively youthful community sample of drug users (mean of 23 
years), all of whom reported both lifetime use and current (recent) drug use patterns. 
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come). The 
sample
Additionally, the participants were not involved currently with drug treatment and 
they voluntarily consented to provide their information. This makes it more likely 
that the information they provided is a true reflection of what happens to people when 
they are involved in illicit drug use, including Ecstasy, and makes it more likely the 
information they provided would generalize to the larger population of drug users. 
The field methods used to recruit users and retain them in the study is easily 
replicable and familiar to the epidemiology literature. Minimal intrusion was used 
and subjects were compensated for their time and inconvenience. In addition, the 
sample was quite heterogeneous coming from three geographically dispersed sites, 
two located in the US (Miami and St. Louis) and one internationally in Sydney, 
Australia. Using data from such heterogeneous places provides a tremendous 
opportunity to examine cultural influences, along with other demographic features of 
a sample that can influence consumption (i.e., race, education, and in
 was predominantly white but included sufficient representation of racial 
minority groups to adequately sample their behavior. The sample characteristics also 
represented a wide range of age groupings ensuring that drug use was not an artifact 
of youthfulness or trend related. There was equivalent proportion of both sexes 
ensuring that any trends in drug consumption did not merely reflect gender specific 
socialization, which has been a factor contributing to differences in rates of alcohol 
consumption, among other drugs. 
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ce 
these d
ata, the more likely a researcher has specified the 
“true” model. The precision of models can be assessed by a wide range of inferential 
The parent study also included economic, epidemiological, psychological as 
well as psychiatric diagnostic information thus providing a broad assessment of 
factors that may increase or decrease consumption. While individually these 
measures may be parts of other studies it is rare they are collected under the umbrella 
of a single study and with such extensive data collection on the same person. On
ata were obtained several steps were taken to ensure their suitability for the 
proposed multivariate statistical analysis. These preliminary steps included extensive 
checks and data manipulations at the item level. Each item or measure was checked 
for normality using key indicators of central tendency such as skewness and kurtosis. 
In all cases, the variables met the recommended criteria and were deemed suitable for 
analysis. In addition, steps were taken to summarize the large number of variables 
available for analysis into a more manageable set. In most cases, items were unit-
weighted and summarized into composite scores, which were then subject to further 
analysis. When these procedures are used higher composite scores indicate greater 
risk. 
The study also used latent-variable structural equation modeling techniques 
which is considered a gold standard in procedures for theory testing. This is because 
the goal of SEMs is to evaluate the concordance between sample data (variances and 
covariances) and an implied population model. The closer the “fit” between the 
hypothesized model and sample d
  206
model 
included in the model there were observed measures primarily assessing 
econom
fit indices, allowing a researcher to discard poor or “ill” fitting models. Such 
procedures are the backbone of logical positivist themes in science and a major part 
of “falsification” (Popper, 1959). In addition to these considerations, the models also 
contained latent constructs hypothesized based on multiple indicators. Overall, this 
specification provides a wider net to assess behavior (more measures can be included 
in a single model), improves model precision by reducing measurement error, and 
increases statistical power.  
Of the four latent constructs included in the SEM, two (Depression and 
Motivation) were specified as exogenous predictors and two (Ecstasy Use and 
Dependence) were specified as endogenous outcomes. This was in no way meant to 
infer “causation” but rather developed and tested to ascertain “unique” variance 
contributions in a predictive framework. This particular procedure offers another 
refinement on previous research because it requires simultaneous multivariate 
estimation of multiple predictors whose effects are estimated on multiple outcomes. 
Also 
ic market forces and high-risk behaviors and their relations were also 
estimated as unique predictors of the outcome constructs.  
One other refinement in the modeling procedure included testing nested 
models comparing a constrained model with restricted parameters fixed to zero, 
against a less restricted model (with freely estimated parameters). The nested 
comparison for each degree of freedom difference provided a means to ascertain 
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ches into a single comprehensive model. In addition, a 
good d
e predictive contributions 
of bot
whether the restricted model offers a more parsimonious and superior fit. This model 
testing procedure represents a further refinement on prior empirical tests of drug 
etiology, particularly with respect to economic measures and psychological risk as 
predictors of Ecstasy consumption. 
To summarize, while numerous studies have investigated the effects of 
economic measures and separately psychological risk factors on drug use, few have 
combined these two approa
eal of research and empirical inquiry with regard to “rational” economic 
models has emphasized licit drugs (i.e., alcohol and tobacco), where regulatory 
measures like taxation and other measures to encourage production or restrict 
consumption can gain traction. This study extended this inquiry to include an illicit 
drug that has stimulated tremendous public health concern because of its deleterious 
effects but not received the same level of attention. Furthermore, economic models 
specify “consumption” as the sole outcome of interest, but problems from 
consumption may also play an important role determining how much of a drug a 
person consumes. Toward this end, this study included several measures of 
consequences that arise from consumption and modeled th
h economic measures and psychological risk factors in one conceptual 
framework, referred to as the psycho-economic model.  
With regard to the selection of economic measures, prior models have 
included at most income and price, but have not directed much attention to the 
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mpairs other role obligations. To address this, the 
current
from opportunity cost to 
consum
amount of time a person spends finding sources for the drug, a factor that can 
severely affect consumption. By necessity, the actual time spent either searching 
and/or negotiating the purchase of an illicit drug can dampen enthusiasm when this 
commitment of personal resources i
 study included “opportunity cost” as a direct measure of time spent locating 
the drug. Finally, prior research was limited to exploratory statistical modeling 
leaving no way to “confirm” the study findings or test a specific theory. The present 
study relied on confirmatory modeling techniques for both the measurement and 
structural component using SEM technique, and provided a host of inferential fit 
statistics to examine the precision in modeling fit between sample data and an 
implied population model. 
2. Overview of the Study Findings  
The study was guided by three hypotheses. The first hypothesis concerned 
whether economic measures including income, unit price, and opportunity cost would 
directly influence Ecstasy consumption and problems from its consumption (or 
dependence), controlling for psychosocial factors and other control measures. 
Findings showed that only two of the economic measures, unit price and opportunity 
cost, were efficient predictors of consumption. The magnitude of the path from price 
to consumption was slightly larger than the one 
ption. Income was not a determinant factor for Ecstasy use. On the other 
hand, only opportunity cost was a significant predictor of dependence. 
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crease significantly the overall proportion of variance 
et of measures. Finding showed that when 
specifie
The second hypothesis stipulated that psychological measures (e.g., 
motivation) and other intra-individual characteristics (i.e., depression and risk-taking) 
would influence both Ecstasy consumption and dependence, controlling for economic 
factors and other control measures. Findings showed that only motivation for drug 
use significantly influenced consumption and this was the largest effect overall in the 
model. In the part of the model predicting dependence, motivation was once again the 
largest effect overall, however, both depression and sexual risk taking were also 
significant predictor of problems from consumption. 
The third hypothesis stipulated that the combination of adding psychological 
and economic measures into a model of drug consumption will improve the overall fit 
of the model and will in
accounted for by each respective s
d as predictors of consumption, the economic measures accounted for R2 = 
13.5% of the variance. When the psychological measures were specified as predictors 
they accounted for R2 = 15.5% of the variance in consumption. When both sets of 
measures were simultaneously specified they accounted for R2 = 21.6% of the 
variance indicating an increase in predictive variance. Also, when both economic 
measures and psychological risk are posited simultaneously, the regression 
coefficients from each respective domain diminish in size but did not lose their 
significance. In fact, there was an increase in the overall variance explained by each 
set of predictors.  
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tween the different domains of 
influen
hological predictors.  
Overall, the results confirms the proposed psycho-economic model of Ecstasy 
use and dependence to be a valid conceptual representation of the determinants of 
consumption as well as the consequences that may arise from continued drug use. 
Notably, the economic measures were smaller in magnitude compared to the effects 
of psychological risk factors but still retained their overall significance. Of all the 
parameters modeled, motivation accounted for the most variance in the outcomes, 
attesting to the strength of internal psychological states as impetus for drug use and 
dependence. One way to think about the balance be
ce is that while psychological factors might explain the “wanting” or desire to 
use Ecstasy, the economic measures facilitate or make this process possible. This 
study also confirms that, among the economic measures considered, Ecstasy users not 
only pay attention to price but they also pay attention to how much personal resources 
must be expended in order to procure the drug. 
Although not specified as a main research hypothesis the same question 
regarding incremental variance can be posed for dependence. In other words, does the 
addition of psychological risk factors to a model positing only economic measures 
increase the proportion of variance accounted for in problems associated with 
consumption. The results once again reinforce the additive value of having both sets 
of measures in one model. In this respect, the R2 = 11.7% in the model with economic 
predictors of dependence increased to R2 = 41.1% with a model specifying both 
economic and psyc
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There were a number of other findings from the model testing procedures that 
help clarify the etiology of Ecstasy use. These points are broken down into (1) 
findings from the measurement model; (2) findings from the empirical specification 
searches; (3) findings from the bootstrapping; and (4) findings from the model 
including demographics. 
Findings from the Measurement Model --- The results of the measurement 
model showed that the latent constructs were correctly hypothesized and were all 
statistically reliable. The correlations between all four constructs indicated divergent 
validity ensuring there was unique variance associated with each construct. The 
measurement model contained a total of six correlations between the latent 
constructs. Motivation and dependence shared the most variance, attesting to the 
large role played by “psychological impetus” in participant’s continued drug use. 
Next in size was the relation between motivation and consumption. Motivation taps 
into “so
continued use of the drug created certain 
cial milieu” and the various anticipated enhancements from using Ecstasy that 
clearly point toward the social functions of using this drug. Ecstasy has been noted to 
be very popular among young adults who use the drug as part of their attendance at 
all night dance raves. The drug is also reported to increase feelings of interpersonal 
closeness and enhance sexual experience. Thus, it is not surprising that motivation 
and Ecstasy use were moderately related. 
The correlation between Ecstasy use and dependence was somewhat smaller 
in magnitude but still reinforced that 
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problem
s that chronic use of drugs carries certain “risks” and can 
lead to
s. Relations between motivation and depression and likewise between 
depression and Ecstasy use were smaller in magnitude perhaps attesting to the fact 
that mental health problems are not a prominent feature of the “drive” to consume 
this particular drug. The relatively small association between depression and 
dependence also reinforce
 impairment at many levels. The fact is that Ecstasy users reported feeling 
blue, sad, having suppressed appetite, trouble concentrating and feeling lethargic and 
these feelings were associated with tolerance, withdrawal, using more of the drug, not 
being able to cut down, spending a lot of time trying to get the drug, giving up 
activities to be further involved in drug use, and continued use despite problems 
(physical and psychological) from use. It should also be noted that one of the 
criterion for dependence includes continued use despite psychological problems, 
which may reinforce that there is a “self-medication” function even to Ecstasy use. 
Findings from the Empirical Specification Searches --- The final model 
reflects all of the hypothesized paths that support testing the research hypotheses. 
However, hidden in the data are non-standard relations that represent “true” variance 
but were not conceived a priori. To illustrate these relations, consider that the three 
economic measures were hypothesized to influence consumption and problems from 
consumption at a very general level. However, it is also possible that economic 
measures can account for predictive variance in one or more specific features of 
consumption (lifetime vs. recent use). These relations go beyond the factor 
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ut 
not at 
determined variances and capture “specific” relations. Models testing these relations 
were restricted (restricted empirical specification searches) to the economic measures 
and the two outcome latent constructs (a broader search may have uncovered 
relations between psychological risk and consumption that are not theoretically 
defensible).  
Overall six relations were added that “augment” the overall model fit (capture 
meaningful variance that was relegated to the residual matrix). One of these involved 
income and number of pills used in the past 30 days and another involved income and 
lifetime quantity. In all of the other models income was not a significant predictor of 
consumption. However, once a search mechanism was implemented that attempted to 
identify variation beyond factor-determined variance income became integral part to 
the model. This means that available financial resources or budget constraints 
actually do factor into the decision to use drugs (both lifetime and in recent use) b
the general level of consumption as hypothesized (rather at a more specific 
level looking at quantity). This may arise because as stated previously, the loadings 
for the latent construct of consumption pulled toward “recent use.” In other words, 
income serves a form of budgetary constraint limiting overall lifetime consumption 
but conveys less influence with regard to whether a person has used Ecstasy recently. 
On the other hand, how much time a person spends searching for a drug also 
mattered in terms of how many pills they consumed in the past 30 days. Price also 
mattered in terms of lifetime quantity, reinforcing the importance of economic 
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gs from the Bootstrapping
measures in the decision process to consume drugs. Overall, the addition of these few 
modifications improved the fit of the model, adding meaningful variance and 
bringing the model closer to the true population model as indicated by its goodness-
of-fit indices. 
Findin  --- At various points in the modeling 
process
sample
, a few parameters showed indications of switching signs, diminishing in 
sheer magnitude or losing their significance. These examples of suppression are 
likely statistical artifacts of the sample data and suggest some concern for the stability 
of these effects with such a modest sample. The procedure for testing the stability of 
parameters either involves cross-validation or bootstrapping with replicate samples. A 
test of 1,000 replicate samples with 500 randomly drawn cases (with replacement) 
indicated that four of the parameters were unstable. These included the path from 
sexual risk-taking to consumption, income to both outcome constructs, and 
depression to consumption. These paths appear fragile and not likely to represent the 
true population model given they appear as null effects in the bootstrapping 
procedure.  
There are many factors that can contribute to a fragile effect with randomly 
simulated samples. One thought is that these paths indicate activity for a subset of the 
 where this predictive variance represents true behavior (e.g., some 
participants take sexual risks and this is related to consumption). The key features of 
sexual risk included frequency of various forms of sexual activity, age of onset 
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for sexual behavior. For instance, there is evidence that personality 
disposi
s that the drug user reduces both opportunity and monetary cost anyway 
they ca
(younger age coded as greater risk), multiple sex partners, forced sexual contact, 
frequency of condom use, and having sex while under the influence. Providing an 
accurate count of these behaviors only pays limited attention to a host of underlying 
“motivations” 
tion (tendency to engage in deviant or unconventional behaviors) may 
encourage some youth to engage in sexual behaviors and there is evidence that drugs 
impair decision-making and lead to poor judgment, including using sex as a ploy to 
get more drugs. Drugs also have “aphrodisiac effects” and can relax inhibitions, a 
feature of Ecstasy that has been reported in the literature. On top of these suggested 
motivation for Ecstasy use, drug users often associate within a social milieu that 
inculcates liberal values and attitudes, and trading sex for drugs is generally not 
discouraged.  
Given these explanations, an economist also might conjecture that trading sex 
for drugs relaxes certain budget constraints, allowing the individual to generate 
income or its equivalent to build addictive stock. The long and short of a ‘rational’ 
perspective i
n. However strong these relations may be from a theoretical perspective, they 
are not reflective of the overall tenor of the behaviors in the sample. Only a few of the 
participants endorsed these behaviors and when examined from an aggregate 
statistical level, they were not sufficiently strong to represent a stable and consistent 
effect throughout. 
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Findings from the Model including Demographics --- Data were obtained 
from three distinct study sites, each containing unique cultural, ethnic (racial), and 
social influences that may affect consumption practices. Earlier variance 
decomposition analyses had indicated relatively equivalent representation of gender 
at the different sites, ensuring that socialization practices should not play a large role 
in any observed differences in drug consumption practices. However, the Miami site 
had fewer white participants and a much greater proportion of Hispanic participants. 
The St. Louis site, on the other hand had more African-American participants, all of 
which may presage any observed difference in the operation of economic or 
psychological factors. For instance, fewer participants from Sydney were in the lower 
income bracket and more Sydney participants were working full time and fewer were 
unemployed than participants from the US sites. 
ifferences suggest that important site differences may influence 
There were also some significant differences in consumption patterns across 
the three sites. In particular, participants from St. Louis were older when they first 
started using Ecstasy and were much newer to the drug in terms of the gap between 
when they started and last used it (or used more recently). These same individuals 
from St. Louis had lower mean levels of consumption than Miami or Sydney 
participants. Sydney participants had used Ecstasy more recently, were more 
“regular” users, and had higher daily intake of Ecstasy based on quantity and 
frequency indicators. Miami participants had fewer drug use days per month. Overall, 
these and related d
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relation
ucation were confounded by site. In 
other 
s between economic measures and consumption practices that would go 
undetected unless they are examined empirically. 
The conditioned models were tested in stages. This was done in order to 
detect any subtle relations that may be produced by the participants’ gender, age, 
race, education, and location. The assumption here is that higher educated, older, 
males earn more than others. In fact, this might have masked the true effects of 
income and opportunity cost. The model including all control measure with the 
exception of site provided an inferior fit compared to the full model (the CFI went 
from .898 down to .849).  
When site was added to the full set of demographic measures, the model 
slightly improved. However, by all indication it still provided a poorer fit than the full 
model. This perhaps underscores that race and ed
words, Sydney had a disproportionate representation of higher-earning 
participants and white drug users, while the remaining sites had relatively more 
African-American and Hispanic participants earning less. Site is essentially capturing 
the effect of race and education and along with these demographics possibly income.   
A model trimmed of race and education and only including the remaining 
demographic measures (gender and age) and site fit reasonably but showed a slight 
decrement in fit. In fact, there is evidence of confounding indicating conditioning of 
the relations between race, age, education, and consumption. In order to tease these 
apart, a trimmed model was tested with site, gender, and age.  
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symptoms. On the other hand, site 
factore
earch 
behavio
type of model requires 
While there was no evidence that age or gender factor into consumption 
practices, both influenced reporting dependence 
d into consumption but not dependence, indicating that market factors such as 
price and time spent locating drugs (or negotiating their price) may vary 
geographically. It also may reflect subtle differences in the drug “culture” at the 
different sites. These differences were also noted in the mean levels of consumption 
that varied by site, with Sydney participants reporting more consumption and cheaper 
drugs. 
3. Limitations of this Res
  As with any secondary data analysis there are limitations associated with the 
research. The measures used were gathered for the purposes of a different study, 
emphasizing reliability and validity of diagnostic information and there were limited 
measures assessing economic matters. In addition, there was also a limited set of 
measures used to assess psychological risk for drug use, although this was the widest 
set of measures by far. Still, depression is one of several mental health measures that 
could be used to account for drug use; others would include anxiety, antisocial 
r, personality or thought disorders (i.e., psychosis or delusions).  
In addition, the data were cross-sectional, which limits making any causal 
inferences. Inclusion of longitudinal data, where temporal precedence can be 
established, would lead to more precise tests of whether economic measures 
contributed unique predictive variance to consumption. This 
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the con
The specified relation between Dependence and Consumption constructs 
 model construction posited a covariance between 
these tw
esentation is 
overly 
ditions of causation be met by establishing association, temporality, and 
proper statistical controls to rule out spuriousness. A model such as this one would 
include economic measures and psychological functioning at baseline, and then 
repeat the same measures at follow-up. This type of “trend” analysis would provide a 
rigorous means to assess whether any one of the economic measures either 
individually or all of them together predict “future” consumption controlling for 
contemporaneous psychological functioning. 
illustrates this problem well. The
o terms because it is hard to specify whether consumption causes problems or 
conversely that certain problems lead to more consumption. Common sense would 
dictate that using more drugs leads to problems including run-ins with the law, family 
disputes, relationship turmoil with significant others, and so forth. In addition, there 
are medical considerations that may arise from overuse of drugs, and psychological 
problems that can go undetected including depression, anxiety, psychotic thinking, 
and identity disruption (drugs disrupt the acquisition of requisite skills during critical 
stages of development). However, a more careful look shows this repr
simplistic. For instance, it is also possible that by becoming dependent on a 
drug, which includes physiological indicators of tolerance and withdrawal, a drug 
user increases his/her consumption to diminish or forestall these negative 
experiences.  
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two views is that tolerance is part of 
depend
eir predictive validity. For instance, there was clear evidence that the 
Tolerance means taking more of the drug to obtain the same effect or to get 
“high.” Economists generally consider tolerance as the result of prior drug 
consumption or what they term “addictive stock.” In other words, past consumption is 
a predictor of future consumption because the individual builds up a “history” of drug 
use that reinforces and even guides future use. In the current model, tolerance was 
specified as an indicator along with several other “consequences” that are features of 
dependence. The difference between these 
ence, representing a compilation of multiple problems that may stem from 
consumption whereas in the RAM tolerance would have been a predictor of 
consumption. 
Withdrawal, on the other hand, results because the absence of the drug causes 
a physiological (or cellular) response where the body demands more drug. During 
withdrawal, users experience headaches, profuse sweating, they become febrile, 
shake, and lose concentration, to name a few key symptoms. Again, problems that 
arise from continued use serve as the stimulus for more consumption. It would be 
problematic then, to specify these relations as ‘causal’ because more of the drug leads 
to more symptoms and more symptoms generate the need for increased consumption. 
Here, a causal relation is at best tenuous and the better way to represent the relation 
between consumption and dependence it to allow them to freely associate.  
In addition, some of the measures may not be adequate or reliable thus 
diminishing th
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latent 
hat the measure of income needs to be strengthened by additional 
informa
 lowered 
correla
construct of consumption tilted toward “recent” use and diminished the 
importance of “lifetime” use. An economic view would posit that consumption 
should really reflect “addictive stock” and go further back in time to capture the full 
spectrum of use (i.e., lifetime consumption as a measure of cumulative use), rather 
than relying on a more recent window. One way to avoid creating a bifurcated 
construct would be to increase the valence of “recent” use items by splitting the 
construct into two measures, one capturing addictive stock while the other assesses 
more recent use (they may be correlated but not perfectly).  
Income too can fall prey to this situation and limit predictive variance. One 
possibility is t
tion. Future studies may want to include an assessment of family financial 
resources, weekly pay (using pay stubs), a wider network of alternative income 
sources, and information on the precise methods of purchasing drugs, and a 
breakdown of expenses for the individual. This will serve to cast a wider net on the 
measure of social anomie to include accepted measures of poverty (based on Federal 
guidelines) and other indicators that tap feelings of marginalization that can 
accompany low income status. A second important consideration that may have 
limited the role of income is that most of the participants earned relatively the same 
(given their youthful age), which restricted the variance for income and
tions between income and other measures in the model. 
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 wider set of measures 
(precis
tance of the null when 
it is false. The alternative approach sought to establish whether gender and site 
Furthermore, there may be concerns that accompany categorization of 
measures used to form composites. There is some loss of information when a 
continuous measure is categorized, leaving open the possibility that some true and 
meaningful variation is lost. Notwithstanding this concern, dimensional approaches 
were used with four latent constructs. However, additional dimensional assessments 
would improve the overall psychometric properties and the ecological validity of the 
model. As stated previously, one suggested area of refinement would include 
improving the measure of social anomie to encompass a
e quantification of government or family support) that capture a more 
“veridical” picture of young people’s earnings.  
Finally, although the sample size was considered appropriate for obtaining 
proper parameter estimates, it was near impossible to conduct multiple group 
comparisons given the sample would be less than halved in some cases. Doing so, in 
order to compare models by gender or site, would strain the robustness of these 
methods. This is because with increasingly smaller samples there is a corresponding 
increase in the size of standard errors with concomitant greater influence of sampling 
error. This would increase the probability of making a Type I error. In SEM, the 
significance of a parameter estimate is calculated by the ratio of the nonstandard 
parameter divided by its standard error. Larger error terms would reduce the 
likelihood of statistically significant findings and lead to accep
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“condit
ially small, as 
was the
ion” model results and conclude that the model findings are thus moderated by 
important demographic characteristics. 
Although not necessarily a true limitation of the current study, some decisions 
were made in the model testing strategy that may influence the final results. For 
instance, a decision was made to leave non-significant paths in the full model. An 
alternative model testing procedure might drop the paths that did not achieve 
significance and re-estimate the model. One consideration is that the procedure of 
fixing paths to zero does ultimately “bias” the remaining paths, because this approach 
specifies a prior relation as “null.” Offsetting this proposed change to model testing 
procedures is, however, the observation that when these effects are triv
 case with sexual risk taking and income, the resulting bias is typically small 
as well. 
4. Implications of this Research 
The findings from this study underscore the continuing need to better 
understand drug user’s behavior. As stated earlier, drug use and its related 
consequences is complex and multi-faceted. In this study, multiple tests of the 
psycho-economic model were performed to examine whether a model combining key 
elements from economic and psychological theories can sufficiently explain Ecstasy 
consumption and its related problems. 
One important finding of this research was that market indicators (income and 
price) play a crucial role in the decision to consume drugs. For other commodities 
  224
d uniquely on market price mechanisms. In 
fact, in
hat is not only illegal, but also whose continued use produces dependence, 
mand. 
 internal self-regulatory cues all have a larger 
effect o
(licit drugs included), this finding alone would argue strongly for and provide support 
in the formulation of drug policy base
creasing the price of illegal drugs has been considered as an important 
objective of the US drug and law enforcement agency. The logic behind interdiction 
was that reducing illegal-drug supply and providing economic aid to illicit drug 
producing countries would reduce the drug availability on the streets, increase drug 
prices, and therefore discourage consumption. So far however, such a strategy has not 
been very successful. More drugs are available now than ever before and the 
prevalence of use has continued to rise, especially among young adults. Such an 
outcome of a drug policy based uniquely on reducing supply surely proves that 
economic principles may be less relevant than thought. This is particularly true for a 
product t
which translates into an inelastic de
What this study does support is the contention that economic factors do have 
an effect on a drug user’s decision whether or not to purchase a drug. However, 
economic factors are not the only factors that shape this decision. Other factors play a 
role as well. In particular, psychological factors, reflected by the ways people get 
Ecstasy, people from whom they get it, places they go to use drugs (raves, clubs, and 
bars), people they share drugs with, and
n drug consumption than income and prices alone. Combining both economic 
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is strange animal. It was also at that point 
that on
blind friends and said “So, the queer animal is just like that.” He then walked back to 
measures and psychological motivations augments the overall model and accounts for 
a larger proportion of variance than when either set is considered alone. 
5. Conclusions 
Allegories are figurative ways to represent meaning and truth. They take 
shape as literary stories, various forms of artwork including paintings and sculpture, 
and visual symbolic representations that convey something special about life and the 
human perspective. There is an allegory for everything, even scientific research. An 
appropriate allegory for the current study is the three blind men and the elephant 
(Kuo & Kuo, 1976). One day, three blind men sat by the side of a road engaged in 
conversation. As they spoke one blind man said to the others, “I have heard that 
elephants are queer animals.” He went on to add that his blindness prevented him 
from knowing whether this is true. It was then that all three blind men agreed they 
lacked the good fortune to know about th
e of the blind men suggested that just feeling the elephant would satisfy his 
curiosity. 
A merchant happened to be walking by with a herd of elephants and overhead 
their conversation. He offered them a chance to “touch” an elephant and satisfy their 
curiosity. He then helped each one of them to walk over to an elephant and touch it. 
The first blind man reached out and touched the elephant’s left leg and then his right. 
He ran his hands over each leg slowly and then with a beaming face, turned to his 
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ched out and 
hant’s tail and blurted out “truly a queer animal.” He then returned 
and sat
 story of drug abuse is also a matter of perspective. That is, if the story 
teller is
where his friends were seated and joined them. It was the second blind man’s turn 
and he walked to the elephant with the assistance of the merchant. He rea
touched the elep
 beside his friends. 
It was the third blind man’s turn and he walked to the elephant whereupon he 
touched its trunk, swaying back and forth from side to side. He blurted out “That's it! 
I've learned.” Each blind man then graciously thanked the merchant and went on their 
merry way. They were excited to share their new knowledge about the elephant. Soon 
they sat under a tree at which point the second blind man blurted out, “this queer 
animal is like our straw fans swinging back and forth to provide a breeze.” It is, he 
continued “rather wispy in touch and feel.” The first blind man shouted in 
disagreement, “No, no, this queer animal is like two big trees that have no branches.” 
Without hesitating, the third blind man stated, “this queer animal is like a snake, long, 
round, and very strong.” 
The
 economically minded analyst, market factors like income, unit price, and the 
considerable time one spends locating a drug accurately foretell consumption 
practices. However, when the world is viewed through a psychologist’s lenses other 
factors like motivation or the underlying desires that foster drug use appear to matter. 
Clearly, the combination of perspectives provides a better view of the “elephant” and 
allows each of the blind men to see the true animal. 
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